baid,activity,aid,sid,mid,cid,geneid,taxid,pmid,aidtype,aidmdate,hasdrc,rnai,protacxn,acname,acvalue,aidsrcname,aidname,cmpdname,targetname,targeturl,dois,ecs,repacxn
97813720,Active,95037,103166695,0,3660962,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,7.2,ChEMBL,In vitro concentration of compound required to inhibit 50% of Kallikrein,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
97813737,Active,95041,103331346,0,11350400,3818,9606,14711304,Confirmatory,20181017,0,0,P03952,Ki,0.849,ChEMBL,Binding affinity against human plasma kallikrein.,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm0300072,3.4.21.34,P03952
97813738,Active,95041,103331423,0,10432907,3818,9606,14711304,Confirmatory,20181017,0,0,P03952,Ki,3.33,ChEMBL,Binding affinity against human plasma kallikrein.,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm0300072,3.4.21.34,P03952
97813739,Active,95041,103332114,0,11244460,3818,9606,14711304,Confirmatory,20181017,0,0,P03952,Ki,2.43,ChEMBL,Binding affinity against human plasma kallikrein.,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm0300072,3.4.21.34,P03952
97813740,Active,95041,103332407,0,11473486,3818,9606,14711304,Confirmatory,20181017,0,0,P03952,Ki,1.37,ChEMBL,Binding affinity against human plasma kallikrein.,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm0300072,3.4.21.34,P03952
97813741,Active,95041,103331390,0,11188793,3818,9606,14711304,Confirmatory,20181017,0,0,P03952,Ki,1.35,ChEMBL,Binding affinity against human plasma kallikrein.,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm0300072,3.4.21.34,P03952
97813742,Active,95041,103331690,0,11361949,3818,9606,14711304,Confirmatory,20181017,0,0,P03952,Ki,0.4,ChEMBL,Binding affinity against human plasma kallikrein.,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm0300072,3.4.21.34,P03952
97813743,Active,95041,103331913,0,11292119,3818,9606,14711304,Confirmatory,20181017,0,0,P03952,Ki,0.23,ChEMBL,Binding affinity against human plasma kallikrein.,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm0300072,3.4.21.34,P03952
97813744,Active,95041,103331915,0,447735,3818,9606,14711304,Confirmatory,20181017,0,0,P03952,Ki,0.436,ChEMBL,Binding affinity against human plasma kallikrein.,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm0300072,3.4.21.34,P03952
97813745,Active,95041,103331972,0,11149953,3818,9606,14711304,Confirmatory,20181017,0,0,P03952,Ki,8,ChEMBL,Binding affinity against human plasma kallikrein.,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm0300072,3.4.21.34,P03952
97813746,Active,95041,103332106,0,447733,3818,9606,14711304,Confirmatory,20181017,0,0,P03952,Ki,7.17,ChEMBL,Binding affinity against human plasma kallikrein.,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm0300072,3.4.21.34,P03952
97813747,Active,95041,103332115,0,11347670,3818,9606,14711304,Confirmatory,20181017,0,0,P03952,Ki,18.1,ChEMBL,Binding affinity against human plasma kallikrein.,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm0300072,3.4.21.34,P03952
97813748,Active,95041,103332474,0,447734,3818,9606,14711304,Confirmatory,20181017,0,0,P03952,Ki,2.72,ChEMBL,Binding affinity against human plasma kallikrein.,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm0300072,3.4.21.34,P03952
97813749,Active,95041,103331424,0,11774107,3818,9606,14711304,Confirmatory,20181017,0,0,P03952,Ki,4.3,ChEMBL,Binding affinity against human plasma kallikrein.,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm0300072,3.4.21.34,P03952
97813750,Active,95041,103322244,0,447732,3818,9606,14711304,Confirmatory,20181017,0,0,P03952,Ki,2.5,ChEMBL,Binding affinity against human plasma kallikrein.,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm0300072,3.4.21.34,P03952
97813751,Active,95041,103322509,0,193409,3818,9606,14711304,Confirmatory,20181017,0,0,P03952,Ki,22.5,ChEMBL,Binding affinity against human plasma kallikrein.,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm0300072,3.4.21.34,P03952
97813752,Active,95041,103332069,0,11186243,3818,9606,14711304,Confirmatory,20181017,0,0,P03952,Ki,2.57,ChEMBL,Binding affinity against human plasma kallikrein.,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm0300072,3.4.21.34,P03952
97813753,Active,95041,103332070,0,9799627,3818,9606,14711304,Confirmatory,20181017,0,0,P03952,Ki,0.145,ChEMBL,Binding affinity against human plasma kallikrein.,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm0300072,3.4.21.34,P03952
97813754,Active,95041,103332071,0,11739438,3818,9606,14711304,Confirmatory,20181017,0,0,P03952,Ki,0.112,ChEMBL,Binding affinity against human plasma kallikrein.,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm0300072,3.4.21.34,P03952
97813756,Active,95042,103323765,0,10696955,3818,9606,9301673,Confirmatory,20181015,0,0,P03952,Ki,15,ChEMBL,Inhibitory activity against Kallikrein (PK),NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm960668h,3.4.21.34,P03952
97813757,Active,95042,103323768,0,10624997,3818,9606,9301673,Confirmatory,20181015,0,0,P03952,Ki,3.3,ChEMBL,Inhibitory activity against Kallikrein (PK),NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm960668h,3.4.21.34,P03952
97813758,Active,95042,103323811,0,10578280,3818,9606,9301673,Confirmatory,20181015,0,0,P03952,Ki,7.3,ChEMBL,Inhibitory activity against Kallikrein (PK),NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm960668h,3.4.21.34,P03952
97813759,Active,95042,103323592,0,44335601,3818,9606,9301673,Confirmatory,20181015,0,0,P03952,Ki,22,ChEMBL,Inhibitory activity against Kallikrein (PK),NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm960668h,3.4.21.34,P03952
97813760,Active,95042,103323651,0,10815545,3818,9606,9301673,Confirmatory,20181015,0,0,P03952,Ki,27,ChEMBL,Inhibitory activity against Kallikrein (PK),NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm960668h,3.4.21.34,P03952
97813766,Active,95038,103166672,0,44265055,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,12,ChEMBL,In vitro concentration of compound required to inhibit 50% of kallikrein,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
97813775,Active,95045,103217580,0,10367012,3818,9606,9171866,Confirmatory,20181015,0,0,P03952,Ki,5,ChEMBL,Inhibitory activity against human serine protease (plasma Kallikrein) (89000*),NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm970140s,3.4.21.34,P03952
97813784,Active,95043,103323627,0,10648370,3818,9606,9301673,Confirmatory,20181015,0,0,P03952,Ki,35,ChEMBL,Inhibitory activity against plasma kallikrein (PK.),NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm960668h,3.4.21.34,P03952
97814616,Active,95170,174505792,0,10253001,3818,9606,8478905,Confirmatory,20181014,0,0,P03952,IC50,28,ChEMBL,Inhibition of kallikrein with benzoyl-L-arginine ethyl ester as substrate,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm00060a016,3.4.21.34,P03952
97814617,Active,95170,174495383,0,10411941,3818,9606,8478905,Confirmatory,20181014,0,0,P03952,IC50,16,ChEMBL,Inhibition of kallikrein with benzoyl-L-arginine ethyl ester as substrate,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm00060a016,3.4.21.34,P03952
97814620,Active,95170,174490346,0,10050676,3818,9606,8478905,Confirmatory,20181014,0,0,P03952,IC50,25,ChEMBL,Inhibition of kallikrein with benzoyl-L-arginine ethyl ester as substrate,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm00060a016,3.4.21.34,P03952
97814622,Active,95170,174516097,0,11754749,3818,9606,8478905,Confirmatory,20181014,0,0,P03952,IC50,26,ChEMBL,Inhibition of kallikrein with benzoyl-L-arginine ethyl ester as substrate,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm00060a016,3.4.21.34,P03952
97814624,Active,95170,174521177,0,10386993,3818,9606,8478905,Confirmatory,20181014,0,0,P03952,IC50,16,ChEMBL,Inhibition of kallikrein with benzoyl-L-arginine ethyl ester as substrate,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm00060a016,3.4.21.34,P03952
97814627,Active,95170,174521178,0,10024676,3818,9606,8478905,Confirmatory,20181014,0,0,P03952,IC50,19,ChEMBL,Inhibition of kallikrein with benzoyl-L-arginine ethyl ester as substrate,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm00060a016,3.4.21.34,P03952
97814628,Active,95170,174500609,0,10365153,3818,9606,8478905,Confirmatory,20181014,0,0,P03952,IC50,35,ChEMBL,Inhibition of kallikrein with benzoyl-L-arginine ethyl ester as substrate,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm00060a016,3.4.21.34,P03952
97814629,Active,95170,174500611,0,9981709,3818,9606,8478905,Confirmatory,20181014,0,0,P03952,IC50,41,ChEMBL,Inhibition of kallikrein with benzoyl-L-arginine ethyl ester as substrate,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm00060a016,3.4.21.34,P03952
97814630,Active,95170,242084562,0,72429,3818,9606,8478905,Confirmatory,20181014,0,0,P03952,IC50,40,ChEMBL,Inhibition of kallikrein with benzoyl-L-arginine ethyl ester as substrate,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm00060a016,3.4.21.34,P03952
97814667,Active,95172,103435480,0,18727836,3818,9606,15013007,Confirmatory,20181001,0,0,P03952,IC50,0.3,ChEMBL,Inhibitory activity against kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2003.11.080,3.4.21.34,P03952
97814669,Active,95172,103436127,0,44385998,3818,9606,15013007,Confirmatory,20181001,0,0,P03952,IC50,0.79,ChEMBL,Inhibitory activity against kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2003.11.080,3.4.21.34,P03952
97814671,Active,95172,103437304,0,9959749,3818,9606,15013007,Confirmatory,20181001,0,0,P03952,IC50,0.13,ChEMBL,Inhibitory activity against kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2003.11.080,3.4.21.34,P03952
97814673,Active,95172,103435344,0,44385679,3818,9606,15013007,Confirmatory,20181001,0,0,P03952,IC50,0.21,ChEMBL,Inhibitory activity against kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2003.11.080,3.4.21.34,P03952
97814676,Active,95172,103435463,0,44385729,3818,9606,15013007,Confirmatory,20181001,0,0,P03952,IC50,0.64,ChEMBL,Inhibitory activity against kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2003.11.080,3.4.21.34,P03952
97814677,Active,95172,103438033,0,44386934,3818,9606,15013007,Confirmatory,20181001,0,0,P03952,IC50,0.5,ChEMBL,Inhibitory activity against kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2003.11.080,3.4.21.34,P03952
97814680,Active,95172,103435965,0,44385935,3818,9606,15013007,Confirmatory,20181001,0,0,P03952,IC50,0.5,ChEMBL,Inhibitory activity against kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2003.11.080,3.4.21.34,P03952
97814684,Active,95172,103436267,0,44386059,3818,9606,15013007,Confirmatory,20181001,0,0,P03952,IC50,0.38,ChEMBL,Inhibitory activity against kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2003.11.080,3.4.21.34,P03952
97814686,Active,95172,103437278,0,10480463,3818,9606,15013007,Confirmatory,20181001,0,0,P03952,IC50,0.56,ChEMBL,Inhibitory activity against kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2003.11.080,3.4.21.34,P03952
97814767,Active,95200,103760890,0,44333955,3818,9606,10091673,Confirmatory,20180909,0,0,P03952,Ki,0.028,ChEMBL,Inhibitory activity of compound against human plasma Kallikrein (PK),NULL,Plasma kallikrein (human),/gene/3818,10.1016/s0960-894x(98)00562-9,3.4.21.34,P03952
97814769,Active,95200,103760899,0,44334160,3818,9606,10091673,Confirmatory,20180909,0,0,P03952,Ki,0.002,ChEMBL,Inhibitory activity of compound against human plasma Kallikrein (PK),NULL,Plasma kallikrein (human),/gene/3818,10.1016/s0960-894x(98)00562-9,3.4.21.34,P03952
97814771,Active,95200,103760889,0,44333945,3818,9606,10091673,Confirmatory,20180909,0,0,P03952,Ki,15.5,ChEMBL,Inhibitory activity of compound against human plasma Kallikrein (PK),NULL,Plasma kallikrein (human),/gene/3818,10.1016/s0960-894x(98)00562-9,3.4.21.34,P03952
97814773,Active,95200,103760891,0,44333957,3818,9606,10091673,Confirmatory,20180909,0,0,P03952,Ki,0.5,ChEMBL,Inhibitory activity of compound against human plasma Kallikrein (PK),NULL,Plasma kallikrein (human),/gene/3818,10.1016/s0960-894x(98)00562-9,3.4.21.34,P03952
97814774,Active,95200,103760893,0,44333986,3818,9606,10091673,Confirmatory,20180909,0,0,P03952,Ki,0.004,ChEMBL,Inhibitory activity of compound against human plasma Kallikrein (PK),NULL,Plasma kallikrein (human),/gene/3818,10.1016/s0960-894x(98)00562-9,3.4.21.34,P03952
97814775,Active,95200,103760894,0,44333999,3818,9606,10091673,Confirmatory,20180909,0,0,P03952,Ki,0.089,ChEMBL,Inhibitory activity of compound against human plasma Kallikrein (PK),NULL,Plasma kallikrein (human),/gene/3818,10.1016/s0960-894x(98)00562-9,3.4.21.34,P03952
97814776,Active,95200,103760895,0,44334001,3818,9606,10091673,Confirmatory,20180909,0,0,P03952,Ki,0.005,ChEMBL,Inhibitory activity of compound against human plasma Kallikrein (PK),NULL,Plasma kallikrein (human),/gene/3818,10.1016/s0960-894x(98)00562-9,3.4.21.34,P03952
97814777,Active,95201,103678411,0,9937921,3818,9606,14640539,Confirmatory,20181017,0,0,P03952,Ki,0.061,ChEMBL,Tested in vitro for inhibition of human plasma Kallikriene,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm030212h,3.4.21.34,P03952
97814778,Active,95202,103396000,0,9915041,3818,9606,14640539,Confirmatory,20181017,0,0,P03952,Ki,0.058,ChEMBL,Tested in vitro for inhibition of human plasma Kallikriene,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm030212h,3.4.21.34,P03952
98205476,Active,160001,103371351,0,10095093,3818,9606,9784099,Confirmatory,20181016,0,0,P03952,Ki,19,ChEMBL,Inhibitory activity against plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm980227t,3.4.21.34,P03952
98205477,Active,160001,103371353,0,10767421,3818,9606,9784099,Confirmatory,20181016,0,0,P03952,Ki,29,ChEMBL,Inhibitory activity against plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm980227t,3.4.21.34,P03952
98205478,Active,160001,103371354,0,10648196,3818,9606,9784099,Confirmatory,20181016,0,0,P03952,Ki,7.6,ChEMBL,Inhibitory activity against plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm980227t,3.4.21.34,P03952
98205479,Active,160001,103371652,0,10718240,3818,9606,9784099,Confirmatory,20181016,0,0,P03952,Ki,36,ChEMBL,Inhibitory activity against plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm980227t,3.4.21.34,P03952
98205480,Active,160001,103371398,0,10695159,3818,9606,9784099,Confirmatory,20181016,0,0,P03952,Ki,18,ChEMBL,Inhibitory activity against plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm980227t,3.4.21.34,P03952
98205481,Active,160001,103371400,0,10435038,3818,9606,9784099,Confirmatory,20181016,0,0,P03952,Ki,8.6,ChEMBL,Inhibitory activity against plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm980227t,3.4.21.34,P03952
98205482,Active,160001,103371426,0,11798089,3818,9606,9784099,Confirmatory,20181016,0,0,P03952,Ki,14,ChEMBL,Inhibitory activity against plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm980227t,3.4.21.34,P03952
98205483,Active,160001,103371254,0,10624948,3818,9606,9784099,Confirmatory,20181016,0,0,P03952,Ki,12,ChEMBL,Inhibitory activity against plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm980227t,3.4.21.34,P03952
98205486,Active,160003,104234376,0,108040,3818,9606,10669559,Confirmatory,20181016,0,0,P03952,Ki,0.57,ChEMBL,Binding affinity against plasma kallikrein.,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm990412m,3.4.21.34,P03952
98205503,Active,160000,103678411,0,9937921,3818,9606,11170646,Confirmatory,20181017,0,0,P03952,Ki,0.061,ChEMBL,In vitro activity against human Plasma kallikrein.,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm000409z,3.4.21.34,P03952
98205522,Active,159999,103326834,0,9895193,3818,9606,10560742,Confirmatory,20180909,0,0,P03952,Ki,7.2,ChEMBL,Compound was tested for inhibition of plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/s0960-894x(99)00541-7,3.4.21.34,P03952
98606010,Active,223797,103357868,0,9884570,3818,9606,11689072,Confirmatory,20181017,0,0,P03952,Ki,0.11,ChEMBL,The compound was tested for inhibition of human p-kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm010244+,3.4.21.34,P03952
98606011,Active,223797,103305289,0,447476,3818,9606,11689072,Confirmatory,20181017,0,0,P03952,Ki,0.0019,ChEMBL,The compound was tested for inhibition of human p-kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm010244+,3.4.21.34,P03952
98606012,Active,223797,103357765,0,445844,3818,9606,11689072,Confirmatory,20181017,0,0,P03952,Ki,0.8,ChEMBL,The compound was tested for inhibition of human p-kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm010244+,3.4.21.34,P03952
98606013,Active,223797,103357766,0,135450980,3818,9606,11689072,Confirmatory,20181017,0,0,P03952,Ki,1.3,ChEMBL,The compound was tested for inhibition of human p-kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm010244+,3.4.21.34,P03952
98606014,Active,223797,103357800,0,11824584,3818,9606,11689072,Confirmatory,20181017,0,0,P03952,Ki,1.3,ChEMBL,The compound was tested for inhibition of human p-kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm010244+,3.4.21.34,P03952
98606015,Active,223797,103357815,0,10871563,3818,9606,11689072,Confirmatory,20181017,0,0,P03952,Ki,4.8,ChEMBL,The compound was tested for inhibition of human p-kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm010244+,3.4.21.34,P03952
98606016,Active,223797,103357867,0,10959252,3818,9606,11689072,Confirmatory,20181017,0,0,P03952,Ki,0.6,ChEMBL,The compound was tested for inhibition of human p-kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm010244+,3.4.21.34,P03952
98934754,Active,263035,103482742,0,135530536,3818,9606,16413183,Confirmatory,20181020,0,0,P03952,Ki,0.013,ChEMBL,Binding affinity to plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2005.12.060,3.4.21.34,P03952
98934755,Active,263035,103482703,0,135530568,3818,9606,16413183,Confirmatory,20181020,0,0,P03952,Ki,0.006,ChEMBL,Binding affinity to plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2005.12.060,3.4.21.34,P03952
98934756,Active,263035,103482759,0,135532848,3818,9606,16413183,Confirmatory,20181020,0,0,P03952,Ki,0.004,ChEMBL,Binding affinity to plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2005.12.060,3.4.21.34,P03952
98934757,Active,263035,103483007,0,135559111,3818,9606,16413183,Confirmatory,20181020,0,0,P03952,Ki,0.003,ChEMBL,Binding affinity to plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2005.12.060,3.4.21.34,P03952
98934760,Active,263035,103483057,0,135559104,3818,9606,16413183,Confirmatory,20181020,0,0,P03952,Ki,0.008,ChEMBL,Binding affinity to plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2005.12.060,3.4.21.34,P03952
98934761,Active,263035,103483124,0,135532851,3818,9606,16413183,Confirmatory,20181020,0,0,P03952,Ki,0.003,ChEMBL,Binding affinity to plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2005.12.060,3.4.21.34,P03952
98934763,Active,263035,103483341,0,135453491,3818,9606,16413183,Confirmatory,20181020,0,0,P03952,Ki,0.012,ChEMBL,Binding affinity to plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2005.12.060,3.4.21.34,P03952
98934770,Active,263035,103485266,0,136094796,3818,9606,16413183,Confirmatory,20181020,0,0,P03952,Ki,0.005,ChEMBL,Binding affinity to plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2005.12.060,3.4.21.34,P03952
98934775,Active,263035,103482848,0,135532849,3818,9606,16413183,Confirmatory,20181020,0,0,P03952,Ki,0.006,ChEMBL,Binding affinity to plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2005.12.060,3.4.21.34,P03952
98934782,Active,263035,103482898,0,135559125,3818,9606,16413183,Confirmatory,20181020,0,0,P03952,Ki,0.037,ChEMBL,Binding affinity to plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2005.12.060,3.4.21.34,P03952
98934783,Active,263035,103483083,0,135543006,3818,9606,16413183,Confirmatory,20181020,0,0,P03952,Ki,0.01,ChEMBL,Binding affinity to plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2005.12.060,3.4.21.34,P03952
98934784,Active,263035,103483269,0,135559128,3818,9606,16413183,Confirmatory,20181020,0,0,P03952,Ki,0.065,ChEMBL,Binding affinity to plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2005.12.060,3.4.21.34,P03952
98934785,Active,263035,103485471,0,135532896,3818,9606,16413183,Confirmatory,20181020,0,0,P03952,Ki,0.0005,ChEMBL,Binding affinity to plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2005.12.060,3.4.21.34,P03952
98934786,Active,263035,103482713,0,135559116,3818,9606,16413183,Confirmatory,20181020,0,0,P03952,Ki,0.006,ChEMBL,Binding affinity to plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2005.12.060,3.4.21.34,P03952
98934787,Active,263035,103482897,0,135559124,3818,9606,16413183,Confirmatory,20181020,0,0,P03952,Ki,0.018,ChEMBL,Binding affinity to plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2005.12.060,3.4.21.34,P03952
98934788,Active,263035,103483347,0,135559129,3818,9606,16413183,Confirmatory,20181020,0,0,P03952,Ki,0.027,ChEMBL,Binding affinity to plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2005.12.060,3.4.21.34,P03952
98974540,Active,267659,103490740,0,15984063,3818,9606,16644215,Confirmatory,20181020,0,0,P03952,Ki,43,ChEMBL,Inhibition of kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2006.04.013,3.4.21.34,P03952
98990501,Active,269402,103490740,0,15984063,3818,9606,16725321,Confirmatory,20181020,0,0,P03952,Ki,43,ChEMBL,Binding affinity to kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2006.04.088,3.4.21.34,P03952
98991617,Active,269508,103496594,0,2264784,3818,9606,16913712,Confirmatory,20181020,0,0,P03952,IC50,5.5,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm0605132,3.4.21.34,P03952
98991619,Active,269508,103496628,0,5876194,3818,9606,16913712,Confirmatory,20181020,0,0,P03952,IC50,13.5,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm0605132,3.4.21.34,P03952
98991623,Active,269508,103496435,0,44415075,3818,9606,16913712,Confirmatory,20181020,0,0,P03952,IC50,46.2,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm0605132,3.4.21.34,P03952
98991624,Active,269508,103496436,0,668744,3818,9606,16913712,Confirmatory,20181020,0,0,P03952,IC50,30.1,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm0605132,3.4.21.34,P03952
98991625,Active,269508,103496437,0,1201257,3818,9606,16913712,Confirmatory,20181020,0,0,P03952,IC50,31.7,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm0605132,3.4.21.34,P03952
98991627,Active,269508,103496899,0,5039074,3818,9606,16913712,Confirmatory,20181020,0,0,P03952,IC50,35.4,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm0605132,3.4.21.34,P03952
98991628,Active,269508,103496409,0,1011274,3818,9606,16913712,Confirmatory,20181020,0,0,P03952,IC50,28.1,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm0605132,3.4.21.34,P03952
99033230,Active,274845,103503902,0,16098910,3818,9606,17181160,Confirmatory,20181021,0,0,P03952,IC50,0.01,ChEMBL,Inhibition of plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm060978s,3.4.21.34,P03952
99143192,Active,290967,103437192,0,3400921,3818,9606,17536795,Confirmatory,20181021,0,0,P03952,Ki,0.037,ChEMBL,Inhibition of human kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm070125f,3.4.21.34,P03952
99143193,Active,290967,103520563,0,16731825,3818,9606,17536795,Confirmatory,20181021,0,0,P03952,Ki,1,ChEMBL,Inhibition of human kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm070125f,3.4.21.34,P03952
99143194,Active,290967,103520606,0,18376720,3818,9606,17536795,Confirmatory,20181021,0,0,P03952,Ki,0.045,ChEMBL,Inhibition of human kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm070125f,3.4.21.34,P03952
99206047,Active,298251,103527802,0,674652,3818,9606,17850059,Confirmatory,20181022,0,0,P03952,IC50,6.6,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm070600+,3.4.21.34,P03952
99206050,Active,298251,103527809,0,674628,3818,9606,17850059,Confirmatory,20181022,0,0,P03952,IC50,5.7,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm070600+,3.4.21.34,P03952
99206051,Active,298251,103527818,0,899247,3818,9606,17850059,Confirmatory,20181022,0,0,P03952,IC50,42.2,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm070600+,3.4.21.34,P03952
99206054,Active,298251,103527820,0,699665,3818,9606,17850059,Confirmatory,20181022,0,0,P03952,IC50,6.1,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm070600+,3.4.21.34,P03952
99206056,Active,298251,103527803,0,674593,3818,9606,17850059,Confirmatory,20181022,0,0,P03952,IC50,11.9,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm070600+,3.4.21.34,P03952
99206059,Active,298251,103527808,0,674656,3818,9606,17850059,Confirmatory,20181022,0,0,P03952,IC50,6.2,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm070600+,3.4.21.34,P03952
99206060,Active,298251,103527810,0,674629,3818,9606,17850059,Confirmatory,20181022,0,0,P03952,IC50,4.4,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm070600+,3.4.21.34,P03952
99206067,Active,298251,103527804,0,674632,3818,9606,17850059,Confirmatory,20181022,0,0,P03952,IC50,11.3,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm070600+,3.4.21.34,P03952
99206068,Active,298251,103527807,0,716930,3818,9606,17850059,Confirmatory,20181022,0,0,P03952,IC50,12.3,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm070600+,3.4.21.34,P03952
99206069,Active,298251,103527821,0,700133,3818,9606,17850059,Confirmatory,20181022,0,0,P03952,IC50,18.8,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm070600+,3.4.21.34,P03952
99217736,Active,299808,103535540,0,11237163,3818,9606,17588746,Confirmatory,20181022,0,0,P03952,Ki,8.458,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2007.06.029,3.4.21.34,P03952
99278690,Active,307344,103546624,0,10343728,3818,9606,17420122,Confirmatory,20181022,0,0,P03952,IC50,25.1,ChEMBL,Inhibition of kallikrein by fluorogenic assay,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2007.03.080,3.4.21.34,P03952
99278691,Active,307344,103546625,0,10095865,3818,9606,17420122,Confirmatory,20181022,0,0,P03952,IC50,5.01,ChEMBL,Inhibition of kallikrein by fluorogenic assay,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2007.03.080,3.4.21.34,P03952
99278693,Active,307344,103509617,0,9911502,3818,9606,17420122,Confirmatory,20181022,0,0,P03952,IC50,15.8,ChEMBL,Inhibition of kallikrein by fluorogenic assay,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2007.03.080,3.4.21.34,P03952
99326345,Active,313685,103560025,0,10275412,3818,9606,18054227,Confirmatory,20181022,0,0,P03952,Ki,8.9,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2007.11.040,3.4.21.34,P03952
99351590,Active,317186,103567312,0,10117027,3818,9606,18077174,Confirmatory,20181023,0,0,P03952,Ki,3,ChEMBL,Inhibition of human kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmc.2007.11.073,3.4.21.34,P03952
99378768,Active,321206,103571989,0,44453827,3818,9606,18053726,Confirmatory,20181023,0,0,P03952,IC50,0.013,ChEMBL,Inhibition of kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmc.2007.11.015,3.4.21.34,P03952
99378774,Active,321206,103572030,0,9939021,3818,9606,18053726,Confirmatory,20181023,0,0,P03952,IC50,0.12,ChEMBL,Inhibition of kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmc.2007.11.015,3.4.21.34,P03952
99378778,Active,321206,103571944,0,9916876,3818,9606,18053726,Confirmatory,20181023,0,0,P03952,IC50,0.014,ChEMBL,Inhibition of kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmc.2007.11.015,3.4.21.34,P03952
99378779,Active,321206,103571993,0,9917846,3818,9606,18053726,Confirmatory,20181023,0,0,P03952,IC50,0.029,ChEMBL,Inhibition of kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmc.2007.11.015,3.4.21.34,P03952
99378780,Active,321206,103503902,0,16098910,3818,9606,18053726,Confirmatory,20181023,0,0,P03952,IC50,0.01,ChEMBL,Inhibition of kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmc.2007.11.015,3.4.21.34,P03952
99385620,Active,322204,103567445,0,10391715,3818,9606,18164204,Confirmatory,20181023,0,0,P03952,Ki,14,ChEMBL,Inhibition of human kallikrein after 30 mins,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmc.2007.12.024,3.4.21.34,P03952
99821582,Active,404327,103620967,0,10456438,3818,9606,18459730,Confirmatory,20181025,0,0,P03952,IC50,0.031,ChEMBL,Inhibition of human kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm8002697,3.4.21.34,P03952
103178171,Active,448904,103704733,0,44255320,3818,9606,19715320,Confirmatory,20180911,0,0,P03952,IC50,10,ChEMBL,Inhibition of plasma kallikrein after 10 to 15 mins by fluorescence assay,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm9009394,3.4.21.34,P03952
204829757,Active,479774,103754281,0,11641515,3818,9606,20355714,Confirmatory,20180913,0,0,P03952,IC50,12,ChEMBL,Inhibition of human kallikrein after 10 mins by chromogenic assay,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm901699j,3.4.21.34,P03952
247270714,Active,507741,164144574,0,52944358,3818,9606,19483697,Confirmatory,20180914,0,0,P03952,IC50,0.0391,ChEMBL,Inhibition of human plasma kallikrein using Z-Phe-Arg-AMC substrate after 30 mins by spectrophotometric assay,NULL,Plasma kallikrein (human),/gene/3818,10.1038/nchembio.184,3.4.21.34,P03952
247270717,Active,507741,123089987,0,52944043,3818,9606,19483697,Confirmatory,20180914,0,0,P03952,IC50,2,ChEMBL,Inhibition of human plasma kallikrein using Z-Phe-Arg-AMC substrate after 30 mins by spectrophotometric assay,NULL,Plasma kallikrein (human),/gene/3818,10.1038/nchembio.184,3.4.21.34,P03952
247270731,Active,507741,174489454,0,52946795,3818,9606,19483697,Confirmatory,20180914,0,0,P03952,IC50,1.5,ChEMBL,Inhibition of human plasma kallikrein using Z-Phe-Arg-AMC substrate after 30 mins by spectrophotometric assay,NULL,Plasma kallikrein (human),/gene/3818,10.1038/nchembio.184,3.4.21.34,P03952
247270734,Active,507741,123095133,0,52946819,3818,9606,19483697,Confirmatory,20180914,0,0,P03952,IC50,5.707,ChEMBL,Inhibition of human plasma kallikrein using Z-Phe-Arg-AMC substrate after 30 mins by spectrophotometric assay,NULL,Plasma kallikrein (human),/gene/3818,10.1038/nchembio.184,3.4.21.34,P03952
247270739,Active,507741,164133363,0,71717265,3818,9606,19483697,Confirmatory,20180914,0,0,P03952,IC50,0.03,ChEMBL,Inhibition of human plasma kallikrein using Z-Phe-Arg-AMC substrate after 30 mins by spectrophotometric assay,NULL,Plasma kallikrein (human),/gene/3818,10.1038/nchembio.184,3.4.21.34,P03952
247270747,Active,507741,164133359,0,71717264,3818,9606,19483697,Confirmatory,20180914,0,0,P03952,IC50,0.0286,ChEMBL,Inhibition of human plasma kallikrein using Z-Phe-Arg-AMC substrate after 30 mins by spectrophotometric assay,NULL,Plasma kallikrein (human),/gene/3818,10.1038/nchembio.184,3.4.21.34,P03952
247270748,Active,507741,164144573,0,71719710,3818,9606,19483697,Confirmatory,20180914,0,0,P03952,IC50,0.0212,ChEMBL,Inhibition of human plasma kallikrein using Z-Phe-Arg-AMC substrate after 30 mins by spectrophotometric assay,NULL,Plasma kallikrein (human),/gene/3818,10.1038/nchembio.184,3.4.21.34,P03952
247270753,Active,507741,164147357,0,71720319,3818,9606,19483697,Confirmatory,20180914,0,0,P03952,IC50,1.8,ChEMBL,Inhibition of human plasma kallikrein using Z-Phe-Arg-AMC substrate after 30 mins by spectrophotometric assay,NULL,Plasma kallikrein (human),/gene/3818,10.1038/nchembio.184,3.4.21.34,P03952
247270754,Active,507741,164127699,0,71716064,3818,9606,19483697,Confirmatory,20180914,0,0,P03952,IC50,0.03,ChEMBL,Inhibition of human plasma kallikrein using Z-Phe-Arg-AMC substrate after 30 mins by spectrophotometric assay,NULL,Plasma kallikrein (human),/gene/3818,10.1038/nchembio.184,3.4.21.34,P03952
247270755,Active,507741,164127698,0,71716063,3818,9606,19483697,Confirmatory,20180914,0,0,P03952,IC50,0.02,ChEMBL,Inhibition of human plasma kallikrein using Z-Phe-Arg-AMC substrate after 30 mins by spectrophotometric assay,NULL,Plasma kallikrein (human),/gene/3818,10.1038/nchembio.184,3.4.21.34,P03952
247270756,Active,507741,164127700,0,71716065,3818,9606,19483697,Confirmatory,20180914,0,0,P03952,IC50,0.05,ChEMBL,Inhibition of human plasma kallikrein using Z-Phe-Arg-AMC substrate after 30 mins by spectrophotometric assay,NULL,Plasma kallikrein (human),/gene/3818,10.1038/nchembio.184,3.4.21.34,P03952
247270757,Active,507741,164141781,0,71719101,3818,9606,19483697,Confirmatory,20180914,0,0,P03952,IC50,0.8,ChEMBL,Inhibition of human plasma kallikrein using Z-Phe-Arg-AMC substrate after 30 mins by spectrophotometric assay,NULL,Plasma kallikrein (human),/gene/3818,10.1038/nchembio.184,3.4.21.34,P03952
247270758,Active,507741,174484853,0,73345352,3818,9606,19483697,Confirmatory,20180914,0,0,P03952,IC50,7.181,ChEMBL,Inhibition of human plasma kallikrein using Z-Phe-Arg-AMC substrate after 30 mins by spectrophotometric assay,NULL,Plasma kallikrein (human),/gene/3818,10.1038/nchembio.184,3.4.21.34,P03952
247270759,Active,507741,164133362,0,52943174,3818,9606,19483697,Confirmatory,20180914,0,0,P03952,IC50,0.0017,ChEMBL,Inhibition of human plasma kallikrein using Z-Phe-Arg-AMC substrate after 30 mins by spectrophotometric assay,NULL,Plasma kallikrein (human),/gene/3818,10.1038/nchembio.184,3.4.21.34,P03952
247270760,Active,507741,123088140,0,52943154,3818,9606,19483697,Confirmatory,20180914,0,0,P03952,IC50,0.033,ChEMBL,Inhibition of human plasma kallikrein using Z-Phe-Arg-AMC substrate after 30 mins by spectrophotometric assay,NULL,Plasma kallikrein (human),/gene/3818,10.1038/nchembio.184,3.4.21.34,P03952
247271032,Active,507759,164133362,0,52943174,3818,9606,19483697,Literature-derived,20180914,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of kallikrein-mediated intrinsic coagulation pathway in human plasma assessed as reduction in factor 12a generation at 160 nM by colorimetric assay,NULL,Plasma kallikrein (human),/gene/3818,10.1038/nchembio.184,3.4.21.34,P03952
286365608,Active,610098,134460981,0,46899577,3818,9606,21741839,Confirmatory,20180919,0,0,P03952,Ki,0.0083,ChEMBL,Inhibition of plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2011.06.033,3.4.21.34,P03952
304722870,Active,633299,136934678,0,53488415,3818,9606,22041058,Confirmatory,20180920,0,0,P03952,Ki,6.218,ChEMBL,Inhibition of human kallikrein by Michaelis-Menten equation analysis,"6-Chloro-N-[(3S)-2-oxo-1-[2-oxo-2-[(1R,9S)-6-oxo-7,11-diazatricyclo[7.3.1.02,7]trideca-2,4-dien-11-yl]ethyl]piperidin-3-yl]naphthalene-2-sulfonamide",Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2011.06.098,3.4.21.34,P03952
304723127,Active,633345,136929672,0,9912771,3818,9606,21995444,Confirmatory,20180920,0,0,P03952,Ki,11,ChEMBL,Inhibition of human plasma kallikrein using chromogenic substrate S2302 by dixon plot analysis,Darexaban,Plasma kallikrein (human),/gene/3818,10.1021/jm200868m,3.4.21.34,P03952
304723131,Active,633345,136936225,0,10168444,3818,9606,21995444,Confirmatory,20180920,0,0,P03952,Ki,17,ChEMBL,Inhibition of human plasma kallikrein using chromogenic substrate S2302 by dixon plot analysis,"(2S,3S,4S,5R,6S)-3,4,5-Trihydroxy-6-[3-[(4-methoxybenzoyl)amino]-2-[[4-(4-methyl-1,4-diazepan-1-yl)benzoyl]amino]phenoxy]oxane-2-carboxylic acid",Plasma kallikrein (human),/gene/3818,10.1021/jm200868m,3.4.21.34,P03952
420580651,Active,652664,160666796,0,70681010,3818,9606,22386244,Confirmatory,20180921,0,0,P03952,IC50,13.5,ChEMBL,"Inhibition of His6-tagged human kallikrein 6 harboring R74G, R76Q and N132Q mutant expressed in baculovirus infected insect sf9 cells by fluorescence analysis",NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2012.02.014,3.4.21.34,P03952
420580652,Active,652664,160672135,0,24689997,3818,9606,22386244,Confirmatory,20180921,0,0,P03952,IC50,8.6,ChEMBL,"Inhibition of His6-tagged human kallikrein 6 harboring R74G, R76Q and N132Q mutant expressed in baculovirus infected insect sf9 cells by fluorescence analysis",NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2012.02.014,3.4.21.34,P03952
420580653,Active,652664,160682776,0,24692287,3818,9606,22386244,Confirmatory,20180921,0,0,P03952,IC50,20.6,ChEMBL,"Inhibition of His6-tagged human kallikrein 6 harboring R74G, R76Q and N132Q mutant expressed in baculovirus infected insect sf9 cells by fluorescence analysis",NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2012.02.014,3.4.21.34,P03952
420580654,Active,652664,160704317,0,70695750,3818,9606,22386244,Confirmatory,20180921,0,0,P03952,IC50,10.6,ChEMBL,"Inhibition of His6-tagged human kallikrein 6 harboring R74G, R76Q and N132Q mutant expressed in baculovirus infected insect sf9 cells by fluorescence analysis",NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2012.02.014,3.4.21.34,P03952
420580655,Active,652664,160704309,0,70695744,3818,9606,22386244,Confirmatory,20180921,0,0,P03952,IC50,7.8,ChEMBL,"Inhibition of His6-tagged human kallikrein 6 harboring R74G, R76Q and N132Q mutant expressed in baculovirus infected insect sf9 cells by fluorescence analysis",NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2012.02.014,3.4.21.34,P03952
420580657,Active,652664,160672145,0,70683146,3818,9606,22386244,Confirmatory,20180921,0,0,P03952,IC50,3.8,ChEMBL,"Inhibition of His6-tagged human kallikrein 6 harboring R74G, R76Q and N132Q mutant expressed in baculovirus infected insect sf9 cells by fluorescence analysis",NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2012.02.014,3.4.21.34,P03952
420580659,Active,652664,160704318,0,57404342,3818,9606,22386244,Confirmatory,20180921,0,0,P03952,IC50,0.3,ChEMBL,"Inhibition of His6-tagged human kallikrein 6 harboring R74G, R76Q and N132Q mutant expressed in baculovirus infected insect sf9 cells by fluorescence analysis",NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2012.02.014,3.4.21.34,P03952
420580662,Active,652664,160704319,0,57404341,3818,9606,22386244,Confirmatory,20180921,0,0,P03952,IC50,1.7,ChEMBL,"Inhibition of His6-tagged human kallikrein 6 harboring R74G, R76Q and N132Q mutant expressed in baculovirus infected insect sf9 cells by fluorescence analysis",NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2012.02.014,3.4.21.34,P03952
420580668,Active,652664,160672144,0,70683145,3818,9606,22386244,Confirmatory,20180921,0,0,P03952,IC50,12.9,ChEMBL,"Inhibition of His6-tagged human kallikrein 6 harboring R74G, R76Q and N132Q mutant expressed in baculovirus infected insect sf9 cells by fluorescence analysis",NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2012.02.014,3.4.21.34,P03952
420580673,Active,652666,194158604,0,44310877,3818,9606,22386244,Confirmatory,20180921,0,0,P03952,IC50,0.71,ChEMBL,Inhibition of plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2012.02.014,3.4.21.34,P03952
420580678,Active,652668,160704319,0,57404341,3818,9606,22386244,Literature-derived,20180921,0,0,P03952,NULL,NULL,ChEMBL,"Binding affinity to human kallikrein 6 harboring R74G, R76Q and N132Q mutant by X-ray crystallography analysis",NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2012.02.014,3.4.21.34,P03952
420597765,Active,656101,160667020,0,56599309,3818,9606,22276953,Confirmatory,20180921,0,0,P03952,Ki,0.0024,ChEMBL,Inhibition of plasma kallikrein by dixon plot method,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm2011996,3.4.21.34,P03952
420597769,Active,656101,160683002,0,70687492,3818,9606,22276953,Confirmatory,20180921,0,0,P03952,Ki,0.0094,ChEMBL,Inhibition of plasma kallikrein by dixon plot method,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm2011996,3.4.21.34,P03952
420597773,Active,656101,160672339,0,70683249,3818,9606,22276953,Confirmatory,20180921,0,0,P03952,Ki,7.5e-05,ChEMBL,Inhibition of plasma kallikrein by dixon plot method,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm2011996,3.4.21.34,P03952
420597776,Active,656101,160672343,0,56954953,3818,9606,22276953,Confirmatory,20180921,0,0,P03952,Ki,0.067,ChEMBL,Inhibition of plasma kallikrein by dixon plot method,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm2011996,3.4.21.34,P03952
420597779,Active,656101,160693821,0,56954834,3818,9606,22276953,Confirmatory,20180921,0,0,P03952,Ki,0.0174,ChEMBL,Inhibition of plasma kallikrein by dixon plot method,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm2011996,3.4.21.34,P03952
420597782,Active,656101,160672340,0,56954620,3818,9606,22276953,Confirmatory,20180921,0,0,P03952,Ki,0.0254,ChEMBL,Inhibition of plasma kallikrein by dixon plot method,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm2011996,3.4.21.34,P03952
420597786,Active,656101,160667019,0,56954732,3818,9606,22276953,Confirmatory,20180921,0,0,P03952,Ki,0.868,ChEMBL,Inhibition of plasma kallikrein by dixon plot method,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm2011996,3.4.21.34,P03952
420597790,Active,656101,160704545,0,56954733,3818,9606,22276953,Confirmatory,20180921,0,0,P03952,Ki,0.493,ChEMBL,Inhibition of plasma kallikrein by dixon plot method,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm2011996,3.4.21.34,P03952
420597794,Active,656101,160699195,0,56954952,3818,9606,22276953,Confirmatory,20180921,0,0,P03952,Ki,0.0101,ChEMBL,Inhibition of plasma kallikrein by dixon plot method,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm2011996,3.4.21.34,P03952
420597798,Active,656101,160672341,0,56640092,3818,9606,22276953,Confirmatory,20180921,0,0,P03952,Ki,0.136,ChEMBL,Inhibition of plasma kallikrein by dixon plot method,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm2011996,3.4.21.34,P03952
420597802,Active,656101,160672342,0,56640226,3818,9606,22276953,Confirmatory,20180921,0,0,P03952,Ki,0.019,ChEMBL,Inhibition of plasma kallikrein by dixon plot method,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm2011996,3.4.21.34,P03952
420597806,Active,656101,160699194,0,56640160,3818,9606,22276953,Confirmatory,20180921,0,0,P03952,Ki,0.0253,ChEMBL,Inhibition of plasma kallikrein by dixon plot method,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm2011996,3.4.21.34,P03952
433565676,Active,724900,164139504,0,71718577,3818,9606,23294255,Confirmatory,20180925,0,0,P03952,Ki,0.118,ChEMBL,Inhibition of human plasma kallikrein using H-D-Pro-Phe-Arg-pNA as substrate after 5 to 10 mins by micro plate reader analysis,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm3012917,3.4.21.34,P03952
433565679,Active,724900,164142266,0,71719190,3818,9606,23294255,Confirmatory,20180925,0,0,P03952,Ki,0.116,ChEMBL,Inhibition of human plasma kallikrein using H-D-Pro-Phe-Arg-pNA as substrate after 5 to 10 mins by micro plate reader analysis,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm3012917,3.4.21.34,P03952
433565681,Active,724900,164128167,0,71716139,3818,9606,23294255,Confirmatory,20180925,0,0,P03952,Ki,0.422,ChEMBL,Inhibition of human plasma kallikrein using H-D-Pro-Phe-Arg-pNA as substrate after 5 to 10 mins by micro plate reader analysis,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm3012917,3.4.21.34,P03952
433565683,Active,724900,164145067,0,71719792,3818,9606,23294255,Confirmatory,20180925,0,0,P03952,Ki,0.5,ChEMBL,Inhibition of human plasma kallikrein using H-D-Pro-Phe-Arg-pNA as substrate after 5 to 10 mins by micro plate reader analysis,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm3012917,3.4.21.34,P03952
433565685,Active,724900,164145068,0,71719793,3818,9606,23294255,Confirmatory,20180925,0,0,P03952,Ki,0.0032,ChEMBL,Inhibition of human plasma kallikrein using H-D-Pro-Phe-Arg-pNA as substrate after 5 to 10 mins by micro plate reader analysis,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm3012917,3.4.21.34,P03952
433565686,Active,724900,164142267,0,71719191,3818,9606,23294255,Confirmatory,20180925,0,0,P03952,Ki,0.0129,ChEMBL,Inhibition of human plasma kallikrein using H-D-Pro-Phe-Arg-pNA as substrate after 5 to 10 mins by micro plate reader analysis,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm3012917,3.4.21.34,P03952
433565690,Active,724900,164131043,0,71716767,3818,9606,23294255,Confirmatory,20180925,0,0,P03952,Ki,0.392,ChEMBL,Inhibition of human plasma kallikrein using H-D-Pro-Phe-Arg-pNA as substrate after 5 to 10 mins by micro plate reader analysis,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm3012917,3.4.21.34,P03952
433565692,Active,724900,164131041,0,71716765,3818,9606,23294255,Confirmatory,20180925,0,0,P03952,Ki,0.187,ChEMBL,Inhibition of human plasma kallikrein using H-D-Pro-Phe-Arg-pNA as substrate after 5 to 10 mins by micro plate reader analysis,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm3012917,3.4.21.34,P03952
433565698,Active,724900,164133878,0,71717373,3818,9606,23294255,Confirmatory,20180925,0,0,P03952,Ki,0.242,ChEMBL,Inhibition of human plasma kallikrein using H-D-Pro-Phe-Arg-pNA as substrate after 5 to 10 mins by micro plate reader analysis,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm3012917,3.4.21.34,P03952
433565700,Active,724900,164147874,0,71720404,3818,9606,23294255,Confirmatory,20180925,0,0,P03952,Ki,0.32,ChEMBL,Inhibition of human plasma kallikrein using H-D-Pro-Phe-Arg-pNA as substrate after 5 to 10 mins by micro plate reader analysis,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm3012917,3.4.21.34,P03952
433565704,Active,724900,164128165,0,71716137,3818,9606,23294255,Confirmatory,20180925,0,0,P03952,Ki,1,ChEMBL,Inhibition of human plasma kallikrein using H-D-Pro-Phe-Arg-pNA as substrate after 5 to 10 mins by micro plate reader analysis,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm3012917,3.4.21.34,P03952
433565705,Active,724900,164131042,0,71716766,3818,9606,23294255,Confirmatory,20180925,0,0,P03952,Ki,0.44,ChEMBL,Inhibition of human plasma kallikrein using H-D-Pro-Phe-Arg-pNA as substrate after 5 to 10 mins by micro plate reader analysis,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm3012917,3.4.21.34,P03952
433565706,Active,724900,164139505,0,71718578,3818,9606,23294255,Confirmatory,20180925,0,0,P03952,Ki,0.024,ChEMBL,Inhibition of human plasma kallikrein using H-D-Pro-Phe-Arg-pNA as substrate after 5 to 10 mins by micro plate reader analysis,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm3012917,3.4.21.34,P03952
433565711,Active,724900,164128166,0,71716138,3818,9606,23294255,Confirmatory,20180925,0,0,P03952,Ki,0.24,ChEMBL,Inhibition of human plasma kallikrein using H-D-Pro-Phe-Arg-pNA as substrate after 5 to 10 mins by micro plate reader analysis,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm3012917,3.4.21.34,P03952
433609803,Active,732084,164135583,0,71711730,3818,9606,23350733,Confirmatory,20180926,0,0,P03952,IC50,10,ChEMBL,Inhibition of Plasma Kallikrein (unknown origin) using Z-FR-AMC substrate incubated for 15 mins prior to substrate addition measured for 2 hrs,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm3017305,3.4.21.34,P03952
433637560,Active,736244,174494480,0,71716975,3818,9606,23586812,Confirmatory,20180926,0,0,P03952,Ki,0.0003,ChEMBL,Inhibition of human recombinant polyhistidine-tagged plasma kallikrein expressed in Escherichia coli XL1 blue using Z-FR-AMC as substrate by fluorimetric analysis,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm400236j,3.4.21.34,P03952
439101395,Active,762526,174502817,0,71818688,3818,9606,23844670,Confirmatory,20180927,0,0,P03952,IC50,11.2,ChEMBL,Inhibition of human plasma kallikrein using benzyloxycarbonyl-Phe-Arg-7-amino-4-methylcoumarin as substrate by fluorescence microplate reader analysis,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm400742j,3.4.21.34,P03952
440222080,Active,1057644,194172816,0,67155199,3818,9606,24175584,Confirmatory,20180928,0,0,P03952,Ki,2.9,ChEMBL,Inhibition of plasma kallikrein (unknown origin),NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm4005835,3.4.21.34,P03952
440323219,Active,1074189,194188740,0,10483775,3818,9606,24405333,Confirmatory,20180929,0,0,P03952,Ki,0.0046,ChEMBL,Binding affinity to human plasma kallikrein assessed as release of p-nitroaniline after 10 to 120 mins by spectrophotometric analysis,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm401670x,3.4.21.34,P03952
441702323,Active,1137958,242633541,0,73051877,3818,9606,24900827,Confirmatory,20181003,0,0,P03952,Ki,0.003,ChEMBL,Inhibition of human plasma kallikrein using S-2302 as substrate at 25 degC after 20 to 180 mins,NULL,Plasma kallikrein (human),/gene/3818,10.1021/ml500084u,3.4.21.34,P03952
441702324,Active,1137958,242633542,0,73052197,3818,9606,24900827,Confirmatory,20181003,0,0,P03952,Ki,0.009,ChEMBL,Inhibition of human plasma kallikrein using S-2302 as substrate at 25 degC after 20 to 180 mins,NULL,Plasma kallikrein (human),/gene/3818,10.1021/ml500084u,3.4.21.34,P03952
441702434,Active,1137959,242633544,0,73052831,3818,9606,24900827,Confirmatory,20181003,0,0,P03952,Ki,0.00239,ChEMBL,Inhibition of human plasma kallikrein using S-2302 as substrate at 37 degC after 20 to 180 mins,NULL,Plasma kallikrein (human),/gene/3818,10.1021/ml500084u,3.4.21.34,P03952
441702436,Active,1137959,242633543,0,73052510,3818,9606,24900827,Confirmatory,20181003,0,0,P03952,Ki,0.001,ChEMBL,Inhibition of human plasma kallikrein using S-2302 as substrate at 37 degC after 20 to 180 mins,NULL,Plasma kallikrein (human),/gene/3818,10.1021/ml500084u,3.4.21.34,P03952
444187108,Active,1171259,312369414,0,118720998,3818,9606,25405503,Confirmatory,20181005,0,0,P03952,Ki,0.765,ChEMBL,Inhibition of human plasma kallikrein using H-D-Pro-Phe-Arg-pNA as substrate,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm5010607,3.4.21.34,P03952
444187116,Active,1171259,312369415,0,118720999,3818,9606,25405503,Confirmatory,20181005,0,0,P03952,Ki,1.31,ChEMBL,Inhibition of human plasma kallikrein using H-D-Pro-Phe-Arg-pNA as substrate,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm5010607,3.4.21.34,P03952
444187117,Active,1171259,312369416,0,118721000,3818,9606,25405503,Confirmatory,20181005,0,0,P03952,Ki,0.91,ChEMBL,Inhibition of human plasma kallikrein using H-D-Pro-Phe-Arg-pNA as substrate,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm5010607,3.4.21.34,P03952
444187125,Active,1171259,312369417,0,118721001,3818,9606,25405503,Confirmatory,20181005,0,0,P03952,Ki,0.92,ChEMBL,Inhibition of human plasma kallikrein using H-D-Pro-Phe-Arg-pNA as substrate,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm5010607,3.4.21.34,P03952
444187126,Active,1171259,312369404,0,118720986,3818,9606,25405503,Confirmatory,20181005,0,0,P03952,Ki,0.94,ChEMBL,Inhibition of human plasma kallikrein using H-D-Pro-Phe-Arg-pNA as substrate,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm5010607,3.4.21.34,P03952
444187141,Active,1171259,312369411,0,118720995,3818,9606,25405503,Confirmatory,20181005,0,0,P03952,Ki,3.82,ChEMBL,Inhibition of human plasma kallikrein using H-D-Pro-Phe-Arg-pNA as substrate,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm5010607,3.4.21.34,P03952
444187142,Active,1171259,312369413,0,118720997,3818,9606,25405503,Confirmatory,20181005,0,0,P03952,Ki,5.27,ChEMBL,Inhibition of human plasma kallikrein using H-D-Pro-Phe-Arg-pNA as substrate,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm5010607,3.4.21.34,P03952
444187155,Active,1171259,312369418,0,118721002,3818,9606,25405503,Confirmatory,20181005,0,0,P03952,Ki,1.902,ChEMBL,Inhibition of human plasma kallikrein using H-D-Pro-Phe-Arg-pNA as substrate,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm5010607,3.4.21.34,P03952
444187156,Active,1171259,312369420,0,118721004,3818,9606,25405503,Confirmatory,20181005,0,0,P03952,Ki,0.02,ChEMBL,Inhibition of human plasma kallikrein using H-D-Pro-Phe-Arg-pNA as substrate,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm5010607,3.4.21.34,P03952
444187163,Active,1171259,312369422,0,118721007,3818,9606,25405503,Confirmatory,20181005,0,0,P03952,Ki,0.05,ChEMBL,Inhibition of human plasma kallikrein using H-D-Pro-Phe-Arg-pNA as substrate,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm5010607,3.4.21.34,P03952
444187167,Active,1171259,312369427,0,66674764,3818,9606,25405503,Confirmatory,20181005,0,0,P03952,Ki,5.023,ChEMBL,Inhibition of human plasma kallikrein using H-D-Pro-Phe-Arg-pNA as substrate,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm5010607,3.4.21.34,P03952
444187170,Active,1171259,312369429,0,66674475,3818,9606,25405503,Confirmatory,20181005,0,0,P03952,Ki,4.5,ChEMBL,Inhibition of human plasma kallikrein using H-D-Pro-Phe-Arg-pNA as substrate,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm5010607,3.4.21.34,P03952
444187171,Active,1171259,312369406,0,118720988,3818,9606,25405503,Confirmatory,20181005,0,0,P03952,Ki,1.36,ChEMBL,Inhibition of human plasma kallikrein using H-D-Pro-Phe-Arg-pNA as substrate,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm5010607,3.4.21.34,P03952
444187184,Active,1171259,312369407,0,118720989,3818,9606,25405503,Confirmatory,20181005,0,0,P03952,Ki,1.17,ChEMBL,Inhibition of human plasma kallikrein using H-D-Pro-Phe-Arg-pNA as substrate,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm5010607,3.4.21.34,P03952
444187192,Active,1171259,312369408,0,118720991,3818,9606,25405503,Confirmatory,20181005,0,0,P03952,Ki,1.47,ChEMBL,Inhibition of human plasma kallikrein using H-D-Pro-Phe-Arg-pNA as substrate,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm5010607,3.4.21.34,P03952
444187193,Active,1171259,312369409,0,118720992,3818,9606,25405503,Confirmatory,20181005,0,0,P03952,Ki,5.54,ChEMBL,Inhibition of human plasma kallikrein using H-D-Pro-Phe-Arg-pNA as substrate,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm5010607,3.4.21.34,P03952
444187196,Active,1171259,312369423,0,118721008,3818,9606,25405503,Confirmatory,20181005,0,0,P03952,Ki,0.005,ChEMBL,Inhibition of human plasma kallikrein using H-D-Pro-Phe-Arg-pNA as substrate,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm5010607,3.4.21.34,P03952
444187197,Active,1171259,312369424,0,118721009,3818,9606,25405503,Confirmatory,20181005,0,0,P03952,Ki,0.002,ChEMBL,Inhibition of human plasma kallikrein using H-D-Pro-Phe-Arg-pNA as substrate,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm5010607,3.4.21.34,P03952
444187202,Active,1171259,312369425,0,66674212,3818,9606,25405503,Confirmatory,20181005,0,0,P03952,Ki,3.44,ChEMBL,Inhibition of human plasma kallikrein using H-D-Pro-Phe-Arg-pNA as substrate,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm5010607,3.4.21.34,P03952
444187203,Active,1171259,312369426,0,66674351,3818,9606,25405503,Confirmatory,20181005,0,0,P03952,Ki,2.217,ChEMBL,Inhibition of human plasma kallikrein using H-D-Pro-Phe-Arg-pNA as substrate,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm5010607,3.4.21.34,P03952
444187216,Active,1171259,194175043,0,60154989,3818,9606,25405503,Confirmatory,20181005,0,0,P03952,Ki,0.002,ChEMBL,Inhibition of human plasma kallikrein using H-D-Pro-Phe-Arg-pNA as substrate,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm5010607,3.4.21.34,P03952
444187217,Active,1171259,312369403,0,118720985,3818,9606,25405503,Confirmatory,20181005,0,0,P03952,Ki,0.33,ChEMBL,Inhibition of human plasma kallikrein using H-D-Pro-Phe-Arg-pNA as substrate,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm5010607,3.4.21.34,P03952
444187219,Active,1171259,312369405,0,118720987,3818,9606,25405503,Confirmatory,20181005,0,0,P03952,Ki,1.924,ChEMBL,Inhibition of human plasma kallikrein using H-D-Pro-Phe-Arg-pNA as substrate,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm5010607,3.4.21.34,P03952
444187220,Active,1171259,312369410,0,118720994,3818,9606,25405503,Confirmatory,20181005,0,0,P03952,Ki,0.06,ChEMBL,Inhibition of human plasma kallikrein using H-D-Pro-Phe-Arg-pNA as substrate,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm5010607,3.4.21.34,P03952
444187226,Active,1171259,312369412,0,118720996,3818,9606,25405503,Confirmatory,20181005,0,0,P03952,Ki,0.22,ChEMBL,Inhibition of human plasma kallikrein using H-D-Pro-Phe-Arg-pNA as substrate,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm5010607,3.4.21.34,P03952
444187227,Active,1171259,312369419,0,118721003,3818,9606,25405503,Confirmatory,20181005,0,0,P03952,Ki,0.045,ChEMBL,Inhibition of human plasma kallikrein using H-D-Pro-Phe-Arg-pNA as substrate,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm5010607,3.4.21.34,P03952
444187239,Active,1171259,312369421,0,118721005,3818,9606,25405503,Confirmatory,20181005,0,0,P03952,Ki,0.008,ChEMBL,Inhibition of human plasma kallikrein using H-D-Pro-Phe-Arg-pNA as substrate,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm5010607,3.4.21.34,P03952
444187241,Active,1171259,312369428,0,136402490,3818,9606,25405503,Confirmatory,20181005,0,0,P03952,Ki,4.82,ChEMBL,Inhibition of human plasma kallikrein using H-D-Pro-Phe-Arg-pNA as substrate,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm5010607,3.4.21.34,P03952
444314989,Active,1190631,312376755,0,86583041,3818,9606,25592713,Confirmatory,20181006,0,0,P03952,Ki,0.024,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2014.12.050,3.4.21.34,P03952
444325924,Active,1192268,312379937,0,57976446,3818,9606,25728130,Confirmatory,20181006,0,0,P03952,Ki,0.24,ChEMBL,Inhibition of plasma kallikrein (unknown origin),NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2015.01.028,3.4.21.34,P03952
444325926,Active,1192268,312379907,0,11684611,3818,9606,25728130,Confirmatory,20181006,0,0,P03952,Ki,0.005,ChEMBL,Inhibition of plasma kallikrein (unknown origin),NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2015.01.028,3.4.21.34,P03952
444325930,Active,1192268,312379939,0,57976444,3818,9606,25728130,Confirmatory,20181006,0,0,P03952,Ki,0.041,ChEMBL,Inhibition of plasma kallikrein (unknown origin),NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2015.01.028,3.4.21.34,P03952
446174267,Active,1229457,318372636,0,77108442,3818,9606,26005539,Confirmatory,20181008,0,0,P03952,Ki,0.007,ChEMBL,Inhibition of plasma kallikrein (unknown origin),NULL,Plasma kallikrein (human),/gene/3818,10.1021/acsmedchemlett.5b00066,3.4.21.34,P03952
446207463,Active,1235267,318378742,0,57842624,3818,9606,26151189,Confirmatory,20181008,0,0,P03952,Ki,3.6,ChEMBL,Inhibition of human plasma kallikrein using S2302 as substrate measured for 30 mins,NULL,Plasma kallikrein (human),/gene/3818,10.1021/acs.jmedchem.5b00788,3.4.21.34,P03952
446207465,Active,1235267,318378744,0,57842812,3818,9606,26151189,Confirmatory,20181008,0,0,P03952,Ki,0.05,ChEMBL,Inhibition of human plasma kallikrein using S2302 as substrate measured for 30 mins,NULL,Plasma kallikrein (human),/gene/3818,10.1021/acs.jmedchem.5b00788,3.4.21.34,P03952
446207467,Active,1235267,318378741,0,57842850,3818,9606,26151189,Confirmatory,20181008,0,0,P03952,Ki,4.6,ChEMBL,Inhibition of human plasma kallikrein using S2302 as substrate measured for 30 mins,NULL,Plasma kallikrein (human),/gene/3818,10.1021/acs.jmedchem.5b00788,3.4.21.34,P03952
446207471,Active,1235267,318378745,0,57842913,3818,9606,26151189,Confirmatory,20181008,0,0,P03952,Ki,1.7,ChEMBL,Inhibition of human plasma kallikrein using S2302 as substrate measured for 30 mins,NULL,Plasma kallikrein (human),/gene/3818,10.1021/acs.jmedchem.5b00788,3.4.21.34,P03952
446366145,Active,1257680,318418739,0,53345970,3818,9606,,Confirmatory,20181009,0,0,P03952,Ki,0.0015,ChEMBL,"Inhibition Assay: The inhibitory effect for the individual enzymes was determined in analogy to a previously disclosed method (Sturzebecher et al., J. Med. Chem., 40, 3091-3099 (1997)).",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
446366149,Active,1257680,318418739,0,53345970,3818,9606,,Confirmatory,20181009,0,0,P03952,Ki,NULL,ChEMBL,"Inhibition Assay: The inhibitory effect for the individual enzymes was determined in analogy to a previously disclosed method (Sturzebecher et al., J. Med. Chem., 40, 3091-3099 (1997)).",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
446366150,Active,1257680,318418739,0,53345970,3818,9606,,Confirmatory,20181009,0,0,P03952,Ki,NULL,ChEMBL,"Inhibition Assay: The inhibitory effect for the individual enzymes was determined in analogy to a previously disclosed method (Sturzebecher et al., J. Med. Chem., 40, 3091-3099 (1997)).",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
446366151,Active,1257680,318418730,0,53346080,3818,9606,,Confirmatory,20181009,0,0,P03952,Ki,0.002,ChEMBL,"Inhibition Assay: The inhibitory effect for the individual enzymes was determined in analogy to a previously disclosed method (Sturzebecher et al., J. Med. Chem., 40, 3091-3099 (1997)).",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
446366152,Active,1257680,318418731,0,53346181,3818,9606,,Confirmatory,20181009,0,0,P03952,Ki,0.0075,ChEMBL,"Inhibition Assay: The inhibitory effect for the individual enzymes was determined in analogy to a previously disclosed method (Sturzebecher et al., J. Med. Chem., 40, 3091-3099 (1997)).",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
446366153,Active,1257680,318418729,0,53346082,3818,9606,,Confirmatory,20181009,0,0,P03952,Ki,0.0009,ChEMBL,"Inhibition Assay: The inhibitory effect for the individual enzymes was determined in analogy to a previously disclosed method (Sturzebecher et al., J. Med. Chem., 40, 3091-3099 (1997)).",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
446366154,Active,1257680,318418743,0,53346081,3818,9606,,Confirmatory,20181009,0,0,P03952,Ki,0.0015,ChEMBL,"Inhibition Assay: The inhibitory effect for the individual enzymes was determined in analogy to a previously disclosed method (Sturzebecher et al., J. Med. Chem., 40, 3091-3099 (1997)).",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
446366155,Active,1257680,318418727,0,53346079,3818,9606,,Confirmatory,20181009,0,0,P03952,Ki,0.0075,ChEMBL,"Inhibition Assay: The inhibitory effect for the individual enzymes was determined in analogy to a previously disclosed method (Sturzebecher et al., J. Med. Chem., 40, 3091-3099 (1997)).",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
446366156,Active,1257680,318418728,0,53345968,3818,9606,,Confirmatory,20181009,0,0,P03952,Ki,0.0003,ChEMBL,"Inhibition Assay: The inhibitory effect for the individual enzymes was determined in analogy to a previously disclosed method (Sturzebecher et al., J. Med. Chem., 40, 3091-3099 (1997)).",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
446366157,Active,1257680,318418732,0,53345862,3818,9606,,Confirmatory,20181009,0,0,P03952,Ki,0.0013,ChEMBL,"Inhibition Assay: The inhibitory effect for the individual enzymes was determined in analogy to a previously disclosed method (Sturzebecher et al., J. Med. Chem., 40, 3091-3099 (1997)).",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
446366158,Active,1257680,318418725,0,53345755,3818,9606,,Confirmatory,20181009,0,0,P03952,Ki,0.003,ChEMBL,"Inhibition Assay: The inhibitory effect for the individual enzymes was determined in analogy to a previously disclosed method (Sturzebecher et al., J. Med. Chem., 40, 3091-3099 (1997)).",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
446366159,Active,1257680,318418741,0,53345655,3818,9606,,Confirmatory,20181009,0,0,P03952,Ki,0.02,ChEMBL,"Inhibition Assay: The inhibitory effect for the individual enzymes was determined in analogy to a previously disclosed method (Sturzebecher et al., J. Med. Chem., 40, 3091-3099 (1997)).",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
446366160,Active,1257680,318418745,0,53345653,3818,9606,,Confirmatory,20181009,0,0,P03952,Ki,0.0027,ChEMBL,"Inhibition Assay: The inhibitory effect for the individual enzymes was determined in analogy to a previously disclosed method (Sturzebecher et al., J. Med. Chem., 40, 3091-3099 (1997)).",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
446366161,Active,1257680,318418744,0,53345754,3818,9606,,Confirmatory,20181009,0,0,P03952,Ki,0.0094,ChEMBL,"Inhibition Assay: The inhibitory effect for the individual enzymes was determined in analogy to a previously disclosed method (Sturzebecher et al., J. Med. Chem., 40, 3091-3099 (1997)).",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
446366162,Active,1257680,318418746,0,53345654,3818,9606,,Confirmatory,20181009,0,0,P03952,Ki,0.0053,ChEMBL,"Inhibition Assay: The inhibitory effect for the individual enzymes was determined in analogy to a previously disclosed method (Sturzebecher et al., J. Med. Chem., 40, 3091-3099 (1997)).",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
446366163,Active,1257680,318418726,0,53345860,3818,9606,,Confirmatory,20181009,0,0,P03952,Ki,0.005,ChEMBL,"Inhibition Assay: The inhibitory effect for the individual enzymes was determined in analogy to a previously disclosed method (Sturzebecher et al., J. Med. Chem., 40, 3091-3099 (1997)).",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
446366164,Active,1257680,318418733,0,53345752,3818,9606,,Confirmatory,20181009,0,0,P03952,Ki,0.009,ChEMBL,"Inhibition Assay: The inhibitory effect for the individual enzymes was determined in analogy to a previously disclosed method (Sturzebecher et al., J. Med. Chem., 40, 3091-3099 (1997)).",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
446366165,Active,1257680,318418740,0,53345652,3818,9606,,Confirmatory,20181009,0,0,P03952,Ki,0.0015,ChEMBL,"Inhibition Assay: The inhibitory effect for the individual enzymes was determined in analogy to a previously disclosed method (Sturzebecher et al., J. Med. Chem., 40, 3091-3099 (1997)).",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
446366166,Active,1257680,318418737,0,53345861,3818,9606,,Confirmatory,20181009,0,0,P03952,Ki,0.002,ChEMBL,"Inhibition Assay: The inhibitory effect for the individual enzymes was determined in analogy to a previously disclosed method (Sturzebecher et al., J. Med. Chem., 40, 3091-3099 (1997)).",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
446366167,Active,1257680,318418735,0,53345863,3818,9606,,Confirmatory,20181009,0,0,P03952,Ki,0.002,ChEMBL,"Inhibition Assay: The inhibitory effect for the individual enzymes was determined in analogy to a previously disclosed method (Sturzebecher et al., J. Med. Chem., 40, 3091-3099 (1997)).",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
446366169,Active,1257680,318418736,0,53345969,3818,9606,,Confirmatory,20181009,0,0,P03952,Ki,0.002,ChEMBL,"Inhibition Assay: The inhibitory effect for the individual enzymes was determined in analogy to a previously disclosed method (Sturzebecher et al., J. Med. Chem., 40, 3091-3099 (1997)).",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
446366170,Active,1257680,318418734,0,53345967,3818,9606,,Confirmatory,20181009,0,0,P03952,Ki,0.004,ChEMBL,"Inhibition Assay: The inhibitory effect for the individual enzymes was determined in analogy to a previously disclosed method (Sturzebecher et al., J. Med. Chem., 40, 3091-3099 (1997)).",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
446437801,Active,1258425,318425443,0,89843744,3818,9606,,Confirmatory,20181009,0,0,P03952,Ki,0.0089,ChEMBL,"Enzyme Assay: The inhibition constants for human plasmin (h plasmin), human plasma kallikrein (h PK), thrombin and factor Xa were determined in analogy to a previously disclosed method (StA(1/4)rzebecher et al., J. Med. Chem., 40, 3091-3099 (1997)), using",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
446437802,Active,1258425,318425445,0,89843696,3818,9606,,Confirmatory,20181009,0,0,P03952,Ki,0.018,ChEMBL,"Enzyme Assay: The inhibition constants for human plasmin (h plasmin), human plasma kallikrein (h PK), thrombin and factor Xa were determined in analogy to a previously disclosed method (StA(1/4)rzebecher et al., J. Med. Chem., 40, 3091-3099 (1997)), using",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
446437804,Active,1258425,318425442,0,89843663,3818,9606,,Confirmatory,20181009,0,0,P03952,Ki,0.55,ChEMBL,"Enzyme Assay: The inhibition constants for human plasmin (h plasmin), human plasma kallikrein (h PK), thrombin and factor Xa were determined in analogy to a previously disclosed method (StA(1/4)rzebecher et al., J. Med. Chem., 40, 3091-3099 (1997)), using",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
446437805,Active,1258425,318425447,0,90145679,3818,9606,,Confirmatory,20181009,0,0,P03952,Ki,0.012,ChEMBL,"Enzyme Assay: The inhibition constants for human plasmin (h plasmin), human plasma kallikrein (h PK), thrombin and factor Xa were determined in analogy to a previously disclosed method (StA(1/4)rzebecher et al., J. Med. Chem., 40, 3091-3099 (1997)), using",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
446437807,Active,1258425,160672341,0,56640092,3818,9606,,Confirmatory,20181009,0,0,P03952,Ki,0.136,ChEMBL,"Enzyme Assay: The inhibition constants for human plasmin (h plasmin), human plasma kallikrein (h PK), thrombin and factor Xa were determined in analogy to a previously disclosed method (StA(1/4)rzebecher et al., J. Med. Chem., 40, 3091-3099 (1997)), using",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
446437809,Active,1258425,160672342,0,56640226,3818,9606,,Confirmatory,20181009,0,0,P03952,Ki,0.0342,ChEMBL,"Enzyme Assay: The inhibition constants for human plasmin (h plasmin), human plasma kallikrein (h PK), thrombin and factor Xa were determined in analogy to a previously disclosed method (StA(1/4)rzebecher et al., J. Med. Chem., 40, 3091-3099 (1997)), using",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
446437811,Active,1258425,160699194,0,56640160,3818,9606,,Confirmatory,20181009,0,0,P03952,Ki,0.0316,ChEMBL,"Enzyme Assay: The inhibition constants for human plasmin (h plasmin), human plasma kallikrein (h PK), thrombin and factor Xa were determined in analogy to a previously disclosed method (StA(1/4)rzebecher et al., J. Med. Chem., 40, 3091-3099 (1997)), using",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
446437815,Active,1258425,160667019,0,56954732,3818,9606,,Confirmatory,20181009,0,0,P03952,Ki,0.868,ChEMBL,"Enzyme Assay: The inhibition constants for human plasmin (h plasmin), human plasma kallikrein (h PK), thrombin and factor Xa were determined in analogy to a previously disclosed method (StA(1/4)rzebecher et al., J. Med. Chem., 40, 3091-3099 (1997)), using",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
446437817,Active,1258425,160672340,0,56954620,3818,9606,,Confirmatory,20181009,0,0,P03952,Ki,0.025,ChEMBL,"Enzyme Assay: The inhibition constants for human plasmin (h plasmin), human plasma kallikrein (h PK), thrombin and factor Xa were determined in analogy to a previously disclosed method (StA(1/4)rzebecher et al., J. Med. Chem., 40, 3091-3099 (1997)), using",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
446437819,Active,1258425,160693821,0,56954834,3818,9606,,Confirmatory,20181009,0,0,P03952,Ki,0.0174,ChEMBL,"Enzyme Assay: The inhibition constants for human plasmin (h plasmin), human plasma kallikrein (h PK), thrombin and factor Xa were determined in analogy to a previously disclosed method (StA(1/4)rzebecher et al., J. Med. Chem., 40, 3091-3099 (1997)), using",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
446437821,Active,1258425,318425444,0,56954835,3818,9606,,Confirmatory,20181009,0,0,P03952,Ki,0.0094,ChEMBL,"Enzyme Assay: The inhibition constants for human plasmin (h plasmin), human plasma kallikrein (h PK), thrombin and factor Xa were determined in analogy to a previously disclosed method (StA(1/4)rzebecher et al., J. Med. Chem., 40, 3091-3099 (1997)), using",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
446437823,Active,1258425,160704545,0,56954733,3818,9606,,Confirmatory,20181009,0,0,P03952,Ki,0.493,ChEMBL,"Enzyme Assay: The inhibition constants for human plasmin (h plasmin), human plasma kallikrein (h PK), thrombin and factor Xa were determined in analogy to a previously disclosed method (StA(1/4)rzebecher et al., J. Med. Chem., 40, 3091-3099 (1997)), using",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
446437825,Active,1258425,160699195,0,56954952,3818,9606,,Confirmatory,20181009,0,0,P03952,Ki,0.0101,ChEMBL,"Enzyme Assay: The inhibition constants for human plasmin (h plasmin), human plasma kallikrein (h PK), thrombin and factor Xa were determined in analogy to a previously disclosed method (StA(1/4)rzebecher et al., J. Med. Chem., 40, 3091-3099 (1997)), using",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
446437826,Active,1258425,160667020,0,56599309,3818,9606,,Confirmatory,20181009,0,0,P03952,Ki,0.0024,ChEMBL,"Enzyme Assay: The inhibition constants for human plasmin (h plasmin), human plasma kallikrein (h PK), thrombin and factor Xa were determined in analogy to a previously disclosed method (StA(1/4)rzebecher et al., J. Med. Chem., 40, 3091-3099 (1997)), using",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
446437827,Active,1258425,374339104,0,134151630,3818,9606,,Confirmatory,20181009,0,0,P03952,Ki,0.32,ChEMBL,"Enzyme Assay: The inhibition constants for human plasmin (h plasmin), human plasma kallikrein (h PK), thrombin and factor Xa were determined in analogy to a previously disclosed method (StA(1/4)rzebecher et al., J. Med. Chem., 40, 3091-3099 (1997)), using",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
452509692,Active,1262330,336882014,0,127035672,3818,9606,26536069,Confirmatory,20180904,0,0,P03952,Ki,0.022,ChEMBL,Inhibition of human plasma kallikrein for 15 mins using H-D-Pro-Phe-Arg-p-nitroanilide as substrate,NULL,Plasma kallikrein (human),/gene/3818,10.1021/acs.jmedchem.5b01128,3.4.21.34,P03952
452509695,Active,1262330,336882898,0,127036086,3818,9606,26536069,Confirmatory,20180904,0,0,P03952,Ki,0.008,ChEMBL,Inhibition of human plasma kallikrein for 15 mins using H-D-Pro-Phe-Arg-p-nitroanilide as substrate,NULL,Plasma kallikrein (human),/gene/3818,10.1021/acs.jmedchem.5b01128,3.4.21.34,P03952
452509699,Active,1262330,336886049,0,127037469,3818,9606,26536069,Confirmatory,20180904,0,0,P03952,Ki,1.58,ChEMBL,Inhibition of human plasma kallikrein for 15 mins using H-D-Pro-Phe-Arg-p-nitroanilide as substrate,NULL,Plasma kallikrein (human),/gene/3818,10.1021/acs.jmedchem.5b01128,3.4.21.34,P03952
452509706,Active,1262330,336882029,0,127035685,3818,9606,26536069,Confirmatory,20180904,0,0,P03952,Ki,0.064,ChEMBL,Inhibition of human plasma kallikrein for 15 mins using H-D-Pro-Phe-Arg-p-nitroanilide as substrate,NULL,Plasma kallikrein (human),/gene/3818,10.1021/acs.jmedchem.5b01128,3.4.21.34,P03952
452509718,Active,1262330,336885585,0,127037264,3818,9606,26536069,Confirmatory,20180904,0,0,P03952,Ki,0.014,ChEMBL,Inhibition of human plasma kallikrein for 15 mins using H-D-Pro-Phe-Arg-p-nitroanilide as substrate,NULL,Plasma kallikrein (human),/gene/3818,10.1021/acs.jmedchem.5b01128,3.4.21.34,P03952
452509959,Active,1262354,336885585,0,127037264,3818,9606,26536069,Confirmatory,20180904,0,0,P03952,Kd,0.00304,ChEMBL,Binding affinity to human plasma kallikrein by surface plasmon resonance assay,NULL,Plasma kallikrein (human),/gene/3818,10.1021/acs.jmedchem.5b01128,3.4.21.34,P03952
452509968,Active,1262354,336886049,0,127037469,3818,9606,26536069,Confirmatory,20180904,0,0,P03952,Kd,0.737,ChEMBL,Binding affinity to human plasma kallikrein by surface plasmon resonance assay,NULL,Plasma kallikrein (human),/gene/3818,10.1021/acs.jmedchem.5b01128,3.4.21.34,P03952
452510240,Active,1262347,336886049,0,127037469,3818,9606,26536069,Confirmatory,20180904,0,0,P03952,Ki,0.907,ChEMBL,Inhibition of human wild-type plasma kallikrein catalytic domain after 15 mins using H-D-Pro-Phe-Arg-p-nitroanilide as substrate,NULL,Plasma kallikrein (human),/gene/3818,10.1021/acs.jmedchem.5b01128,3.4.21.34,P03952
452510247,Active,1262347,336885585,0,127037264,3818,9606,26536069,Confirmatory,20180904,0,0,P03952,Ki,0.00993,ChEMBL,Inhibition of human wild-type plasma kallikrein catalytic domain after 15 mins using H-D-Pro-Phe-Arg-p-nitroanilide as substrate,NULL,Plasma kallikrein (human),/gene/3818,10.1021/acs.jmedchem.5b01128,3.4.21.34,P03952
452510252,Active,1262348,336886049,0,127037469,3818,9606,26536069,Confirmatory,20180904,0,0,P03952,Ki,0.938,ChEMBL,Inhibition of human plasma kallikrein catalytic domain E217A mutant after 15 mins using H-D-Pro-Phe-Arg-p-nitroanilide as substrate,NULL,Plasma kallikrein (human),/gene/3818,10.1021/acs.jmedchem.5b01128,3.4.21.34,P03952
452510258,Active,1262348,336885585,0,127037264,3818,9606,26536069,Confirmatory,20180904,0,0,P03952,Ki,0.0319,ChEMBL,Inhibition of human plasma kallikrein catalytic domain E217A mutant after 15 mins using H-D-Pro-Phe-Arg-p-nitroanilide as substrate,NULL,Plasma kallikrein (human),/gene/3818,10.1021/acs.jmedchem.5b01128,3.4.21.34,P03952
452510282,Active,1262349,336886049,0,127037469,3818,9606,26536069,Confirmatory,20180904,0,0,P03952,Ki,1.694,ChEMBL,Inhibition of human plasma kallikrein catalytic domain E217R mutant after 15 mins using H-D-Pro-Phe-Arg-p-nitroanilide as substrate,NULL,Plasma kallikrein (human),/gene/3818,10.1021/acs.jmedchem.5b01128,3.4.21.34,P03952
452510284,Active,1262349,336885585,0,127037264,3818,9606,26536069,Confirmatory,20180904,0,0,P03952,Ki,0.166,ChEMBL,Inhibition of human plasma kallikrein catalytic domain E217R mutant after 15 mins using H-D-Pro-Phe-Arg-p-nitroanilide as substrate,NULL,Plasma kallikrein (human),/gene/3818,10.1021/acs.jmedchem.5b01128,3.4.21.34,P03952
452510291,Active,1262350,336886049,0,127037469,3818,9606,26536069,Confirmatory,20180904,0,0,P03952,Ki,0.136,ChEMBL,Inhibition of human plasma kallikrein catalytic domain G99Y mutant after 15 mins using H-D-Pro-Phe-Arg-p-nitroanilide as substrate,NULL,Plasma kallikrein (human),/gene/3818,10.1021/acs.jmedchem.5b01128,3.4.21.34,P03952
452510296,Active,1262350,336885585,0,127037264,3818,9606,26536069,Confirmatory,20180904,0,0,P03952,Ki,0.0536,ChEMBL,Inhibition of human plasma kallikrein catalytic domain G99Y mutant after 15 mins using H-D-Pro-Phe-Arg-p-nitroanilide as substrate,NULL,Plasma kallikrein (human),/gene/3818,10.1021/acs.jmedchem.5b01128,3.4.21.34,P03952
452533365,Active,1265727,136923162,0,16220264,3818,9606,26575094,Confirmatory,20180904,0,0,P03952,IC50,1.34,ChEMBL,Inhibition of human plasma kallikrein using D-Pro-Phe-Arg-pNA-2HCl as substrate measured for 5 mins by spectrophotometric assay,NULL,Plasma kallikrein (human),/gene/3818,10.1021/acs.jmedchem.5b01171,3.4.21.34,P03952
452533369,Active,1265727,103292587,0,3447,3818,9606,26575094,Confirmatory,20180904,0,0,P03952,IC50,1.35,ChEMBL,Inhibition of human plasma kallikrein using D-Pro-Phe-Arg-pNA-2HCl as substrate measured for 5 mins by spectrophotometric assay,NULL,Plasma kallikrein (human),/gene/3818,10.1021/acs.jmedchem.5b01171,3.4.21.34,P03952
452565173,Active,1271914,336868696,0,127027302,3818,9606,26704266,Confirmatory,20180904,0,0,P03952,Ki,0.804,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2015.11.089,3.4.21.34,P03952
452565174,Active,1271914,336868697,0,127027303,3818,9606,26704266,Confirmatory,20180904,0,0,P03952,Ki,0.317,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2015.11.089,3.4.21.34,P03952
452565175,Active,1271914,336869133,0,25166810,3818,9606,26704266,Confirmatory,20180904,0,0,P03952,Ki,0.27,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2015.11.089,3.4.21.34,P03952
452565178,Active,1271914,336869134,0,59402039,3818,9606,26704266,Confirmatory,20180904,0,0,P03952,Ki,0.023,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2015.11.089,3.4.21.34,P03952
452565180,Active,1271914,336872306,0,127029803,3818,9606,26704266,Confirmatory,20180904,0,0,P03952,Ki,0.12,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2015.11.089,3.4.21.34,P03952
452565182,Active,1271914,336872307,0,136003658,3818,9606,26704266,Confirmatory,20180904,0,0,P03952,Ki,0.036,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2015.11.089,3.4.21.34,P03952
452565183,Active,1271914,336872308,0,59402077,3818,9606,26704266,Confirmatory,20180904,0,0,P03952,Ki,0.02,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2015.11.089,3.4.21.34,P03952
452565188,Active,1271914,336865552,0,59401943,3818,9606,26704266,Confirmatory,20180904,0,0,P03952,Ki,0.024,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2015.11.089,3.4.21.34,P03952
452565196,Active,1271914,336866045,0,59402011,3818,9606,26704266,Confirmatory,20180904,0,0,P03952,Ki,0.11,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2015.11.089,3.4.21.34,P03952
452565197,Active,1271914,336868676,0,59401924,3818,9606,26704266,Confirmatory,20180904,0,0,P03952,Ki,0.35,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2015.11.089,3.4.21.34,P03952
452565207,Active,1271914,336872304,0,59402125,3818,9606,26704266,Confirmatory,20180904,0,0,P03952,Ki,0.24,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2015.11.089,3.4.21.34,P03952
452565214,Active,1271914,336865998,0,54741583,3818,9606,26704266,Confirmatory,20180904,0,0,P03952,Ki,0.028,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2015.11.089,3.4.21.34,P03952
452565218,Active,1271914,336865999,0,25166809,3818,9606,26704266,Confirmatory,20180904,0,0,P03952,Ki,0.122,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2015.11.089,3.4.21.34,P03952
452565221,Active,1271914,336866000,0,59402239,3818,9606,26704266,Confirmatory,20180904,0,0,P03952,Ki,0.21,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2015.11.089,3.4.21.34,P03952
452565224,Active,1271914,336868674,0,25166807,3818,9606,26704266,Confirmatory,20180904,0,0,P03952,Ki,0.13,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2015.11.089,3.4.21.34,P03952
452565231,Active,1271914,336869155,0,127027635,3818,9606,26704266,Confirmatory,20180904,0,0,P03952,Ki,0.059,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2015.11.089,3.4.21.34,P03952
452565237,Active,1271914,336869156,0,127027636,3818,9606,26704266,Confirmatory,20180904,0,0,P03952,Ki,0.055,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2015.11.089,3.4.21.34,P03952
452565238,Active,1271914,336865551,0,25167018,3818,9606,26704266,Confirmatory,20180904,0,0,P03952,Ki,0.12,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2015.11.089,3.4.21.34,P03952
452565239,Active,1271914,336865592,0,127025168,3818,9606,26704266,Confirmatory,20180904,0,0,P03952,Ki,0.0075,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2015.11.089,3.4.21.34,P03952
452565243,Active,1271914,336866044,0,59401978,3818,9606,26704266,Confirmatory,20180904,0,0,P03952,Ki,0.34,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2015.11.089,3.4.21.34,P03952
452565245,Active,1271914,336868675,0,25166808,3818,9606,26704266,Confirmatory,20180904,0,0,P03952,Ki,0.17,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2015.11.089,3.4.21.34,P03952
452565246,Active,1271914,336868695,0,59402220,3818,9606,26704266,Confirmatory,20180904,0,0,P03952,Ki,0.046,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2015.11.089,3.4.21.34,P03952
452565247,Active,1271914,336872305,0,127029802,3818,9606,26704266,Confirmatory,20180904,0,0,P03952,Ki,0.15,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2015.11.089,3.4.21.34,P03952
452852437,Active,1288598,336876467,0,118987013,3818,9606,27073051,Confirmatory,20180905,0,0,P03952,Ki,0.042,ChEMBL,Inhibition of human plasma kallikrein assessed as reduction in release of p-nitroaniline after 10 to 120 mins by Michaelis-Menten equation analysis,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmc.2016.03.062,3.4.21.34,P03952
452852438,Active,1288598,336874657,0,127031390,3818,9606,27073051,Confirmatory,20180905,0,0,P03952,Ki,0.55,ChEMBL,Inhibition of human plasma kallikrein assessed as reduction in release of p-nitroaniline after 10 to 120 mins by Michaelis-Menten equation analysis,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmc.2016.03.062,3.4.21.34,P03952
452852439,Active,1288598,312376755,0,86583041,3818,9606,27073051,Confirmatory,20180905,0,0,P03952,Ki,0.024,ChEMBL,Inhibition of human plasma kallikrein assessed as reduction in release of p-nitroaniline after 10 to 120 mins by Michaelis-Menten equation analysis,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmc.2016.03.062,3.4.21.34,P03952
452852440,Active,1288598,336872331,0,57976410,3818,9606,27073051,Confirmatory,20180905,0,0,P03952,Ki,1.85,ChEMBL,Inhibition of human plasma kallikrein assessed as reduction in release of p-nitroaniline after 10 to 120 mins by Michaelis-Menten equation analysis,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmc.2016.03.062,3.4.21.34,P03952
452854176,Active,1288744,336879254,0,44537923,3818,9606,,Confirmatory,20180905,0,0,P03952,IC50,19,ChEMBL,Inhibition of kallikrein (unknown origin),NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453180335,Active,1315784,374280881,0,72551247,3818,9606,27455395,Confirmatory,20180906,0,0,P03952,Ki,0.52,ChEMBL,Inhibition of human plasma kallikrein using H-(D)-Pro-Phe-Arg-pNA as substrate assessed as release of pNA after 10 to 120 mins by spectrophotometric method,NULL,Plasma kallikrein (human),/gene/3818,10.1021/acs.jmedchem.6b00469,3.4.21.34,P03952
453294766,Active,1337085,374266174,0,134131303,3818,9606,28197309,Confirmatory,20180907,0,0,P03952,IC50,0.0048,ChEMBL,Inhibition of human plasma kallikrein using D-Pro-Phe-Arg-pNA as substrate preincubated for 30 mins followed by substrate addition,NULL,Plasma kallikrein (human),/gene/3818,10.1021/acsmedchemlett.6b00384,3.4.21.34,P03952
453294768,Active,1337085,374265856,0,134131077,3818,9606,28197309,Confirmatory,20180907,0,0,P03952,IC50,0.153,ChEMBL,Inhibition of human plasma kallikrein using D-Pro-Phe-Arg-pNA as substrate preincubated for 30 mins followed by substrate addition,NULL,Plasma kallikrein (human),/gene/3818,10.1021/acsmedchemlett.6b00384,3.4.21.34,P03952
453294771,Active,1337085,374265896,0,134131107,3818,9606,28197309,Confirmatory,20180907,0,0,P03952,IC50,8.31,ChEMBL,Inhibition of human plasma kallikrein using D-Pro-Phe-Arg-pNA as substrate preincubated for 30 mins followed by substrate addition,NULL,Plasma kallikrein (human),/gene/3818,10.1021/acsmedchemlett.6b00384,3.4.21.34,P03952
453294798,Active,1337085,374265864,0,134131084,3818,9606,28197309,Confirmatory,20180907,0,0,P03952,IC50,0.0423,ChEMBL,Inhibition of human plasma kallikrein using D-Pro-Phe-Arg-pNA as substrate preincubated for 30 mins followed by substrate addition,NULL,Plasma kallikrein (human),/gene/3818,10.1021/acsmedchemlett.6b00384,3.4.21.34,P03952
453294799,Active,1337085,374266270,0,134131383,3818,9606,28197309,Confirmatory,20180907,0,0,P03952,IC50,1.21,ChEMBL,Inhibition of human plasma kallikrein using D-Pro-Phe-Arg-pNA as substrate preincubated for 30 mins followed by substrate addition,NULL,Plasma kallikrein (human),/gene/3818,10.1021/acsmedchemlett.6b00384,3.4.21.34,P03952
453294800,Active,1337085,374265360,0,134130781,3818,9606,28197309,Confirmatory,20180907,0,0,P03952,IC50,0.0024,ChEMBL,Inhibition of human plasma kallikrein using D-Pro-Phe-Arg-pNA as substrate preincubated for 30 mins followed by substrate addition,NULL,Plasma kallikrein (human),/gene/3818,10.1021/acsmedchemlett.6b00384,3.4.21.34,P03952
453294801,Active,1337085,374266568,0,134131589,3818,9606,28197309,Confirmatory,20180907,0,0,P03952,IC50,0.002,ChEMBL,Inhibition of human plasma kallikrein using D-Pro-Phe-Arg-pNA as substrate preincubated for 30 mins followed by substrate addition,NULL,Plasma kallikrein (human),/gene/3818,10.1021/acsmedchemlett.6b00384,3.4.21.34,P03952
453294802,Active,1337085,374265809,0,134131040,3818,9606,28197309,Confirmatory,20180907,0,0,P03952,IC50,1.57,ChEMBL,Inhibition of human plasma kallikrein using D-Pro-Phe-Arg-pNA as substrate preincubated for 30 mins followed by substrate addition,NULL,Plasma kallikrein (human),/gene/3818,10.1021/acsmedchemlett.6b00384,3.4.21.34,P03952
453760690,Active,1343645,374310496,0,89350829,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.764,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760691,Active,1343645,374300791,0,118520054,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.86,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760692,Active,1343645,374327691,0,71187364,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.457,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760693,Active,1343645,374348425,0,71204163,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.01,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760694,Active,1343645,374331952,0,71204124,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.045,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760695,Active,1343645,374348145,0,122362656,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,2.083,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760696,Active,1343645,374351944,0,122199213,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.417,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760697,Active,1343645,374326582,0,89350754,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.598,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760698,Active,1343645,374274436,0,122199206,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,10,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760699,Active,1343645,374335293,0,122199208,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.452,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760700,Active,1343645,374335268,0,122199211,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.455,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760701,Active,1343645,374293774,0,122199212,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.427,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760702,Active,1343645,374325194,0,122199215,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.519,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760703,Active,1343645,374282725,0,122199209,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.539,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760704,Active,1343645,374341778,0,122199210,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.485,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760705,Active,1343645,374336026,0,122199207,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.545,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760706,Active,1343645,374359641,0,122199214,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.54,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760707,Active,1343645,374277607,0,71185507,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.241,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760708,Active,1343645,374305399,0,71185534,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.424,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760709,Active,1343645,374269703,0,71185541,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.398,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760710,Active,1343645,374360668,0,71185593,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.047,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760711,Active,1343645,374358879,0,71185648,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.65,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760712,Active,1343645,374333980,0,71185660,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.025,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760713,Active,1343645,374349705,0,71185662,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,10,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760714,Active,1343645,374357660,0,71185663,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.934,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760715,Active,1343645,374298931,0,71185671,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,1.083,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760716,Active,1343645,374338491,0,71185696,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,1,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760717,Active,1343645,374334681,0,71185707,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,NULL,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760718,Active,1343645,374334681,0,71185707,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,2.1,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760719,Active,1343645,374322429,0,71185712,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,10,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760720,Active,1343645,374337039,0,71185720,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,10,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760721,Active,1343645,374267699,0,71185740,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.012,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760722,Active,1343645,374293987,0,71185766,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,10,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760723,Active,1343645,374330187,0,71185771,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.17,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760724,Active,1343645,374297128,0,71185782,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,7.54,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760725,Active,1343645,374294268,0,71185798,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.621,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760726,Active,1343645,374279361,0,71185838,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.45,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760727,Active,1343645,374335601,0,71185879,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.081,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760728,Active,1343645,374331423,0,71185907,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.254,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760729,Active,1343645,374357174,0,71185969,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.159,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760730,Active,1343645,374296725,0,71185978,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.185,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760731,Active,1343645,374294322,0,71185980,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.18,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760732,Active,1343645,374291078,0,71186063,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.474,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760733,Active,1343645,374295340,0,71186065,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,8.2,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760734,Active,1343645,374316463,0,71186096,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,1.3,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760735,Active,1343645,374303813,0,71186105,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.576,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760736,Active,1343645,374290642,0,71186140,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.08,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760737,Active,1343645,374346564,0,71186165,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,1,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760738,Active,1343645,374317066,0,71186172,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,2.009,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760739,Active,1343645,374279695,0,71186174,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,1.3,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760740,Active,1343645,374308644,0,71186175,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,2.491,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760741,Active,1343645,374339143,0,71186187,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.31,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760742,Active,1343645,374349738,0,76901379,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.042,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760743,Active,1343645,374315963,0,90301817,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,5.1,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760744,Active,1343645,374351015,0,71185488,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.82,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760745,Active,1343645,374352854,0,71185519,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.47,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760746,Active,1343645,374324177,0,71185520,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,10,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760747,Active,1343645,374339216,0,71185521,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.031,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760748,Active,1343645,374292241,0,71185535,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,1.209,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760749,Active,1343645,374333635,0,71185545,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,4.7,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760750,Active,1343645,374290218,0,71185567,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.73,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760751,Active,1343645,374334353,0,71185569,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.048,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760752,Active,1343645,374298774,0,71185586,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.34,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760753,Active,1343645,374348961,0,71185589,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,7.2,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760754,Active,1343645,374284065,0,71185601,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.276,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760755,Active,1343645,374297989,0,71185604,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.4,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760756,Active,1343645,374278703,0,71185610,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,2,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760757,Active,1343645,374324760,0,71185645,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,10,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760758,Active,1343645,374329857,0,71185646,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.34,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760759,Active,1343645,374341676,0,71185650,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,8.9,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760760,Active,1343645,374336025,0,71185653,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.126,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760761,Active,1343645,374289030,0,71185666,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,8.8,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760762,Active,1343645,374323022,0,71185684,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.46,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760763,Active,1343645,374323125,0,71185705,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.29,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760764,Active,1343645,374276765,0,71185746,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.078,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760765,Active,1343645,374287809,0,71185756,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.58,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760766,Active,1343645,374341660,0,71185793,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.046,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760767,Active,1343645,374323525,0,71185799,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.79,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760768,Active,1343645,374340423,0,71185839,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.755,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760769,Active,1343645,374284135,0,71185842,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,4.3,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760770,Active,1343645,374337514,0,71185845,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.53,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760771,Active,1343645,374318945,0,71185867,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.022,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760772,Active,1343645,374334522,0,71185917,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.74,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760773,Active,1343645,374265464,0,71185943,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,1.8,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760774,Active,1343645,374303539,0,71185997,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.31,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760775,Active,1343645,374277898,0,71186011,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,10,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760776,Active,1343645,374268509,0,71186043,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.861,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760777,Active,1343645,374299927,0,71186049,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.089,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760778,Active,1343645,374332599,0,71186113,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.012,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760779,Active,1343645,374301331,0,71186117,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.091,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760780,Active,1343645,374328573,0,71186163,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,10,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760781,Active,1343645,374313832,0,71187144,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.028,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760782,Active,1343645,374349162,0,90302182,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.051,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760783,Active,1343645,374345064,0,90302159,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,5.8,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760784,Active,1343645,374268263,0,90302844,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,1.08,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760785,Active,1343645,374314966,0,90306458,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,1.6,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760786,Active,1343645,374346551,0,90302004,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.01,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760787,Active,1343645,374332522,0,71185486,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,4.013,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760788,Active,1343645,374328258,0,71185506,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,1.7,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760789,Active,1343645,374310176,0,71185530,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,10,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760790,Active,1343645,374354589,0,71185561,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.3,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760791,Active,1343645,374317996,0,71185568,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.074,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760792,Active,1343645,374319611,0,71185576,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,1.017,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760793,Active,1343645,374326520,0,71185578,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.23,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760794,Active,1343645,374286176,0,71185627,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,3.4,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760795,Active,1343645,374359001,0,71185632,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.31,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760796,Active,1343645,374329228,0,71185658,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.2,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760797,Active,1343645,374338911,0,71185695,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.175,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760798,Active,1343645,374299889,0,71185721,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.021,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760799,Active,1343645,374274987,0,71185787,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,10,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760800,Active,1343645,374357947,0,71185801,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,10,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760801,Active,1343645,374276918,0,71185811,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,10,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760802,Active,1343645,374318098,0,71185818,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,1.3,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760803,Active,1343645,374281814,0,71185850,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.095,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760804,Active,1343645,374309113,0,71185860,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.05,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760805,Active,1343645,374271602,0,71185878,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,4.3,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760806,Active,1343645,374337577,0,71185886,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.219,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760807,Active,1343645,374337291,0,71185934,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.064,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760808,Active,1343645,374295595,0,71185938,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.214,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760809,Active,1343645,374343250,0,71185964,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.09,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760810,Active,1343645,374357254,0,71186020,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,2.2,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760811,Active,1343645,374289150,0,71186101,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,1.959,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760812,Active,1343645,374269087,0,71186135,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,1.4,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760813,Active,1343645,374279651,0,71186147,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.077,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760814,Active,1343645,374332965,0,71187198,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.22,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760815,Active,1343645,374276467,0,76901757,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,NULL,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760816,Active,1343645,374276467,0,76901757,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.007,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760817,Active,1343645,374303484,0,76901566,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.032,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760818,Active,1343645,374361708,0,76901567,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.007,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760819,Active,1343645,374334954,0,76901380,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.013,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760820,Active,1343645,374337576,0,71185478,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,2,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760821,Active,1343645,374268561,0,71185485,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,1.113,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760822,Active,1343645,374316784,0,71185495,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.5,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760823,Active,1343645,374352702,0,71185539,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.053,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760824,Active,1343645,374285984,0,71185608,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,1.141,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760825,Active,1343645,374307662,0,71185613,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.052,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760826,Active,1343645,374278137,0,71185674,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.04,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760827,Active,1343645,374359125,0,71185698,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.91,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760828,Active,1343645,374296857,0,71185716,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.022,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760829,Active,1343645,374314746,0,71185751,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.232,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760830,Active,1343645,374340618,0,71185775,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.099,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760831,Active,1343645,374288733,0,71185872,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.262,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760832,Active,1343645,374279109,0,71185895,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,1.1,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760833,Active,1343645,374273777,0,71185939,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.01,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760834,Active,1343645,374264051,0,71185941,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,10,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760835,Active,1343645,374323981,0,71185963,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.083,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760836,Active,1343645,374275513,0,71185979,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.032,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760837,Active,1343645,374346341,0,71185989,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.155,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760838,Active,1343645,374357407,0,71185996,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.046,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760839,Active,1343645,374341940,0,71186001,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.521,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760840,Active,1343645,374311227,0,71186002,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.031,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760841,Active,1343645,374264333,0,71186092,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.423,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760842,Active,1343645,374310868,0,71499156,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,NULL,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760843,Active,1343645,374310868,0,71499156,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.014,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760844,Active,1343645,374318356,0,71499165,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.025,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760845,Active,1343645,374284880,0,71499167,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.038,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760846,Active,1343645,374346418,0,71499168,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.012,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760847,Active,1343645,374267566,0,71499173,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.058,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760848,Active,1343645,374292095,0,71499183,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.298,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760849,Active,1343645,374289921,0,71499201,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.015,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760850,Active,1343645,374339925,0,71499276,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.232,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760851,Active,1343645,374266889,0,71499303,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.123,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760852,Active,1343645,374305958,0,71499401,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.047,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760853,Active,1343645,374350385,0,71499475,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.256,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760854,Active,1343645,374309544,0,71499155,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.023,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760855,Active,1343645,374276021,0,71499158,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.025,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760856,Active,1343645,374315530,0,71499248,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.055,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760857,Active,1343645,374354035,0,71499304,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.284,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760858,Active,1343645,374268481,0,71499479,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.01,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760859,Active,1343645,374284862,0,71499498,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.049,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760860,Active,1343645,374287132,0,71499500,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.028,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760861,Active,1343645,374297706,0,71499166,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.27,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760862,Active,1343645,374319431,0,71499172,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.04,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760863,Active,1343645,374359038,0,71499184,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.133,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760864,Active,1343645,374276047,0,71499185,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.018,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760865,Active,1343645,374302869,0,71499249,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.096,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760866,Active,1343645,374337246,0,71499277,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.01,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760867,Active,1343645,374324896,0,71499331,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.045,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760868,Active,1343645,374281829,0,71499363,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.023,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760869,Active,1343645,374275811,0,71499364,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.01,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760870,Active,1343645,374279989,0,71499365,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.009,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760871,Active,1343645,374361129,0,71499431,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.036,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760872,Active,1343645,374315588,0,71499476,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.083,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760873,Active,1343645,374346155,0,71499497,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.073,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760874,Active,1343645,374352086,0,71499499,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.014,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760875,Active,1343645,374281123,0,71499157,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.02,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760876,Active,1343645,374317887,0,71499200,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.061,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760877,Active,1343645,374272815,0,71499221,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.044,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760878,Active,1343645,374268830,0,71499222,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.076,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760879,Active,1343645,374298596,0,71499250,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.045,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760880,Active,1343645,374283520,0,71499278,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.02,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760881,Active,1343645,374309140,0,71499330,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.213,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760882,Active,1343645,374279092,0,71499332,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.881,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760883,Active,1343645,374279026,0,71499399,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.051,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760884,Active,1343645,374275387,0,71499400,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.022,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760885,Active,1343645,374336691,0,71499432,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.015,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760886,Active,1343645,374330121,0,71499433,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.049,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760887,Active,1343645,374266858,0,71499451,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.01,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760888,Active,1343645,374295186,0,71499452,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.07,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760889,Active,1343645,374303124,0,71499477,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.003,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453760890,Active,1343645,374359964,0,71499478,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.015,ChEMBL,"In Vitro Inhibition Assay: Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori et al., Biochem. Pharmacol., 1992, 43, 1209; Stiirzebecher et al.,",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776562,Active,1343924,374295668,0,56835798,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.006,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776563,Active,1343924,374329705,0,56835799,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,1.3,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776565,Active,1343924,374312434,0,56835801,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,2,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776566,Active,1343924,374278170,0,56835860,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.642,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776568,Active,1343924,374296890,0,56835861,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.752,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776570,Active,1343924,374333931,0,56835862,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.369,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776571,Active,1343924,374289768,0,56835925,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.291,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776572,Active,1343924,374302238,0,56835928,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,4.1,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776573,Active,1343924,374289386,0,56836188,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.0002,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776574,Active,1343924,374338152,0,56836327,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,1.7,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776575,Active,1343924,374343468,0,56836484,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.009,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776576,Active,1343924,374289127,0,56836485,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,3.9,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776577,Active,1343924,374306407,0,56836487,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.634,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776578,Active,1343924,374359814,0,56836488,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,35.5,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776579,Active,1343924,374303256,0,56836554,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.045,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776580,Active,1343924,374294766,0,56836704,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.379,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776581,Active,1343924,374300902,0,56836785,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.19,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776582,Active,1343924,374320370,0,56836786,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.06,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776583,Active,1343924,374347689,0,56836859,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.018,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776584,Active,1343924,374342257,0,56836861,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.166,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776585,Active,1343924,374269062,0,56836926,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.937,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776586,Active,1343924,374349759,0,56836929,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.014,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776587,Active,1343924,374297309,0,56835924,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,1.9,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776588,Active,1343924,374349926,0,56835993,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.498,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776589,Active,1343924,374350987,0,56835995,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.009,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776590,Active,1343924,374332110,0,56835998,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.036,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776591,Active,1343924,374344117,0,56836060,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.061,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776592,Active,1343924,374274036,0,56836061,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.075,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776593,Active,1343924,374294306,0,56836122,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,7.67,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776594,Active,1343924,374328543,0,56836125,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,7.6,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776595,Active,1343924,374309707,0,56836190,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.32,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776596,Active,1343924,374307008,0,56836260,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,2.54,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776597,Active,1343924,374289671,0,56836261,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.019,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776598,Active,1343924,374295303,0,56836330,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.009,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776599,Active,1343924,374281424,0,56836332,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.021,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776600,Active,1343924,374282635,0,56836409,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.046,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776601,Active,1343924,374331267,0,56836411,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.262,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776602,Active,1343924,374322718,0,56836413,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.215,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776603,Active,1343924,374310091,0,56836483,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.113,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776604,Active,1343924,374297391,0,56836486,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,1.1,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776605,Active,1343924,374282783,0,56836552,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.679,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776606,Active,1343924,374278496,0,56836553,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.108,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776607,Active,1343924,374277580,0,56836555,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,3.2,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776608,Active,1343924,374356310,0,56836622,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.143,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776609,Active,1343924,374304593,0,56836624,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,1.8,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776610,Active,1343924,374322318,0,56836627,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.046,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776611,Active,1343924,374304091,0,56836705,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.681,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776612,Active,1343924,374290691,0,56836708,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,3.8,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776613,Active,1343924,374278657,0,56836782,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,7,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776614,Active,1343924,374335829,0,56836858,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.0031,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776615,Active,1343924,374270849,0,56836930,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.029,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776616,Active,1343924,374291855,0,56835797,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.325,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776617,Active,1343924,374292825,0,56835800,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.133,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776618,Active,1343924,374333202,0,56835858,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,3.8,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776619,Active,1343924,374308883,0,56835922,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.867,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776620,Active,1343924,374301834,0,56835926,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,1.8,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776621,Active,1343924,374353190,0,56835996,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.071,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776622,Active,1343924,374305759,0,56836124,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,2.26,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776623,Active,1343924,374269995,0,56836192,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,2.03,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776624,Active,1343924,374266702,0,56836193,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.03,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776625,Active,1343924,374358371,0,56836257,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,12.2,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776626,Active,1343924,374320315,0,56836258,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.15,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776627,Active,1343924,374314835,0,56836329,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.238,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776628,Active,1343924,374271048,0,56836331,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.248,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776629,Active,1343924,374308064,0,56836408,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.204,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776630,Active,1343924,374307046,0,56836623,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.041,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776631,Active,1343924,374273505,0,56836626,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,6.3,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776632,Active,1343924,374345535,0,56836706,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.011,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776633,Active,1343924,374314402,0,56836709,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,4.4,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776634,Active,1343924,374289349,0,56836781,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.739,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776635,Active,1343924,374325098,0,56836860,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.117,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776636,Active,1343924,374332918,0,56836862,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.678,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776637,Active,1343924,374360310,0,56836863,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.411,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776638,Active,1343924,374346137,0,56836927,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.114,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776639,Active,1343924,374313195,0,56836928,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,4.1,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776640,Active,1343924,374309762,0,56835859,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.07,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776641,Active,1343924,374358715,0,56835863,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.485,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776642,Active,1343924,374349657,0,56835923,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.0021,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776643,Active,1343924,374279331,0,56835927,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.674,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776644,Active,1343924,374270253,0,56835997,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.67,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776645,Active,1343924,374302157,0,56836123,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,2.64,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776646,Active,1343924,374349790,0,56836189,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.15,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776647,Active,1343924,374277759,0,56836191,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,9.12e-05,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776648,Active,1343924,374329199,0,56836259,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.23,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776649,Active,1343924,374291996,0,56836262,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.109,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776650,Active,1343924,374318772,0,56836328,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.343,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776651,Active,1343924,374286231,0,56836410,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.000134,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776652,Active,1343924,374327563,0,56836783,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,3.6,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776653,Active,1343924,374309027,0,56836784,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,1.6,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776654,Active,1343924,374328981,0,56836925,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.949,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776655,Active,1343924,374269602,0,56836412,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.019,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776656,Active,1343924,374301390,0,56836556,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,5.3,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776657,Active,1343924,374318720,0,56836557,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.145,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776658,Active,1343924,374304429,0,56836625,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.144,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776659,Active,1343924,374355636,0,56836707,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.209,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776660,Active,1343924,374283825,0,66723582,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.007,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776661,Active,1343924,374275350,0,58081177,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,1.1,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776662,Active,1343924,374332674,0,58081204,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.002,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776663,Active,1343924,374294803,0,58081219,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,45,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776664,Active,1343924,374297129,0,58081227,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.0078,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776665,Active,1343924,374321028,0,58081230,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.0097,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776666,Active,1343924,374357511,0,58081241,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,1.8,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776667,Active,1343924,374269184,0,58081244,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.06,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776668,Active,1343924,374357274,0,58081264,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,4e-05,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776669,Active,1343924,374308460,0,58081265,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.003,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776670,Active,1343924,374293399,0,58081267,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.098,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776671,Active,1343924,374274332,0,58081271,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.0026,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776672,Active,1343924,374358514,0,58081288,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.196,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776673,Active,1343924,374347799,0,58081291,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,1.2,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776674,Active,1343924,374323485,0,58081310,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,2.1,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776676,Active,1343924,374356841,0,58081320,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.005,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776677,Active,1343924,374280166,0,58081326,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.016,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776678,Active,1343924,374326523,0,58081339,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,10.1,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776679,Active,1343924,374283424,0,58081345,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,4,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776681,Active,1343924,374357344,0,58081360,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.244,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776682,Active,1343924,374341176,0,66723684,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.016,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776683,Active,1343924,374323823,0,66723766,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.0033,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776684,Active,1343924,374344261,0,66723843,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.183,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776685,Active,1343924,374342432,0,58081180,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.197,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776686,Active,1343924,374266399,0,58081184,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.067,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776687,Active,1343924,374277545,0,58081196,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.798,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776688,Active,1343924,374333049,0,58081200,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,NULL,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776689,Active,1343924,374333049,0,58081200,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,7,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776690,Active,1343924,374312230,0,58081242,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.0001,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776691,Active,1343924,374338495,0,58081248,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.0004,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776692,Active,1343924,374356554,0,58081250,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.003,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776693,Active,1343924,374309365,0,58081254,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.0001,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776694,Active,1343924,374346458,0,58081275,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,42.4,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776695,Active,1343924,374266840,0,58081299,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.005,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776696,Active,1343924,374347185,0,58081309,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.089,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776697,Active,1343924,374293571,0,58081327,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.004,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776698,Active,1343924,374302456,0,58081333,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.004,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776699,Active,1343924,374309422,0,58081334,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.127,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776700,Active,1343924,374301804,0,58081340,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,7.4,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776701,Active,1343924,374352794,0,58081342,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.072,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776702,Active,1343924,374309474,0,58081346,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.0046,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776703,Active,1343924,374293479,0,58081195,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.013,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776704,Active,1343924,374361724,0,58081207,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.113,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776705,Active,1343924,374310343,0,58081208,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.301,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776706,Active,1343924,374286236,0,58081243,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.0002,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776707,Active,1343924,374269031,0,58081292,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,4.5,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776708,Active,1343924,374298836,0,58081301,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.034,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776711,Active,1343924,374345557,0,58081335,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.026,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776712,Active,1343924,374265487,0,58081338,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.0012,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776713,Active,1343924,374299231,0,58081343,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.02,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776715,Active,1343924,374278055,0,66723385,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.071,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776716,Active,1343924,374346870,0,66723409,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,1.3,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776717,Active,1343924,374359436,0,66723596,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.152,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776718,Active,1343924,374285187,0,58081158,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,1.37,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776719,Active,1343924,374344451,0,58081164,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,2.24e-05,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776720,Active,1343924,374332149,0,58081165,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.595,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776721,Active,1343924,374361544,0,58081168,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.002,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776722,Active,1343924,374301397,0,58081186,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.81,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776723,Active,1343924,374276112,0,58081190,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.006,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776724,Active,1343924,374278352,0,58081205,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.01,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776725,Active,1343924,374300945,0,58081206,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.229,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776726,Active,1343924,374307131,0,58081222,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.00092,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776728,Active,1343924,374346837,0,58081255,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.07,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776729,Active,1343924,374349647,0,58081259,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.0002,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776730,Active,1343924,374358088,0,66723583,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,5.8,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776731,Active,1343924,374286006,0,66723607,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,15.8,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776732,Active,1343924,374272400,0,66723614,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.415,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776733,Active,1343924,374343247,0,66723687,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.03,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776734,Active,1343924,374314632,0,66723764,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.168,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776736,Active,1343924,374273590,0,58081260,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,3e-05,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776737,Active,1343924,374334473,0,58081263,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.223,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776738,Active,1343924,374337313,0,58081279,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,5.7,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776739,Active,1343924,374275928,0,58081287,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,1.1,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776740,Active,1343924,374286508,0,58081296,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.024,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776741,Active,1343924,374270164,0,58081298,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.0002,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776742,Active,1343924,374336610,0,58081304,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,37,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776743,Active,1343924,374302803,0,58081316,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.289,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776744,Active,1343924,374354158,0,58081321,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.299,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776745,Active,1343924,374285285,0,58081359,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.004,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776746,Active,1343924,374311491,0,58081365,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.0049,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776747,Active,1343924,374360058,0,58081367,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.249,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811639,Active,1344651,374322955,0,134147089,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.077,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811640,Active,1344651,374355479,0,134156310,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.00056,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811641,Active,1344651,374323129,0,134147141,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.038,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811642,Active,1344651,374290053,0,134137941,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.1545,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811643,Active,1344651,374289421,0,134137772,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.02546,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811644,Active,1344651,374289512,0,134137795,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.338,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811645,Active,1344651,374289560,0,134137809,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.03929,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811646,Active,1344651,374355894,0,134156402,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,3.809,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811647,Active,1344651,374354615,0,134156074,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.02157,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811648,Active,1344651,374322362,0,134146924,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.669,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811649,Active,1344651,374321543,0,134146712,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.003,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811650,Active,1344651,374355840,0,134156389,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.06,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811651,Active,1344651,374355571,0,134156331,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,2.027,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811652,Active,1344651,374345385,0,73052987,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.001,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811653,Active,1344651,374354882,0,134156147,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.005,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811654,Active,1344651,374354932,0,134156162,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.00296,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811655,Active,1344651,374355123,0,134156223,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.049,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811656,Active,1344651,374291092,0,134138214,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,9.318,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811657,Active,1344651,374291206,0,134138251,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.06046,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811658,Active,1344651,374321983,0,134146824,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.00227,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811659,Active,1344651,374322753,0,134147029,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.013,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811660,Active,1344651,374278636,0,137303216,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.2708,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811661,Active,1344651,374278257,0,137303208,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,1.317,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811662,Active,1344651,374298136,0,137283385,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.5012,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811663,Active,1344651,374311289,0,137290224,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.052,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811664,Active,1344651,374354816,0,137316438,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.004,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811665,Active,1344651,374270528,0,134132671,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.137,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811666,Active,1344651,374270363,0,134132632,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.001,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811667,Active,1344651,374273637,0,134133517,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.0031,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811668,Active,1344651,374331232,0,90060437,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,3.92,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811669,Active,1344651,374294407,0,90060521,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.00685,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811670,Active,1344651,374290136,0,90060542,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.196,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811671,Active,1344651,374313141,0,90060582,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.107,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811672,Active,1344651,374292852,0,90060346,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.088,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811673,Active,1344651,374323647,0,90060373,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.004,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811674,Active,1344651,374306433,0,90060422,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.214,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811675,Active,1344651,374305038,0,90060469,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.0243,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811676,Active,1344651,374348549,0,90060522,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.029,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811677,Active,1344651,374274640,0,134133778,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.1249,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811678,Active,1344651,374360694,0,90060550,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.026,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811679,Active,1344651,374279286,0,134135041,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.1989,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811680,Active,1344651,374279389,0,134135078,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.0039,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811681,Active,1344651,374314601,0,90060433,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.04,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811682,Active,1344651,374354292,0,90060487,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.89,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811683,Active,1344651,374350549,0,90060534,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.003,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811684,Active,1344651,374318645,0,90060547,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.006,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811685,Active,1344651,374278503,0,134134823,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,6.046,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811686,Active,1344651,374321927,0,137314328,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.1464,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811687,Active,1344651,374272649,0,134133253,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.045,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811688,Active,1344651,374312721,0,137290245,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.973,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811689,Active,1344651,374275783,0,134134067,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.003,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811690,Active,1344651,374269806,0,134132503,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.02649,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811691,Active,1344651,374270092,0,134132571,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.01562,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811692,Active,1344651,374273750,0,134133546,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.05011,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811693,Active,1344651,374265987,0,134131180,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.001,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811694,Active,1344651,374277092,0,134134447,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.001,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811695,Active,1344651,374274603,0,134133766,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.02801,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811696,Active,1344651,374274246,0,134133679,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,NULL,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811697,Active,1344651,374274246,0,134133679,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.5226,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811699,Active,1344651,374274385,0,134133713,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,NULL,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811700,Active,1344651,374274385,0,134133713,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,NULL,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811701,Active,1344651,374274385,0,134133713,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,NULL,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811702,Active,1344651,374274385,0,134133713,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,NULL,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811703,Active,1344651,374274385,0,134133713,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.1648,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811704,Active,1344651,374281172,0,134135577,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.00361,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811705,Active,1344651,374281247,0,134135597,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.3622,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811706,Active,1344651,374279777,0,134135191,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.00751,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811707,Active,1344651,374285750,0,134136822,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.7388,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811708,Active,1344651,374281098,0,134135553,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,NULL,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811709,Active,1344651,374281098,0,134135553,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,NULL,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811710,Active,1344651,374281098,0,134135553,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.00568,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811711,Active,1344651,374285521,0,134136751,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.002,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811712,Active,1344651,374285369,0,134136696,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.001,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811713,Active,1344651,374288281,0,134137485,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.00887,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811714,Active,1344651,374278081,0,134134713,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.002,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811715,Active,1344651,374307866,0,134142878,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.01431,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811716,Active,1344651,374307181,0,134142698,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.053,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811717,Active,1344651,374298421,0,134140246,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,1.027,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811718,Active,1344651,374305442,0,134142188,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.068,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811719,Active,1344651,374306010,0,134142358,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.00329,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811720,Active,1344651,374292490,0,134138631,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.015,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811721,Active,1344651,374293558,0,134138946,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,3.37,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811722,Active,1344651,374291920,0,134138477,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.019,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811723,Active,1344651,374288223,0,134137468,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.02871,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811724,Active,1344651,374279380,0,134135072,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.7684,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811725,Active,1344651,374276807,0,134134352,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.047,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811726,Active,1344651,374281820,0,90060543,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,NULL,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811727,Active,1344651,374281820,0,90060543,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.4834,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811728,Active,1344651,374334030,0,90060546,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.015,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811729,Active,1344651,374334633,0,134150336,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.001,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811730,Active,1344651,374347946,0,134154182,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.1179,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811731,Active,1344651,374335260,0,134150512,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.004,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811732,Active,1344651,374352074,0,134155348,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.006,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811733,Active,1344651,374351299,0,134155112,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.066,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811734,Active,1344651,374300121,0,134140695,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.01732,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811735,Active,1344651,374302443,0,134141364,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.002,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811737,Active,1344651,374348886,0,134154429,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.025,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811738,Active,1344651,374352046,0,134155335,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.01738,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811739,Active,1344651,374361653,0,134158008,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.02255,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811740,Active,1344651,374268046,0,134131995,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.0116,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811741,Active,1344651,374317844,0,134145667,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.09128,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811742,Active,1344651,374286741,0,134137087,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.1126,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811743,Active,1344651,374267325,0,134131797,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.00179,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811744,Active,1344651,374300328,0,134140758,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,1.968,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811745,Active,1344651,374268142,0,134132025,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.4573,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811746,Active,1344651,374283164,0,134136115,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.00483,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811747,Active,1344651,374360863,0,134157780,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.1874,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811748,Active,1344651,374284205,0,134136409,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.002,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811749,Active,1344651,374334289,0,134150259,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,1.2,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811750,Active,1344651,374331295,0,134149430,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.02082,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811751,Active,1344651,374267160,0,134131751,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.1175,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811752,Active,1344651,374268246,0,134132055,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.179,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811753,Active,1344651,374282841,0,134136028,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,NULL,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811754,Active,1344651,374282841,0,134136028,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,1.398,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811755,Active,1344651,374352005,0,134155326,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.1231,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811756,Active,1344651,374348638,0,134154359,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.04042,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811757,Active,1344651,374334376,0,134150278,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.008,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811758,Active,1344651,374334100,0,134150198,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.001,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811759,Active,1344651,374301684,0,134141147,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.014,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811760,Active,1344651,374349199,0,134154524,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.05646,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811761,Active,1344651,374331937,0,134149605,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.015,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811762,Active,1344651,374318567,0,134145858,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.171,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811763,Active,1344651,374316125,0,134145217,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.13,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811764,Active,1344651,374302003,0,134141239,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.352,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811765,Active,1344651,374302671,0,134141424,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.001,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811766,Active,1344651,374360084,0,134157554,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.108,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811767,Active,1344651,374341835,0,134152425,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.00644,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811768,Active,1344651,374346730,0,134153841,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.019,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811769,Active,1344651,374360481,0,134157667,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,1.09,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811770,Active,1344651,374352680,0,134155522,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.00776,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811771,Active,1344651,374353533,0,134155754,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.00111,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811772,Active,1344651,374353816,0,134155835,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.003,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811773,Active,1344651,374358829,0,134157217,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.00338,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811774,Active,1344651,374340813,0,134152110,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.005,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811775,Active,1344651,374336952,0,134151007,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,2.402,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811776,Active,1344651,374342097,0,134152500,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.1181,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811777,Active,1344651,374359489,0,134157389,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.31,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811778,Active,1344651,374360093,0,134157557,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.022,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811779,Active,1344651,374329047,0,134148790,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.351,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811780,Active,1344651,374333995,0,134150160,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.003,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811781,Active,1344651,374320642,0,134146427,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.012,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811782,Active,1344651,374321276,0,134146623,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.007,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811783,Active,1344651,374320828,0,134146479,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.036,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811784,Active,1344651,374324469,0,134147507,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.173,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811785,Active,1344651,374327344,0,134148328,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.05016,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811786,Active,1344651,374313591,0,134144517,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.03011,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811787,Active,1344651,374340149,0,134151930,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.01,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811788,Active,1344651,374314760,0,134144854,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.007,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811789,Active,1344651,374358635,0,134157164,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.046,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811790,Active,1344651,374358042,0,134156989,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.105,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811791,Active,1344651,374350161,0,134154801,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.003,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811792,Active,1344651,374347026,0,134153912,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.003,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811793,Active,1344651,374347093,0,134153927,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.1432,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811794,Active,1344651,374347095,0,134153929,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.002,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811795,Active,1344651,374347602,0,134154078,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.007,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811796,Active,1344651,374347608,0,134154080,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,9.471,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811797,Active,1344651,374337491,0,134151173,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.02167,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811798,Active,1344651,374293669,0,134138971,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.003,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811799,Active,1344651,374296227,0,134139645,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.004,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811800,Active,1344651,374295691,0,134139519,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.00997,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811801,Active,1344651,374296476,0,134139714,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.048,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811802,Active,1344651,374352722,0,134155530,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.2123,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811803,Active,1344651,374350399,0,134154863,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.067,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811804,Active,1344651,374352420,0,134155453,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.00773,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811805,Active,1344651,374309713,0,134143403,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.01598,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811806,Active,1344651,374310313,0,134143582,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.038,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811807,Active,1344651,374292063,0,134138516,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.00152,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811808,Active,1344651,374323606,0,134147267,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.02008,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811809,Active,1344651,374324991,0,134147652,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.1816,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811810,Active,1344651,374325049,0,134147669,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.03758,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811811,Active,1344651,374341356,0,134152275,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,1.916,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811812,Active,1344651,374325936,0,134147912,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.00325,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811813,Active,1344651,374330949,0,134149332,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.003,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811814,Active,1344651,374344568,0,134153227,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.1079,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811815,Active,1344651,374328308,0,134148564,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.001,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811816,Active,1344651,374329940,0,134149037,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.00391,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811817,Active,1344651,374328307,0,134148563,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.0058,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811818,Active,1344651,374284910,0,134136581,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.01261,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811819,Active,1344651,374320439,0,134146375,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.063,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811820,Active,1344651,374320715,0,134146449,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.303,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811821,Active,1344651,374338755,0,134151531,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.02382,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811822,Active,1344651,374339765,0,134151814,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.01,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811823,Active,1344651,374339667,0,134151785,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,NULL,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811824,Active,1344651,374339667,0,134151785,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.0474,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811825,Active,1344651,374338379,0,134151434,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.04405,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811826,Active,1344651,374321004,0,134146540,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.297,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811827,Active,1344651,374338211,0,134151375,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,1.095,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811828,Active,1344651,374329727,0,134148981,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.008,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811829,Active,1344651,374323741,0,134147308,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.114,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811830,Active,1344651,374325596,0,134147817,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.005,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811831,Active,1344651,374327471,0,134148353,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.238,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811832,Active,1344651,374291633,0,134138386,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.001,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811833,Active,1344651,374309416,0,134143310,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,3.249,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811834,Active,1344651,374306802,0,134142590,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.005,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811835,Active,1344651,374306834,0,134142600,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.1924,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811836,Active,1344651,374295643,0,134139499,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.193,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811837,Active,1344651,374295695,0,134139521,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.003,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811838,Active,1344651,374305103,0,134142099,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.001,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811839,Active,1344651,374296347,0,134139674,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.00391,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811840,Active,1344651,374320885,0,134146500,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.001,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811841,Active,1344651,374338416,0,134151447,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.01925,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811842,Active,1344651,374320415,0,134146368,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.08836,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811843,Active,1344651,374316472,0,134145316,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.2862,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811844,Active,1344651,374295160,0,134139385,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.016,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811845,Active,1344651,374309819,0,134143433,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.02871,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811846,Active,1344651,374309487,0,134143331,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.004,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811847,Active,1344651,374291602,0,134138374,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.00242,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811848,Active,1344651,374306342,0,134142459,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.003,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811849,Active,1344651,374292277,0,134138573,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.0317,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811850,Active,1344651,374308869,0,134143158,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.00646,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811851,Active,1344651,374307208,0,134142707,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.5345,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811852,Active,1344651,374298227,0,134140198,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,10.9,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811853,Active,1344651,374298193,0,134140184,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.00251,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811854,Active,1344651,374299077,0,134140404,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.018,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811855,Active,1344651,374296723,0,134139791,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.02316,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811856,Active,1344651,374280952,0,134135511,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.02746,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817379,Active,1344784,374316849,0,86297948,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.2,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817380,Active,1344784,374297797,0,86297950,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.012,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817381,Active,1344784,374313639,0,86297546,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.046,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817382,Active,1344784,374344659,0,86297748,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,NULL,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817383,Active,1344784,374344659,0,86297748,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.0041,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817384,Active,1344784,374290276,0,86297752,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.078,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817385,Active,1344784,374322623,0,117623009,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.21,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817386,Active,1344784,374347941,0,117623021,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.36,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817387,Active,1344784,374331261,0,117623022,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.43,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817388,Active,1344784,374276949,0,117622607,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.59,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817389,Active,1344784,374314502,0,117622610,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.23,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817390,Active,1344784,374310638,0,117622617,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.32,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817391,Active,1344784,374266805,0,117622627,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,NULL,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817392,Active,1344784,374266805,0,117622627,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.067,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817393,Active,1344784,374311841,0,117622715,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.6,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817394,Active,1344784,374312914,0,117622737,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.84,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817395,Active,1344784,374300596,0,117622744,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.595,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817396,Active,1344784,374307246,0,117622773,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.021,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817397,Active,1344784,374288009,0,117622774,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,NULL,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817398,Active,1344784,374288009,0,117622774,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.0052,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817399,Active,1344784,374302786,0,117622774,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,NULL,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817400,Active,1344784,374302786,0,117622774,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.045,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817401,Active,1344784,374352352,0,117622779,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.028,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817402,Active,1344784,374264013,0,117622781,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.24,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817403,Active,1344784,374356564,0,117622796,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.068,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817404,Active,1344784,374325699,0,117622872,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.2,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817405,Active,1344784,374274121,0,117622893,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.16,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817406,Active,1344784,374348345,0,117622897,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,1.3,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817407,Active,1344784,374307398,0,117622900,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.027,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817408,Active,1344784,374269913,0,117622904,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.058,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817409,Active,1344784,374305959,0,117622926,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,NULL,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817410,Active,1344784,374305959,0,117622926,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.024,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817411,Active,1344784,374331866,0,117622932,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,1.1,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817412,Active,1344784,374264027,0,117622943,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.011,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817413,Active,1344784,374305140,0,117622947,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.39,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817414,Active,1344784,374277818,0,117622950,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.04,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817415,Active,1344784,374357617,0,117622955,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.0031,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817416,Active,1344784,374306494,0,117622966,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.021,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817417,Active,1344784,374278519,0,117622969,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.063,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817418,Active,1344784,374336431,0,117622616,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.067,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817419,Active,1344784,374353209,0,117622624,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,NULL,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817420,Active,1344784,374353209,0,117622624,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.017,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817421,Active,1344784,374353177,0,117622628,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.22,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817422,Active,1344784,374348508,0,117622631,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.11,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817423,Active,1344784,374283810,0,117622690,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,NULL,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817424,Active,1344784,374283810,0,117622690,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.51,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817425,Active,1344784,374299588,0,117622723,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.64,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817426,Active,1344784,374334927,0,117622752,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,NULL,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817427,Active,1344784,374334927,0,117622752,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.62,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817428,Active,1344784,374347552,0,117622778,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.029,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817429,Active,1344784,374329411,0,117622782,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,NULL,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817430,Active,1344784,374329411,0,117622782,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.034,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817431,Active,1344784,374298554,0,117622784,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.0063,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817432,Active,1344784,374350237,0,117622788,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.011,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817433,Active,1344784,374349533,0,117622798,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.035,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817434,Active,1344784,374296657,0,117622878,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.064,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817435,Active,1344784,374331919,0,117622902,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.63,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817436,Active,1344784,374321634,0,117622923,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.046,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817437,Active,1344784,374296196,0,117622933,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.059,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817438,Active,1344784,374272932,0,117622935,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.0084,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817439,Active,1344784,374316604,0,117622938,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.054,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817440,Active,1344784,374276465,0,117622951,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.028,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817441,Active,1344784,374277537,0,117622952,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.016,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817442,Active,1344784,374309073,0,117622964,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.082,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817443,Active,1344784,374293779,0,117623002,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.02,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817444,Active,1344784,374310211,0,117623020,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.11,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817445,Active,1344784,374332413,0,117622612,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.57,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817446,Active,1344784,374302656,0,117622618,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,NULL,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817447,Active,1344784,374302656,0,117622618,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,NULL,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817448,Active,1344784,374302656,0,117622618,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,NULL,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817449,Active,1344784,374302656,0,117622618,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.013,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817450,Active,1344784,374318180,0,117622630,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.018,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817451,Active,1344784,374326831,0,117622632,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.0082,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817452,Active,1344784,374345967,0,117622636,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.061,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817453,Active,1344784,374360966,0,117622637,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.0063,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817454,Active,1344784,374354382,0,117622742,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.22,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817455,Active,1344784,374320013,0,117622783,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.089,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817456,Active,1344784,374346210,0,117622838,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.11,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817457,Active,1344784,374278788,0,117622844,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.017,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817458,Active,1344784,374319300,0,117622873,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,NULL,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817459,Active,1344784,374319300,0,117622873,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.0094,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817460,Active,1344784,374297108,0,117622898,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.52,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817461,Active,1344784,374358944,0,117622907,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.25,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817462,Active,1344784,374315058,0,117622918,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.054,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817463,Active,1344784,374267728,0,117622956,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.0036,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817464,Active,1344784,374341469,0,117622957,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.67,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817465,Active,1344784,374325084,0,117622965,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,1.5,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817466,Active,1344784,374319995,0,117622987,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.31,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817467,Active,1344784,374302556,0,117622993,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.029,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817468,Active,1344784,374347996,0,117623008,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.22,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817469,Active,1344784,374301926,0,117622901,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.0155,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817470,Active,1344784,374352212,0,117622905,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.78,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817471,Active,1344784,374267812,0,117622919,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.016,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817472,Active,1344784,374330568,0,117622939,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.35,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817473,Active,1344784,374342153,0,117622968,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,NULL,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817474,Active,1344784,374342153,0,117622968,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.062,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817475,Active,1344784,374326058,0,117622970,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.01,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817476,Active,1344784,374274348,0,117622989,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,1.6,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817477,Active,1344784,374351829,0,117623031,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.035,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817478,Active,1344784,374319203,0,117622611,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.12,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817479,Active,1344784,374301455,0,117622619,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.14,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817480,Active,1344784,374298933,0,117622633,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,NULL,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817481,Active,1344784,374298933,0,117622633,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.045,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817482,Active,1344784,374273596,0,117622634,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.031,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817483,Active,1344784,374322481,0,117622732,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,NULL,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817484,Active,1344784,374322481,0,117622732,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.15,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817485,Active,1344784,374279196,0,117622754,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,NULL,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817486,Active,1344784,374279196,0,117622754,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,NULL,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817487,Active,1344784,374279196,0,117622754,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.031,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817488,Active,1344784,374331121,0,117622760,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.01,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817489,Active,1344784,374317033,0,117622761,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,NULL,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817490,Active,1344784,374317033,0,117622761,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.015,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817491,Active,1344784,374340762,0,117622769,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.7,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817492,Active,1344784,374356708,0,117622790,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.18,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817493,Active,1344784,374304199,0,117622799,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.039,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817494,Active,1344784,374331791,0,117622828,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.029,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817495,Active,1344784,374271071,0,117622831,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.55,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817496,Active,1344784,374330402,0,118877947,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,NULL,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817497,Active,1344784,374330402,0,118877947,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.0079,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817498,Active,1344784,374330402,0,118877947,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,NULL,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817499,Active,1344784,374330402,0,118877947,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,NULL,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817500,Active,1344784,374330402,0,118877947,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,NULL,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817501,Active,1344784,374316193,0,86298154,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,NULL,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817502,Active,1344784,374316193,0,86298154,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,NULL,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817503,Active,1344784,374316193,0,86298154,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.0058,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817504,Active,1344784,374279453,0,86297750,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,NULL,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817505,Active,1344784,374279453,0,86297750,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.019,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817506,Active,1344784,374331380,0,86297951,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.22,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817507,Active,1344784,374343297,0,86297952,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,NULL,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817508,Active,1344784,374343297,0,86297952,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,NULL,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817509,Active,1344784,374343297,0,86297952,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,NULL,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817510,Active,1344784,374343297,0,86297952,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,NULL,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817511,Active,1344784,374343297,0,86297952,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.0046,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817512,Active,1344784,374331696,0,86297342,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.49,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817513,Active,1344784,374306176,0,86297547,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.016,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817514,Active,1344784,374302573,0,136930240,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.0094,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817515,Active,1344784,374324774,0,136930241,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.49,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817516,Active,1344784,374320453,0,136930242,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,NULL,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817517,Active,1344784,374320453,0,136930242,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.014,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817518,Active,1344784,374314227,0,86298155,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,NULL,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817519,Active,1344784,374314227,0,86298155,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,NULL,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817520,Active,1344784,374314227,0,86298155,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.07,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817521,Active,1344784,374360673,0,86297949,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,NULL,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817522,Active,1344784,374360673,0,86297949,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.039,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817523,Active,1344784,374338781,0,86297749,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,NULL,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817524,Active,1344784,374338781,0,86297749,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,NULL,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817525,Active,1344784,374338781,0,86297749,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.018,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817526,Active,1344784,374314320,0,86297751,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.056,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817527,Active,1344784,374308345,0,86297545,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.33,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817528,Active,1344784,374315935,0,118877926,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.059,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817529,Active,1344784,374347126,0,78425871,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.0019,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817530,Active,1344784,374288819,0,118877945,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,NULL,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817531,Active,1344784,374288819,0,118877945,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,NULL,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817532,Active,1344784,374288819,0,118877945,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,NULL,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817533,Active,1344784,374288819,0,118877945,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.015,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453817534,Active,1344784,374348772,0,118877955,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,0.65,ChEMBL,Inhibition Assay: Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000  inverted question markM to 0.0078  inverted question markM; resulting final concentrations in the test: 50  inverted question markM t,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453819368,Active,1344829,374296222,0,118286674,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.028,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453819370,Active,1344829,374312877,0,134144320,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,NULL,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453819372,Active,1344829,374312877,0,134144320,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.022,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453819374,Active,1344829,374308495,0,134143056,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,NULL,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453819376,Active,1344829,374308495,0,134143056,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.019,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453819378,Active,1344829,374360268,0,134157610,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.035,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453819380,Active,1344829,374310780,0,134143709,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.033,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453819382,Active,1344829,374333581,0,134150043,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.01,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453819384,Active,1344829,374353464,0,134155733,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.037,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453819386,Active,1344829,374351512,0,134155174,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,NULL,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453819388,Active,1344829,374351512,0,134155174,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,0.032,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
454228611,Active,1345924,252166701,0,135532896,3818,9606,16413183,Literature-derived,20181115,0,0,P03952,NULL,NULL,IUPHAR/BPS Guide to PHARMACOLOGY,Human kallikrein B1 (S1: Chymotrypsin),NULL,plasma kallikrein isoform 1 preproprotein [Homo sapiens] (human),/gene/3818,10.1016/j.bmcl.2005.12.060,3.4.21.34,P03952
98205474,Inconclusive,159998,103223044,0,448677,3818,9606,9703466,Literature-derived,20181015,0,0,P03952,NULL,NULL,ChEMBL,Binding affinity was evaluated on serine protease plasma kallikrein; Not Determined,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm9801713,3.4.21.34,P03952
98205485,Inconclusive,160002,103330132,0,44338476,3818,9606,9703466,Literature-derived,20181015,0,0,P03952,NULL,NULL,ChEMBL,Selectivity was evaluated as the binding affinity between thrombin versus plasma kallikrein; Not determined,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm9801713,3.4.21.34,P03952
98936314,Inconclusive,263271,103484658,0,15950345,3818,9606,16434195,Confirmatory,20181020,0,0,P03952,Ki,NULL,ChEMBL,Binding affinity to human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2006.01.010,3.4.21.34,P03952
99226150,Inconclusive,300716,103539101,0,44434815,3818,9606,17643988,Confirmatory,20181022,0,0,P03952,Ki,NULL,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2007.07.020,3.4.21.34,P03952
247270712,Inconclusive,507741,123083628,0,52940768,3818,9606,19483697,Confirmatory,20180914,0,0,P03952,IC50,NULL,ChEMBL,Inhibition of human plasma kallikrein using Z-Phe-Arg-AMC substrate after 30 mins by spectrophotometric assay,NULL,Plasma kallikrein (human),/gene/3818,10.1038/nchembio.184,3.4.21.34,P03952
247270728,Inconclusive,507741,123085831,0,52941923,3818,9606,19483697,Confirmatory,20180914,0,0,P03952,IC50,NULL,ChEMBL,Inhibition of human plasma kallikrein using Z-Phe-Arg-AMC substrate after 30 mins by spectrophotometric assay,NULL,Plasma kallikrein (human),/gene/3818,10.1038/nchembio.184,3.4.21.34,P03952
247270733,Inconclusive,507741,174525495,0,52946797,3818,9606,19483697,Confirmatory,20180914,0,0,P03952,IC50,NULL,ChEMBL,Inhibition of human plasma kallikrein using Z-Phe-Arg-AMC substrate after 30 mins by spectrophotometric assay,NULL,Plasma kallikrein (human),/gene/3818,10.1038/nchembio.184,3.4.21.34,P03952
247270737,Inconclusive,507741,123095079,0,52946796,3818,9606,19483697,Confirmatory,20180914,0,0,P03952,IC50,NULL,ChEMBL,Inhibition of human plasma kallikrein using Z-Phe-Arg-AMC substrate after 30 mins by spectrophotometric assay,NULL,Plasma kallikrein (human),/gene/3818,10.1038/nchembio.184,3.4.21.34,P03952
247270746,Inconclusive,507741,164130545,0,71716670,3818,9606,19483697,Confirmatory,20180914,0,0,P03952,IC50,NULL,ChEMBL,Inhibition of human plasma kallikrein using Z-Phe-Arg-AMC substrate after 30 mins by spectrophotometric assay,NULL,Plasma kallikrein (human),/gene/3818,10.1038/nchembio.184,3.4.21.34,P03952
247270749,Inconclusive,507741,164144575,0,71719711,3818,9606,19483697,Confirmatory,20180914,0,0,P03952,IC50,NULL,ChEMBL,Inhibition of human plasma kallikrein using Z-Phe-Arg-AMC substrate after 30 mins by spectrophotometric assay,NULL,Plasma kallikrein (human),/gene/3818,10.1038/nchembio.184,3.4.21.34,P03952
247270750,Inconclusive,507741,164141783,0,71719102,3818,9606,19483697,Confirmatory,20180914,0,0,P03952,IC50,NULL,ChEMBL,Inhibition of human plasma kallikrein using Z-Phe-Arg-AMC substrate after 30 mins by spectrophotometric assay,NULL,Plasma kallikrein (human),/gene/3818,10.1038/nchembio.184,3.4.21.34,P03952
247270751,Inconclusive,507741,164141784,0,71719103,3818,9606,19483697,Confirmatory,20180914,0,0,P03952,IC50,NULL,ChEMBL,Inhibition of human plasma kallikrein using Z-Phe-Arg-AMC substrate after 30 mins by spectrophotometric assay,NULL,Plasma kallikrein (human),/gene/3818,10.1038/nchembio.184,3.4.21.34,P03952
247270752,Inconclusive,507741,164147356,0,71720318,3818,9606,19483697,Confirmatory,20180914,0,0,P03952,IC50,NULL,ChEMBL,Inhibition of human plasma kallikrein using Z-Phe-Arg-AMC substrate after 30 mins by spectrophotometric assay,NULL,Plasma kallikrein (human),/gene/3818,10.1038/nchembio.184,3.4.21.34,P03952
247270761,Inconclusive,507741,123088141,0,52943155,3818,9606,19483697,Confirmatory,20180914,0,0,P03952,IC50,NULL,ChEMBL,Inhibition of human plasma kallikrein using Z-Phe-Arg-AMC substrate after 30 mins by spectrophotometric assay,NULL,Plasma kallikrein (human),/gene/3818,10.1038/nchembio.184,3.4.21.34,P03952
441670522,Inconclusive,1132633,242630930,0,85939302,3818,9606,660589,Literature-derived,20181003,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of 2 X 10'-7 M human plasma kallikrein using Z-Lys-nitrophenyl ester as substrate assessed as second-order rate inactivation constant incubated up to 1 hr at pH 7.4,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm00203a009,3.4.21.34,P03952
97814604,Inactive,95171,174500610,0,11740752,3818,9606,8478905,Literature-derived,20181014,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of kallikrein with benzoyl-L-arginine ethyl ester as substrate; Not significantly active,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm00060a016,3.4.21.34,P03952
97814605,Inactive,95171,174485345,0,10048449,3818,9606,8478905,Literature-derived,20181014,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of kallikrein with benzoyl-L-arginine ethyl ester as substrate; Not significantly active,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm00060a016,3.4.21.34,P03952
97814606,Inactive,95171,174485346,0,73345753,3818,9606,8478905,Literature-derived,20181014,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of kallikrein with benzoyl-L-arginine ethyl ester as substrate; Not significantly active,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm00060a016,3.4.21.34,P03952
97814607,Inactive,95171,174490345,0,7408462,3818,9606,8478905,Literature-derived,20181014,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of kallikrein with benzoyl-L-arginine ethyl ester as substrate; Not significantly active,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm00060a016,3.4.21.34,P03952
97814608,Inactive,95171,174505795,0,10000942,3818,9606,8478905,Literature-derived,20181014,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of kallikrein with benzoyl-L-arginine ethyl ester as substrate; Not significantly active,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm00060a016,3.4.21.34,P03952
97814610,Inactive,95171,174505796,0,10432960,3818,9606,8478905,Literature-derived,20181014,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of kallikrein with benzoyl-L-arginine ethyl ester as substrate; Not significantly active,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm00060a016,3.4.21.34,P03952
98991763,Inactive,269531,103496570,0,5292405,3818,9606,16913712,Literature-derived,20181020,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein at 120 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm0605132,3.4.21.34,P03952
98991766,Inactive,269532,103496630,0,4330580,3818,9606,16913712,Literature-derived,20181020,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein at 90 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm0605132,3.4.21.34,P03952
98991768,Inactive,269531,103496571,0,6250177,3818,9606,16913712,Literature-derived,20181020,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein at 120 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm0605132,3.4.21.34,P03952
98991780,Inactive,269529,103496629,0,5499839,3818,9606,16913712,Literature-derived,20181020,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein at 75 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm0605132,3.4.21.34,P03952
98991781,Inactive,269530,103496727,0,44415219,3818,9606,16913712,Literature-derived,20181020,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein at 100 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm0605132,3.4.21.34,P03952
98991795,Inactive,269553,103496764,0,767163,3818,9606,16913712,Literature-derived,20181020,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein at 160 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm0605132,3.4.21.34,P03952
98991810,Inactive,269558,103496765,0,776842,3818,9606,16913712,Literature-derived,20181020,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein at 175 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm0605132,3.4.21.34,P03952
99206282,Inactive,298259,103527826,0,674653,3818,9606,17850059,Literature-derived,20181022,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein at 55 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm070600+,3.4.21.34,P03952
99206283,Inactive,298259,103527833,0,685230,3818,9606,17850059,Literature-derived,20181022,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein at 55 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm070600+,3.4.21.34,P03952
99206284,Inactive,298259,103527835,0,674635,3818,9606,17850059,Literature-derived,20181022,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein at 55 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm070600+,3.4.21.34,P03952
99206285,Inactive,298259,103527842,0,714833,3818,9606,17850059,Literature-derived,20181022,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein at 55 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm070600+,3.4.21.34,P03952
99206286,Inactive,298259,103527844,0,753830,3818,9606,17850059,Literature-derived,20181022,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein at 55 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm070600+,3.4.21.34,P03952
99206287,Inactive,298259,103527851,0,674647,3818,9606,17850059,Literature-derived,20181022,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein at 55 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm070600+,3.4.21.34,P03952
99206288,Inactive,298259,103527853,0,728108,3818,9606,17850059,Literature-derived,20181022,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein at 55 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm070600+,3.4.21.34,P03952
99206289,Inactive,298259,103527855,0,675868,3818,9606,17850059,Literature-derived,20181022,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein at 55 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm070600+,3.4.21.34,P03952
99206290,Inactive,298259,103527856,0,753833,3818,9606,17850059,Literature-derived,20181022,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein at 55 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm070600+,3.4.21.34,P03952
99206291,Inactive,298259,103527857,0,754113,3818,9606,17850059,Literature-derived,20181022,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein at 55 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm070600+,3.4.21.34,P03952
99206292,Inactive,298259,103527871,0,674659,3818,9606,17850059,Literature-derived,20181022,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein at 55 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm070600+,3.4.21.34,P03952
99206293,Inactive,298259,103527872,0,603511,3818,9606,17850059,Literature-derived,20181022,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein at 55 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm070600+,3.4.21.34,P03952
99206294,Inactive,298259,103527874,0,1036823,3818,9606,17850059,Literature-derived,20181022,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein at 55 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm070600+,3.4.21.34,P03952
99206295,Inactive,298259,103527805,0,680939,3818,9606,17850059,Literature-derived,20181022,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein at 55 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm070600+,3.4.21.34,P03952
99206296,Inactive,298259,103527806,0,674651,3818,9606,17850059,Literature-derived,20181022,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein at 55 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm070600+,3.4.21.34,P03952
99206297,Inactive,298259,103527823,0,674641,3818,9606,17850059,Literature-derived,20181022,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein at 55 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm070600+,3.4.21.34,P03952
99206298,Inactive,298259,103527824,0,577102,3818,9606,17850059,Literature-derived,20181022,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein at 55 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm070600+,3.4.21.34,P03952
99206299,Inactive,298259,103527838,0,674640,3818,9606,17850059,Literature-derived,20181022,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein at 55 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm070600+,3.4.21.34,P03952
99206338,Inactive,298259,103527840,0,685663,3818,9606,17850059,Literature-derived,20181022,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein at 55 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm070600+,3.4.21.34,P03952
99206339,Inactive,298259,103527854,0,675749,3818,9606,17850059,Literature-derived,20181022,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein at 55 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm070600+,3.4.21.34,P03952
99206340,Inactive,298259,103527858,0,2847058,3818,9606,17850059,Literature-derived,20181022,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein at 55 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm070600+,3.4.21.34,P03952
99206341,Inactive,298259,103527862,0,785958,3818,9606,17850059,Literature-derived,20181022,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein at 55 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm070600+,3.4.21.34,P03952
99206342,Inactive,298259,103527867,0,674638,3818,9606,17850059,Literature-derived,20181022,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein at 55 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm070600+,3.4.21.34,P03952
99206343,Inactive,298259,103527869,0,674655,3818,9606,17850059,Literature-derived,20181022,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein at 55 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm070600+,3.4.21.34,P03952
99206344,Inactive,298259,103527876,0,599596,3818,9606,17850059,Literature-derived,20181022,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein at 55 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm070600+,3.4.21.34,P03952
99206345,Inactive,298259,103527827,0,674650,3818,9606,17850059,Literature-derived,20181022,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein at 55 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm070600+,3.4.21.34,P03952
99206346,Inactive,298259,103527836,0,674639,3818,9606,17850059,Literature-derived,20181022,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein at 55 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm070600+,3.4.21.34,P03952
99206347,Inactive,298259,103527843,0,2213207,3818,9606,17850059,Literature-derived,20181022,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein at 55 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm070600+,3.4.21.34,P03952
99206348,Inactive,298259,103527845,0,674637,3818,9606,17850059,Literature-derived,20181022,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein at 55 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm070600+,3.4.21.34,P03952
99206349,Inactive,298259,103527850,0,1273163,3818,9606,17850059,Literature-derived,20181022,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein at 55 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm070600+,3.4.21.34,P03952
99206350,Inactive,298259,103527852,0,674649,3818,9606,17850059,Literature-derived,20181022,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein at 55 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm070600+,3.4.21.34,P03952
99206351,Inactive,298259,103527859,0,810040,3818,9606,17850059,Literature-derived,20181022,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein at 55 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm070600+,3.4.21.34,P03952
99206352,Inactive,298259,103527861,0,910410,3818,9606,17850059,Literature-derived,20181022,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein at 55 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm070600+,3.4.21.34,P03952
99206353,Inactive,298259,103527875,0,674646,3818,9606,17850059,Literature-derived,20181022,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein at 55 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm070600+,3.4.21.34,P03952
99206354,Inactive,298259,103527814,0,674642,3818,9606,17850059,Literature-derived,20181022,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein at 55 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm070600+,3.4.21.34,P03952
99206355,Inactive,298259,103527829,0,833517,3818,9606,17850059,Literature-derived,20181022,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein at 55 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm070600+,3.4.21.34,P03952
99206382,Inactive,298259,103527831,0,674633,3818,9606,17850059,Literature-derived,20181022,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein at 55 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm070600+,3.4.21.34,P03952
99206383,Inactive,298259,103527846,0,674636,3818,9606,17850059,Literature-derived,20181022,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein at 55 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm070600+,3.4.21.34,P03952
99206384,Inactive,298259,103527847,0,579427,3818,9606,17850059,Literature-derived,20181022,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein at 55 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm070600+,3.4.21.34,P03952
99206385,Inactive,298259,103527848,0,674660,3818,9606,17850059,Literature-derived,20181022,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein at 55 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm070600+,3.4.21.34,P03952
99206386,Inactive,298259,103527849,0,674661,3818,9606,17850059,Literature-derived,20181022,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein at 55 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm070600+,3.4.21.34,P03952
99206387,Inactive,298259,103527864,0,691916,3818,9606,17850059,Literature-derived,20181022,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein at 55 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm070600+,3.4.21.34,P03952
99206433,Inactive,298259,103527866,0,878793,3818,9606,17850059,Literature-derived,20181022,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein at 55 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm070600+,3.4.21.34,P03952
99484583,Inactive,343872,103583901,0,44560382,3818,9606,18550370,Literature-derived,20181026,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2008.05.095,3.4.21.34,P03952
99484584,Inactive,343872,103585021,0,44593413,3818,9606,18550370,Literature-derived,20181026,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2008.05.095,3.4.21.34,P03952
99484585,Inactive,343872,103585022,0,10007463,3818,9606,18550370,Literature-derived,20181026,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2008.05.095,3.4.21.34,P03952
99484586,Inactive,343872,103585089,0,44593414,3818,9606,18550370,Literature-derived,20181026,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2008.05.095,3.4.21.34,P03952
99484587,Inactive,343872,103584631,0,10254797,3818,9606,18550370,Literature-derived,20181026,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2008.05.095,3.4.21.34,P03952
99484588,Inactive,343872,103584633,0,44560776,3818,9606,18550370,Literature-derived,20181026,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2008.05.095,3.4.21.34,P03952
99484589,Inactive,343872,103584715,0,44560813,3818,9606,18550370,Literature-derived,20181026,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2008.05.095,3.4.21.34,P03952
99484590,Inactive,343872,103584776,0,44560836,3818,9606,18550370,Literature-derived,20181026,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2008.05.095,3.4.21.34,P03952
99484591,Inactive,343872,103584874,0,10052951,3818,9606,18550370,Literature-derived,20181026,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2008.05.095,3.4.21.34,P03952
99484592,Inactive,343872,103584876,0,9890878,3818,9606,18550370,Literature-derived,20181026,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2008.05.095,3.4.21.34,P03952
99484593,Inactive,343872,103584960,0,44560918,3818,9606,18550370,Literature-derived,20181026,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2008.05.095,3.4.21.34,P03952
99484594,Inactive,343872,103585090,0,10369141,3818,9606,18550370,Literature-derived,20181026,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2008.05.095,3.4.21.34,P03952
99484595,Inactive,343872,103584560,0,44560756,3818,9606,18550370,Literature-derived,20181026,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2008.05.095,3.4.21.34,P03952
99484596,Inactive,343872,103584712,0,10434906,3818,9606,18550370,Literature-derived,20181026,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2008.05.095,3.4.21.34,P03952
99484597,Inactive,343872,103584713,0,10073425,3818,9606,18550370,Literature-derived,20181026,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2008.05.095,3.4.21.34,P03952
99484598,Inactive,343872,103584777,0,10347624,3818,9606,18550370,Literature-derived,20181026,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2008.05.095,3.4.21.34,P03952
99484599,Inactive,343872,103584877,0,10345230,3818,9606,18550370,Literature-derived,20181026,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2008.05.095,3.4.21.34,P03952
99484600,Inactive,343872,103584961,0,11756561,3818,9606,18550370,Literature-derived,20181026,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2008.05.095,3.4.21.34,P03952
99484601,Inactive,343872,103584962,0,24836819,3818,9606,18550370,Literature-derived,20181026,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2008.05.095,3.4.21.34,P03952
99484602,Inactive,343872,103584559,0,10346320,3818,9606,18550370,Literature-derived,20181026,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2008.05.095,3.4.21.34,P03952
99484603,Inactive,343872,103584632,0,10366592,3818,9606,18550370,Literature-derived,20181026,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2008.05.095,3.4.21.34,P03952
99484604,Inactive,343872,103584714,0,44560812,3818,9606,18550370,Literature-derived,20181026,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2008.05.095,3.4.21.34,P03952
99484605,Inactive,343872,103584775,0,11756558,3818,9606,18550370,Literature-derived,20181026,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2008.05.095,3.4.21.34,P03952
99484606,Inactive,343872,103584875,0,44560883,3818,9606,18550370,Literature-derived,20181026,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2008.05.095,3.4.21.34,P03952
99484607,Inactive,343872,103585023,0,10482395,3818,9606,18550370,Literature-derived,20181026,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2008.05.095,3.4.21.34,P03952
99484608,Inactive,343872,103585091,0,10099008,3818,9606,18550370,Literature-derived,20181026,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2008.05.095,3.4.21.34,P03952
99821646,Inactive,404328,103174806,0,402499,3818,9606,18459730,Literature-derived,20181025,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human kallikrein at 50 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm8002697,3.4.21.34,P03952
99821647,Inactive,404328,103293445,0,10516846,3818,9606,18459730,Literature-derived,20181025,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human kallikrein at 50 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm8002697,3.4.21.34,P03952
99821648,Inactive,404328,103620909,0,24860444,3818,9606,18459730,Literature-derived,20181025,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human kallikrein at 50 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm8002697,3.4.21.34,P03952
99821649,Inactive,404328,103620910,0,24860445,3818,9606,18459730,Literature-derived,20181025,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human kallikrein at 50 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm8002697,3.4.21.34,P03952
99821650,Inactive,404328,103620911,0,24860446,3818,9606,18459730,Literature-derived,20181025,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human kallikrein at 50 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm8002697,3.4.21.34,P03952
99821651,Inactive,404328,103620912,0,24860447,3818,9606,18459730,Literature-derived,20181025,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human kallikrein at 50 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm8002697,3.4.21.34,P03952
99821652,Inactive,404328,103620963,0,3753834,3818,9606,18459730,Literature-derived,20181025,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human kallikrein at 50 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm8002697,3.4.21.34,P03952
99821653,Inactive,404328,103620206,0,24860441,3818,9606,18459730,Literature-derived,20181025,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human kallikrein at 50 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm8002697,3.4.21.34,P03952
99821654,Inactive,404328,103620304,0,40956,3818,9606,18459730,Literature-derived,20181025,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human kallikrein at 50 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm8002697,3.4.21.34,P03952
99821655,Inactive,404328,103620856,0,24860436,3818,9606,18459730,Literature-derived,20181025,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human kallikrein at 50 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm8002697,3.4.21.34,P03952
99821657,Inactive,404328,103620858,0,24860438,3818,9606,18459730,Literature-derived,20181025,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human kallikrein at 50 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm8002697,3.4.21.34,P03952
99821658,Inactive,404328,103620906,0,747661,3818,9606,18459730,Literature-derived,20181025,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human kallikrein at 50 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm8002697,3.4.21.34,P03952
99821659,Inactive,404328,103620908,0,24860443,3818,9606,18459730,Literature-derived,20181025,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human kallikrein at 50 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm8002697,3.4.21.34,P03952
99821660,Inactive,404328,103620913,0,24860448,3818,9606,18459730,Literature-derived,20181025,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human kallikrein at 50 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm8002697,3.4.21.34,P03952
99821661,Inactive,404328,103620965,0,24860450,3818,9606,18459730,Literature-derived,20181025,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human kallikrein at 50 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm8002697,3.4.21.34,P03952
99821662,Inactive,404328,103620301,0,24860433,3818,9606,18459730,Literature-derived,20181025,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human kallikrein at 50 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm8002697,3.4.21.34,P03952
99821673,Inactive,404328,103620853,0,24860434,3818,9606,18459730,Literature-derived,20181025,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human kallikrein at 50 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm8002697,3.4.21.34,P03952
99821674,Inactive,404328,103620854,0,24860435,3818,9606,18459730,Literature-derived,20181025,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human kallikrein at 50 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm8002697,3.4.21.34,P03952
99821675,Inactive,404328,103620903,0,24860439,3818,9606,18459730,Literature-derived,20181025,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human kallikrein at 50 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm8002697,3.4.21.34,P03952
99821676,Inactive,404328,103620904,0,341782,3818,9606,18459730,Literature-derived,20181025,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human kallikrein at 50 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm8002697,3.4.21.34,P03952
99821679,Inactive,404328,103174835,0,402501,3818,9606,18459730,Literature-derived,20181025,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human kallikrein at 50 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm8002697,3.4.21.34,P03952
99821680,Inactive,404328,103620205,0,24860440,3818,9606,18459730,Literature-derived,20181025,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human kallikrein at 50 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm8002697,3.4.21.34,P03952
99821683,Inactive,404328,103620305,0,24860442,3818,9606,18459730,Literature-derived,20181025,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human kallikrein at 50 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm8002697,3.4.21.34,P03952
99821684,Inactive,404328,103620857,0,24860437,3818,9606,18459730,Literature-derived,20181025,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human kallikrein at 50 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm8002697,3.4.21.34,P03952
99821697,Inactive,404328,103620905,0,739350,3818,9606,18459730,Literature-derived,20181025,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human kallikrein at 50 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm8002697,3.4.21.34,P03952
439101705,Inactive,762516,174487398,0,71818404,3818,9606,23844670,Literature-derived,20180927,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein using benzyloxycarbonyl-Phe-Arg-7-amino-4-methylcoumarin as substrate at 50 uM by fluorescence microplate reader analysis,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm400742j,3.4.21.34,P03952
439101706,Inactive,762516,174507990,0,71818549,3818,9606,23844670,Literature-derived,20180927,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein using benzyloxycarbonyl-Phe-Arg-7-amino-4-methylcoumarin as substrate at 50 uM by fluorescence microplate reader analysis,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm400742j,3.4.21.34,P03952
439101707,Inactive,762516,174502817,0,71818688,3818,9606,23844670,Literature-derived,20180927,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein using benzyloxycarbonyl-Phe-Arg-7-amino-4-methylcoumarin as substrate at 50 uM by fluorescence microplate reader analysis,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm400742j,3.4.21.34,P03952
439101708,Inactive,762516,174513101,0,71818829,3818,9606,23844670,Literature-derived,20180927,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein using benzyloxycarbonyl-Phe-Arg-7-amino-4-methylcoumarin as substrate at 50 uM by fluorescence microplate reader analysis,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm400742j,3.4.21.34,P03952
439101709,Inactive,762516,174492445,0,71818830,3818,9606,23844670,Literature-derived,20180927,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein using benzyloxycarbonyl-Phe-Arg-7-amino-4-methylcoumarin as substrate at 50 uM by fluorescence microplate reader analysis,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm400742j,3.4.21.34,P03952
439101710,Inactive,762516,174502832,0,71818832,3818,9606,23844670,Literature-derived,20180927,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein using benzyloxycarbonyl-Phe-Arg-7-amino-4-methylcoumarin as substrate at 50 uM by fluorescence microplate reader analysis,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm400742j,3.4.21.34,P03952
439101711,Inactive,762516,174502814,0,71819102,3818,9606,23844670,Literature-derived,20180927,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein using benzyloxycarbonyl-Phe-Arg-7-amino-4-methylcoumarin as substrate at 50 uM by fluorescence microplate reader analysis,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm400742j,3.4.21.34,P03952
439101712,Inactive,762516,174507991,0,71818689,3818,9606,23844670,Literature-derived,20180927,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein using benzyloxycarbonyl-Phe-Arg-7-amino-4-methylcoumarin as substrate at 50 uM by fluorescence microplate reader analysis,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm400742j,3.4.21.34,P03952
439101713,Inactive,762516,174518129,0,71819103,3818,9606,23844670,Literature-derived,20180927,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein using benzyloxycarbonyl-Phe-Arg-7-amino-4-methylcoumarin as substrate at 50 uM by fluorescence microplate reader analysis,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm400742j,3.4.21.34,P03952
439101714,Inactive,762516,174502819,0,71818692,3818,9606,23844670,Literature-derived,20180927,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein using benzyloxycarbonyl-Phe-Arg-7-amino-4-methylcoumarin as substrate at 50 uM by fluorescence microplate reader analysis,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm400742j,3.4.21.34,P03952
439101715,Inactive,762516,174487412,0,71818964,3818,9606,23844670,Literature-derived,20180927,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein using benzyloxycarbonyl-Phe-Arg-7-amino-4-methylcoumarin as substrate at 50 uM by fluorescence microplate reader analysis,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm400742j,3.4.21.34,P03952
439101716,Inactive,762516,174487410,0,71818831,3818,9606,23844670,Literature-derived,20180927,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein using benzyloxycarbonyl-Phe-Arg-7-amino-4-methylcoumarin as substrate at 50 uM by fluorescence microplate reader analysis,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm400742j,3.4.21.34,P03952
97813721,Unspecified,95040,103243526,0,9892148,3818,9606,9379436,Literature-derived,20181015,0,0,P03952,NULL,NULL,ChEMBL,Binding affinity for human plasma kallikrein; No inhibition at 188 uM (highest concentration tested),NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm970250z,3.4.21.34,P03952
97813722,Unspecified,95040,103285051,0,9910174,3818,9606,9379436,Literature-derived,20181015,0,0,P03952,NULL,NULL,ChEMBL,Binding affinity for human plasma kallikrein; No inhibition at 188 uM (highest concentration tested),NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm970250z,3.4.21.34,P03952
97813723,Unspecified,95039,103576842,0,3631189,3818,9606,2231595,Literature-derived,20181012,0,0,P03952,NULL,NULL,ChEMBL,Inhibition against human plasma Kallikrein at 2 mM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm00173a008,3.4.21.34,P03952
97813724,Unspecified,95039,103734053,0,3580940,3818,9606,2231595,Literature-derived,20181012,0,0,P03952,NULL,NULL,ChEMBL,Inhibition against human plasma Kallikrein at 2 mM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm00173a008,3.4.21.34,P03952
97813725,Unspecified,95039,103176153,0,16157,3818,9606,2231595,Literature-derived,20181012,0,0,P03952,NULL,NULL,ChEMBL,Inhibition against human plasma Kallikrein at 2 mM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm00173a008,3.4.21.34,P03952
97813726,Unspecified,95039,103219689,0,409364,3818,9606,2231595,Literature-derived,20181012,0,0,P03952,NULL,NULL,ChEMBL,Inhibition against human plasma Kallikrein at 2 mM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm00173a008,3.4.21.34,P03952
97813727,Unspecified,95039,103220595,0,12253678,3818,9606,2231595,Literature-derived,20181012,0,0,P03952,NULL,NULL,ChEMBL,Inhibition against human plasma Kallikrein at 2 mM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm00173a008,3.4.21.34,P03952
97813728,Unspecified,95039,103760850,0,12336481,3818,9606,2231595,Literature-derived,20181012,0,0,P03952,NULL,NULL,ChEMBL,Inhibition against human plasma Kallikrein at 2 mM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm00173a008,3.4.21.34,P03952
97813729,Unspecified,95039,103760855,0,409363,3818,9606,2231595,Literature-derived,20181012,0,0,P03952,NULL,NULL,ChEMBL,Inhibition against human plasma Kallikrein at 2 mM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm00173a008,3.4.21.34,P03952
97813730,Unspecified,95039,103176081,0,10374840,3818,9606,2231595,Literature-derived,20181012,0,0,P03952,NULL,NULL,ChEMBL,Inhibition against human plasma Kallikrein at 2 mM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm00173a008,3.4.21.34,P03952
97813731,Unspecified,95039,103187036,0,159772,3818,9606,2231595,Literature-derived,20181012,0,0,P03952,NULL,NULL,ChEMBL,Inhibition against human plasma Kallikrein at 2 mM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm00173a008,3.4.21.34,P03952
97813732,Unspecified,95039,103220560,0,2757788,3818,9606,2231595,Literature-derived,20181012,0,0,P03952,NULL,NULL,ChEMBL,Inhibition against human plasma Kallikrein at 2 mM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm00173a008,3.4.21.34,P03952
97813733,Unspecified,95039,103734052,0,80002,3818,9606,2231595,Literature-derived,20181012,0,0,P03952,NULL,NULL,ChEMBL,Inhibition against human plasma Kallikrein at 2 mM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm00173a008,3.4.21.34,P03952
97813734,Unspecified,95039,103760849,0,12420538,3818,9606,2231595,Literature-derived,20181012,0,0,P03952,NULL,NULL,ChEMBL,Inhibition against human plasma Kallikrein at 2 mM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm00173a008,3.4.21.34,P03952
97813735,Unspecified,95039,103219752,0,19841587,3818,9606,2231595,Literature-derived,20181012,0,0,P03952,NULL,NULL,ChEMBL,Inhibition against human plasma Kallikrein at 2 mM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm00173a008,3.4.21.34,P03952
97813736,Unspecified,95039,103219753,0,5173985,3818,9606,2231595,Literature-derived,20181012,0,0,P03952,NULL,NULL,ChEMBL,Inhibition against human plasma Kallikrein at 2 mM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm00173a008,3.4.21.34,P03952
97813755,Unspecified,95042,103323647,0,44335624,3818,9606,9301673,Confirmatory,20181015,0,0,P03952,Ki,97,ChEMBL,Inhibitory activity against Kallikrein (PK),NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm960668h,3.4.21.34,P03952
97813761,Unspecified,95042,103323810,0,10816339,3818,9606,9301673,Confirmatory,20181015,0,0,P03952,Ki,58,ChEMBL,Inhibitory activity against Kallikrein (PK),NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm960668h,3.4.21.34,P03952
97813762,Unspecified,95039,103220406,0,3621644,3818,9606,2231595,Literature-derived,20181012,0,0,P03952,NULL,NULL,ChEMBL,Inhibition against human plasma Kallikrein at 2 mM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm00173a008,3.4.21.34,P03952
97813763,Unspecified,95039,103760851,0,14346967,3818,9606,2231595,Literature-derived,20181012,0,0,P03952,NULL,NULL,ChEMBL,Inhibition against human plasma Kallikrein at 2 mM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm00173a008,3.4.21.34,P03952
97813764,Unspecified,95039,103760852,0,1549311,3818,9606,2231595,Literature-derived,20181012,0,0,P03952,NULL,NULL,ChEMBL,Inhibition against human plasma Kallikrein at 2 mM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm00173a008,3.4.21.34,P03952
97813765,Unspecified,95039,103760853,0,22098976,3818,9606,2231595,Literature-derived,20181012,0,0,P03952,NULL,NULL,ChEMBL,Inhibition against human plasma Kallikrein at 2 mM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm00173a008,3.4.21.34,P03952
97813767,Unspecified,95039,103760854,0,21434854,3818,9606,2231595,Literature-derived,20181012,0,0,P03952,NULL,NULL,ChEMBL,Inhibition against human plasma Kallikrein at 2 mM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm00173a008,3.4.21.34,P03952
97813768,Unspecified,95044,103350929,0,44347477,3818,9606,9357536,Confirmatory,20181015,0,0,P03952,Ki,1000,ChEMBL,Inhibitory activity against serine protease plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm970397q,3.4.21.34,P03952
97813769,Unspecified,95044,103350930,0,44347479,3818,9606,9357536,Confirmatory,20181015,0,0,P03952,Ki,476,ChEMBL,Inhibitory activity against serine protease plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm970397q,3.4.21.34,P03952
97813770,Unspecified,95044,103351095,0,44347533,3818,9606,9357536,Confirmatory,20181015,0,0,P03952,Ki,767,ChEMBL,Inhibitory activity against serine protease plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm970397q,3.4.21.34,P03952
97813771,Unspecified,95044,103351330,0,44347623,3818,9606,9357536,Confirmatory,20181015,0,0,P03952,Ki,1000,ChEMBL,Inhibitory activity against serine protease plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm970397q,3.4.21.34,P03952
97813772,Unspecified,95044,103678022,0,45264998,3818,9606,9357536,Confirmatory,20181015,0,0,P03952,Ki,775,ChEMBL,Inhibitory activity against serine protease plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm970397q,3.4.21.34,P03952
97813773,Unspecified,95044,103351184,0,44347573,3818,9606,9357536,Confirmatory,20181015,0,0,P03952,Ki,1000,ChEMBL,Inhibitory activity against serine protease plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm970397q,3.4.21.34,P03952
97813774,Unspecified,95044,103673118,0,45261772,3818,9606,9357536,Confirmatory,20181015,0,0,P03952,Ki,170,ChEMBL,Inhibitory activity against serine protease plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm970397q,3.4.21.34,P03952
97813779,Unspecified,95046,103760549,0,44314051,3818,9606,8295209,Literature-derived,20181014,0,0,P03952,NULL,NULL,ChEMBL,The compound was measured for inhibitory activity against human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm00028a004,3.4.21.34,P03952
97813780,Unspecified,95046,103760566,0,384450,3818,9606,8295209,Literature-derived,20181014,0,0,P03952,NULL,NULL,ChEMBL,The compound was measured for inhibitory activity against human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm00028a004,3.4.21.34,P03952
97813781,Unspecified,95046,103760527,0,9986233,3818,9606,8295209,Literature-derived,20181014,0,0,P03952,NULL,NULL,ChEMBL,The compound was measured for inhibitory activity against human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm00028a004,3.4.21.34,P03952
97813782,Unspecified,95046,103543207,0,9827867,3818,9606,8295209,Literature-derived,20181014,0,0,P03952,NULL,NULL,ChEMBL,The compound was measured for inhibitory activity against human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm00028a004,3.4.21.34,P03952
97813783,Unspecified,95046,103760567,0,44314376,3818,9606,8295209,Literature-derived,20181014,0,0,P03952,NULL,NULL,ChEMBL,The compound was measured for inhibitory activity against human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm00028a004,3.4.21.34,P03952
97814618,Unspecified,95170,174505794,0,10455169,3818,9606,8478905,Confirmatory,20181014,0,0,P03952,IC50,54,ChEMBL,Inhibition of kallikrein with benzoyl-L-arginine ethyl ester as substrate,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm00060a016,3.4.21.34,P03952
97814730,Unspecified,95188,103211488,0,9956559,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,20,ChEMBL,Binding affinity against serine protease plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
98205505,Unspecified,159997,103330165,0,10742217,3818,9606,9703466,Confirmatory,20181015,0,0,P03952,Ki,816,ChEMBL,Binding affinity was evaluated on serine protease plasma kallikrein.,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm9801713,3.4.21.34,P03952
98205506,Unspecified,159997,103223010,0,10669349,3818,9606,9703466,Confirmatory,20181015,0,0,P03952,Ki,586,ChEMBL,Binding affinity was evaluated on serine protease plasma kallikrein.,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm9801713,3.4.21.34,P03952
98205507,Unspecified,159997,103330168,0,10744643,3818,9606,9703466,Confirmatory,20181015,0,0,P03952,Ki,399,ChEMBL,Binding affinity was evaluated on serine protease plasma kallikrein.,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm9801713,3.4.21.34,P03952
98205508,Unspecified,159997,103330952,0,10529121,3818,9606,9703466,Confirmatory,20181015,0,0,P03952,Ki,79,ChEMBL,Binding affinity was evaluated on serine protease plasma kallikrein.,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm9801713,3.4.21.34,P03952
98712632,Unspecified,238234,103297924,0,10461790,3818,9606,15341970,Confirmatory,20181018,0,0,P03952,Ki,50,ChEMBL,Binding affinity towards human kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2004.07.007,3.4.21.34,P03952
98712633,Unspecified,238234,103451007,0,44394250,3818,9606,15341970,Confirmatory,20181018,0,0,P03952,Ki,50,ChEMBL,Binding affinity towards human kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2004.07.007,3.4.21.34,P03952
98712642,Unspecified,238234,103451009,0,3011892,3818,9606,15341970,Confirmatory,20181018,0,0,P03952,Ki,50,ChEMBL,Binding affinity towards human kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2004.07.007,3.4.21.34,P03952
98712646,Unspecified,238234,174500474,0,73350210,3818,9606,15341970,Confirmatory,20181018,0,0,P03952,Ki,50,ChEMBL,Binding affinity towards human kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2004.07.007,3.4.21.34,P03952
98712647,Unspecified,238234,174510781,0,15955412,3818,9606,15341970,Confirmatory,20181018,0,0,P03952,Ki,50,ChEMBL,Binding affinity towards human kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2004.07.007,3.4.21.34,P03952
98712649,Unspecified,238234,103451006,0,44394249,3818,9606,15341970,Confirmatory,20181018,0,0,P03952,Ki,50,ChEMBL,Binding affinity towards human kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2004.07.007,3.4.21.34,P03952
98712658,Unspecified,238234,103615439,0,3088969,3818,9606,15341970,Confirmatory,20181018,0,0,P03952,Ki,50,ChEMBL,Binding affinity towards human kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2004.07.007,3.4.21.34,P03952
98712659,Unspecified,238234,174490201,0,73347119,3818,9606,15341970,Confirmatory,20181018,0,0,P03952,Ki,50,ChEMBL,Binding affinity towards human kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2004.07.007,3.4.21.34,P03952
98852621,Unspecified,254779,103470724,0,44404049,3818,9606,16250649,Confirmatory,20181018,0,0,P03952,IC50,400,ChEMBL,Inhibitory concentration against kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm050488k,3.4.21.34,P03952
98881254,Unspecified,257643,103474309,0,11720955,3818,9606,16213711,Confirmatory,20181019,0,0,P03952,Ki,19.4,ChEMBL,Binding affinity to plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2005.08.107,3.4.21.34,P03952
98936310,Unspecified,263271,103484609,0,23646295,3818,9606,16434195,Confirmatory,20181020,0,0,P03952,Ki,2.3,ChEMBL,Binding affinity to human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2006.01.010,3.4.21.34,P03952
98936312,Unspecified,263271,103484397,0,10143532,3818,9606,16434195,Confirmatory,20181020,0,0,P03952,Ki,2.3,ChEMBL,Binding affinity to human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2006.01.010,3.4.21.34,P03952
98936316,Unspecified,263271,103484776,0,204102,3818,9606,16434195,Confirmatory,20181020,0,0,P03952,Ki,2.3,ChEMBL,Binding affinity to human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2006.01.010,3.4.21.34,P03952
98974541,Unspecified,267659,103675550,0,45263389,3818,9606,16644215,Confirmatory,20181020,0,0,P03952,Ki,83,ChEMBL,Inhibition of kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2006.04.013,3.4.21.34,P03952
98991615,Unspecified,269508,103339848,0,67145,3818,9606,16913712,Confirmatory,20181020,0,0,P03952,IC50,67.9,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm0605132,3.4.21.34,P03952
98991620,Unspecified,269508,103496663,0,1269450,3818,9606,16913712,Confirmatory,20181020,0,0,P03952,IC50,67.4,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm0605132,3.4.21.34,P03952
98991621,Unspecified,269508,103496664,0,44415189,3818,9606,16913712,Confirmatory,20181020,0,0,P03952,IC50,75,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm0605132,3.4.21.34,P03952
98991622,Unspecified,269508,103496695,0,7028541,3818,9606,16913712,Confirmatory,20181020,0,0,P03952,IC50,120.1,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm0605132,3.4.21.34,P03952
98991626,Unspecified,269508,103496631,0,5348879,3818,9606,16913712,Confirmatory,20181020,0,0,P03952,IC50,96.2,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm0605132,3.4.21.34,P03952
98991629,Unspecified,269508,103496593,0,5430316,3818,9606,16913712,Confirmatory,20181020,0,0,P03952,IC50,54.2,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm0605132,3.4.21.34,P03952
98991630,Unspecified,269508,103496793,0,767161,3818,9606,16913712,Confirmatory,20181020,0,0,P03952,IC50,60.5,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm0605132,3.4.21.34,P03952
98995352,Unspecified,269929,103495266,0,6914623,3818,9606,16730984,Confirmatory,20181020,0,0,P03952,Ki,2.8,ChEMBL,Binding affinity to human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2006.02.069,3.4.21.34,P03952
98995353,Unspecified,269929,103484776,0,204102,3818,9606,16730984,Confirmatory,20181020,0,0,P03952,Ki,2.3,ChEMBL,Binding affinity to human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2006.02.069,3.4.21.34,P03952
99217734,Unspecified,299808,103535586,0,11351302,3818,9606,17588746,Confirmatory,20181022,0,0,P03952,Ki,10,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2007.06.029,3.4.21.34,P03952
99217735,Unspecified,299808,103535541,0,9954980,3818,9606,17588746,Confirmatory,20181022,0,0,P03952,Ki,16,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2007.06.029,3.4.21.34,P03952
99217737,Unspecified,299808,103535608,0,44432538,3818,9606,17588746,Confirmatory,20181022,0,0,P03952,Ki,10,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2007.06.029,3.4.21.34,P03952
99226145,Unspecified,300716,103539112,0,24180463,3818,9606,17643988,Confirmatory,20181022,0,0,P03952,Ki,6,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2007.07.020,3.4.21.34,P03952
99226146,Unspecified,300716,103539128,0,44434835,3818,9606,17643988,Confirmatory,20181022,0,0,P03952,Ki,10.8,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2007.07.020,3.4.21.34,P03952
99226147,Unspecified,300716,103539091,0,44434809,3818,9606,17643988,Confirmatory,20181022,0,0,P03952,Ki,6,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2007.07.020,3.4.21.34,P03952
99226148,Unspecified,300716,103539109,0,44434818,3818,9606,17643988,Confirmatory,20181022,0,0,P03952,Ki,6,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2007.07.020,3.4.21.34,P03952
99226149,Unspecified,300716,103539090,0,44434808,3818,9606,17643988,Confirmatory,20181022,0,0,P03952,Ki,10.8,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2007.07.020,3.4.21.34,P03952
99267488,Unspecified,305788,103549291,0,16664096,3818,9606,17174550,Confirmatory,20181022,0,0,P03952,Activity,11000,ChEMBL,Inhibition of plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2006.11.071,3.4.21.34,P03952
99267489,Unspecified,305788,103439681,0,9895762,3818,9606,17174550,Confirmatory,20181022,0,0,P03952,Activity,61,ChEMBL,Inhibition of plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2006.11.071,3.4.21.34,P03952
99297122,Unspecified,309717,103553663,0,44443532,3818,9606,17855089,Confirmatory,20181022,0,0,P03952,Activity,30,ChEMBL,Inhibition of plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2007.07.063,3.4.21.34,P03952
99326343,Unspecified,313685,103484776,0,204102,3818,9606,18054227,Confirmatory,20181022,0,0,P03952,Ki,2.3,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2007.11.040,3.4.21.34,P03952
99345203,Unspecified,316547,103338073,0,387447,3818,9606,18247547,Literature-derived,20181023,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein at 10 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm7010589,3.4.21.34,P03952
99345204,Unspecified,316547,103577996,0,24800541,3818,9606,18247547,Literature-derived,20181023,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein at 10 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm7010589,3.4.21.34,P03952
99377840,Unspecified,320974,103572215,0,24180717,3818,9606,18272363,Literature-derived,20181023,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of kallikrein at 10 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2008.01.093,3.4.21.34,P03952
99718982,Unspecified,385493,103583123,0,44560022,3818,9606,17684009,Literature-derived,20181025,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human kallikrein at 1 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1074/jbc.M705600200,3.4.21.34,P03952
99821584,Unspecified,404327,103620300,0,24860432,3818,9606,18459730,Confirmatory,20181025,0,0,P03952,IC50,50,ChEMBL,Inhibition of human kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm8002697,3.4.21.34,P03952
99821590,Unspecified,404327,103620302,0,3162843,3818,9606,18459730,Confirmatory,20181025,0,0,P03952,IC50,50,ChEMBL,Inhibition of human kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm8002697,3.4.21.34,P03952
99821591,Unspecified,404327,103620207,0,754821,3818,9606,18459730,Confirmatory,20181025,0,0,P03952,IC50,50,ChEMBL,Inhibition of human kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm8002697,3.4.21.34,P03952
99821593,Unspecified,404327,103620303,0,747662,3818,9606,18459730,Confirmatory,20181025,0,0,P03952,IC50,50,ChEMBL,Inhibition of human kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm8002697,3.4.21.34,P03952
99821595,Unspecified,404327,103620855,0,10423722,3818,9606,18459730,Confirmatory,20181025,0,0,P03952,IC50,50,ChEMBL,Inhibition of human kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm8002697,3.4.21.34,P03952
99821600,Unspecified,404327,103620907,0,741761,3818,9606,18459730,Confirmatory,20181025,0,0,P03952,IC50,50,ChEMBL,Inhibition of human kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm8002697,3.4.21.34,P03952
99821608,Unspecified,404327,103620964,0,24860449,3818,9606,18459730,Confirmatory,20181025,0,0,P03952,IC50,50,ChEMBL,Inhibition of human kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm8002697,3.4.21.34,P03952
99821622,Unspecified,404327,103620966,0,24860451,3818,9606,18459730,Confirmatory,20181025,0,0,P03952,IC50,50,ChEMBL,Inhibition of human kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm8002697,3.4.21.34,P03952
99821623,Unspecified,404327,103620208,0,3123858,3818,9606,18459730,Confirmatory,20181025,0,0,P03952,IC50,50,ChEMBL,Inhibition of human kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm8002697,3.4.21.34,P03952
99821624,Unspecified,404327,103620209,0,5400404,3818,9606,18459730,Confirmatory,20181025,0,0,P03952,IC50,50,ChEMBL,Inhibition of human kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm8002697,3.4.21.34,P03952
103173233,Unspecified,448207,103704733,0,44255320,3818,9606,19715320,Literature-derived,20180911,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of plasma kallikrein assessed as residual activity at 10 uM after 10 to 15 mins by fluorescence assay relative to control,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm9009394,3.4.21.34,P03952
247270713,Unspecified,507741,123097409,0,52948030,3818,9606,19483697,Confirmatory,20180914,0,0,P03952,IC50,10,ChEMBL,Inhibition of human plasma kallikrein using Z-Phe-Arg-AMC substrate after 30 mins by spectrophotometric assay,NULL,Plasma kallikrein (human),/gene/3818,10.1038/nchembio.184,3.4.21.34,P03952
247270715,Unspecified,507741,123090517,0,52944360,3818,9606,19483697,Confirmatory,20180914,0,0,P03952,IC50,10,ChEMBL,Inhibition of human plasma kallikrein using Z-Phe-Arg-AMC substrate after 30 mins by spectrophotometric assay,NULL,Plasma kallikrein (human),/gene/3818,10.1038/nchembio.184,3.4.21.34,P03952
247270719,Unspecified,507741,123085891,0,52941956,3818,9606,19483697,Confirmatory,20180914,0,0,P03952,IC50,10,ChEMBL,Inhibition of human plasma kallikrein using Z-Phe-Arg-AMC substrate after 30 mins by spectrophotometric assay,NULL,Plasma kallikrein (human),/gene/3818,10.1038/nchembio.184,3.4.21.34,P03952
254106550,Unspecified,575819,123099410,0,42601552,3818,9606,20823284,Literature-derived,20180917,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human kallikrein at 10 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1128/AAC.00787-10,3.4.21.34,P03952
304679048,Unspecified,626484,136934002,0,57397312,3818,9606,21944858,Literature-derived,20180919,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of plasma kallikrein at 1000 uM,N-[(1S)-5-Amino-1-cyanopentyl]-3-[3-(1H-indol-3-yl)propanoylamino]-4-(pyridin-4-ylmethoxy)benzamide,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2011.08.121,3.4.21.34,P03952
304679049,Unspecified,626484,136943501,0,57402478,3818,9606,21944858,Literature-derived,20180919,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of plasma kallikrein at 1000 uM,N-[(1S)-5-Amino-1-cyanopentyl]-4-(pyridin-4-ylmethoxy)benzamide,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2011.08.121,3.4.21.34,P03952
304679054,Unspecified,626484,136927308,0,57393748,3818,9606,21944858,Literature-derived,20180919,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of plasma kallikrein at 1000 uM,N-[(1S)-5-Amino-1-cyanopentyl]-3-[3-[1-[(4-fluorophenyl)methyl]indol-3-yl]propanoylamino]-4-(pyridin-4-ylmethoxy)benzamide,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2011.08.121,3.4.21.34,P03952
304679055,Unspecified,626484,136933985,0,57397305,3818,9606,21944858,Literature-derived,20180919,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of plasma kallikrein at 1000 uM,"(2R,3R)-2-Amino-N-[(2S)-1-[[(1S)-5-amino-1-cyanopentyl]amino]-1-oxo-3-phenylpropan-2-yl]-3-methylpentanamide",Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2011.08.121,3.4.21.34,P03952
304679058,Unspecified,626484,136940310,0,57400705,3818,9606,21944858,Literature-derived,20180919,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of plasma kallikrein at 1000 uM,N-[(1S)-5-Amino-1-cyanopentyl]-3-[[2-(4-fluorophenyl)acetyl]amino]-4-(pyridin-4-ylmethoxy)benzamide,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2011.08.121,3.4.21.34,P03952
304679059,Unspecified,626484,136920745,0,57390228,3818,9606,21944858,Literature-derived,20180919,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of plasma kallikrein at 1000 uM,"(2S)-6-Amino-2-[[(2S)-2-[[(2R,3R)-2-amino-3-methylpentanoyl]amino]-3-phenylpropanoyl]amino]hexanamide",Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2011.08.121,3.4.21.34,P03952
304679647,Unspecified,626531,136920762,0,57390236,3818,9606,21944858,Confirmatory,20180919,0,0,P03952,IC50,910,ChEMBL,Inhibition of plasma kallikrein,Tert-butyl 3-[3-[5-[[(1S)-5-amino-1-cyanopentyl]carbamoyl]-2-(pyridin-4-ylmethoxy)anilino]-3-oxopropyl]indole-1-carboxylate,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2011.08.121,3.4.21.34,P03952
304679648,Unspecified,626531,136927377,0,57393799,3818,9606,21944858,Confirmatory,20180919,0,0,P03952,IC50,380,ChEMBL,Inhibition of plasma kallikrein,N-[(1S)-5-Amino-1-cyanopentyl]-3-[(2-naphthalen-2-ylacetyl)amino]-4-(pyridin-4-ylmethoxy)benzamide,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2011.08.121,3.4.21.34,P03952
304679649,Unspecified,626531,136940398,0,57400764,3818,9606,21944858,Confirmatory,20180919,0,0,P03952,IC50,680,ChEMBL,Inhibition of plasma kallikrein,N-[(1S)-5-Amino-1-cyanopentyl]-3-[(2-naphthalen-1-ylacetyl)amino]-4-(pyridin-4-ylmethoxy)benzamide,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2011.08.121,3.4.21.34,P03952
304679666,Unspecified,626532,136934003,0,57397313,3818,9606,21944858,Literature-derived,20180919,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of plasma kallikrein at 250 uM,N-[(1S)-5-Amino-1-cyanopentyl]-3-[3-[1-[(4-fluorophenyl)methyl]indol-3-yl]propanoylamino]-4-methoxybenzamide,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2011.08.121,3.4.21.34,P03952
304737194,Unspecified,635175,136924700,0,57392333,3818,9606,22047802,Confirmatory,20180920,0,0,P03952,Ki,2000,ChEMBL,Inhibition of plasma kallikrein,"6-Amino-N-[(3S,7E,9S,12R,16S,19S)-16-[[3-(aminomethyl)phenyl]methyl]-12-[(2S)-butan-2-yl]-9-[(4-hydroxyphenyl)methyl]-2,6,11,14,18-pentaoxo-1,5,10,13,17-pentazabicyclo[17.3.0]docos-7-en-3-yl]hexanamide",Plasma kallikrein (human),/gene/3818,10.1016/j.bmc.2011.09.050,3.4.21.34,P03952
304737201,Unspecified,635175,136931186,0,57395841,3818,9606,22047802,Confirmatory,20180920,0,0,P03952,Ki,3300,ChEMBL,Inhibition of plasma kallikrein,"N-[(3S,7E,9S,12R,16S,19S)-16-[[3-(Aminomethyl)phenyl]methyl]-12-[(2S)-butan-2-yl]-9-[(4-hydroxyphenyl)methyl]-2,6,11,14,18-pentaoxo-1,5,10,13,17-pentazabicyclo[17.3.0]docos-7-en-3-yl]acetamide",Plasma kallikrein (human),/gene/3818,10.1016/j.bmc.2011.09.050,3.4.21.34,P03952
433612215,Unspecified,732603,164135583,0,71711730,3818,9606,23350733,Literature-derived,20180926,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of Plasma Kallikrein (unknown origin) using Z-FR-AMC substrate assessed as residual activity at 10 uM incubated for 15 mins prior to substrate addition measured for 2 hrs,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm3017305,3.4.21.34,P03952
433637743,Unspecified,736262,174499629,0,71716976,3818,9606,23586812,Confirmatory,20180926,0,0,P03952,Ki,120,ChEMBL,Inhibition of human PK using Z-Phe-Arg-AMC as substrate assessed as residual activity by fluorometric analysis,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm400236j,3.4.21.34,P03952
433637744,Unspecified,736262,174494480,0,71716975,3818,9606,23586812,Confirmatory,20180926,0,0,P03952,Ki,120,ChEMBL,Inhibition of human PK using Z-Phe-Arg-AMC as substrate assessed as residual activity by fluorometric analysis,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm400236j,3.4.21.34,P03952
441655581,Unspecified,1129678,242619906,0,90655504,3818,9606,24613052,Confirmatory,20181003,0,0,P03952,IC50,1000,ChEMBL,Inhibition of human plasma kallikerin using H-D-Phe-Pro-Arg-pNA (S-2302) peptide as substrate assessed as reduction of enzyme hydrolytic activity,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmc.2014.02.002,3.4.21.34,P03952
441655582,Unspecified,1129678,242619908,0,90655506,3818,9606,24613052,Confirmatory,20181003,0,0,P03952,IC50,1000,ChEMBL,Inhibition of human plasma kallikerin using H-D-Phe-Pro-Arg-pNA (S-2302) peptide as substrate assessed as reduction of enzyme hydrolytic activity,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmc.2014.02.002,3.4.21.34,P03952
441655583,Unspecified,1129678,242625170,0,90655486,3818,9606,24613052,Confirmatory,20181003,0,0,P03952,IC50,740,ChEMBL,Inhibition of human plasma kallikerin using H-D-Phe-Pro-Arg-pNA (S-2302) peptide as substrate assessed as reduction of enzyme hydrolytic activity,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmc.2014.02.002,3.4.21.34,P03952
441655584,Unspecified,1129678,242625172,0,90655488,3818,9606,24613052,Confirmatory,20181003,0,0,P03952,IC50,1000,ChEMBL,Inhibition of human plasma kallikerin using H-D-Phe-Pro-Arg-pNA (S-2302) peptide as substrate assessed as reduction of enzyme hydrolytic activity,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmc.2014.02.002,3.4.21.34,P03952
441655585,Unspecified,1129678,242625177,0,90655493,3818,9606,24613052,Confirmatory,20181003,0,0,P03952,IC50,1000,ChEMBL,Inhibition of human plasma kallikerin using H-D-Phe-Pro-Arg-pNA (S-2302) peptide as substrate assessed as reduction of enzyme hydrolytic activity,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmc.2014.02.002,3.4.21.34,P03952
441655586,Unspecified,1129678,242625179,0,90655495,3818,9606,24613052,Confirmatory,20181003,0,0,P03952,IC50,1000,ChEMBL,Inhibition of human plasma kallikerin using H-D-Phe-Pro-Arg-pNA (S-2302) peptide as substrate assessed as reduction of enzyme hydrolytic activity,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmc.2014.02.002,3.4.21.34,P03952
441655587,Unspecified,1129678,242625186,0,90655501,3818,9606,24613052,Confirmatory,20181003,0,0,P03952,IC50,1000,ChEMBL,Inhibition of human plasma kallikerin using H-D-Phe-Pro-Arg-pNA (S-2302) peptide as substrate assessed as reduction of enzyme hydrolytic activity,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmc.2014.02.002,3.4.21.34,P03952
441655588,Unspecified,1129678,242625181,0,90655497,3818,9606,24613052,Confirmatory,20181003,0,0,P03952,IC50,1000,ChEMBL,Inhibition of human plasma kallikerin using H-D-Phe-Pro-Arg-pNA (S-2302) peptide as substrate assessed as reduction of enzyme hydrolytic activity,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmc.2014.02.002,3.4.21.34,P03952
441655589,Unspecified,1129678,242625182,0,86302628,3818,9606,24613052,Confirmatory,20181003,0,0,P03952,IC50,1000,ChEMBL,Inhibition of human plasma kallikerin using H-D-Phe-Pro-Arg-pNA (S-2302) peptide as substrate assessed as reduction of enzyme hydrolytic activity,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmc.2014.02.002,3.4.21.34,P03952
441655590,Unspecified,1129678,242625183,0,90655498,3818,9606,24613052,Confirmatory,20181003,0,0,P03952,IC50,1000,ChEMBL,Inhibition of human plasma kallikerin using H-D-Phe-Pro-Arg-pNA (S-2302) peptide as substrate assessed as reduction of enzyme hydrolytic activity,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmc.2014.02.002,3.4.21.34,P03952
441655591,Unspecified,1129678,242625184,0,90655499,3818,9606,24613052,Confirmatory,20181003,0,0,P03952,IC50,1000,ChEMBL,Inhibition of human plasma kallikerin using H-D-Phe-Pro-Arg-pNA (S-2302) peptide as substrate assessed as reduction of enzyme hydrolytic activity,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmc.2014.02.002,3.4.21.34,P03952
441655592,Unspecified,1129678,242625185,0,90655500,3818,9606,24613052,Confirmatory,20181003,0,0,P03952,IC50,1000,ChEMBL,Inhibition of human plasma kallikerin using H-D-Phe-Pro-Arg-pNA (S-2302) peptide as substrate assessed as reduction of enzyme hydrolytic activity,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmc.2014.02.002,3.4.21.34,P03952
441655593,Unspecified,1129678,242625180,0,90655496,3818,9606,24613052,Confirmatory,20181003,0,0,P03952,IC50,1000,ChEMBL,Inhibition of human plasma kallikerin using H-D-Phe-Pro-Arg-pNA (S-2302) peptide as substrate assessed as reduction of enzyme hydrolytic activity,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmc.2014.02.002,3.4.21.34,P03952
441655594,Unspecified,1129678,242625187,0,90655502,3818,9606,24613052,Confirmatory,20181003,0,0,P03952,IC50,1000,ChEMBL,Inhibition of human plasma kallikerin using H-D-Phe-Pro-Arg-pNA (S-2302) peptide as substrate assessed as reduction of enzyme hydrolytic activity,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmc.2014.02.002,3.4.21.34,P03952
441655595,Unspecified,1129678,242619905,0,90655503,3818,9606,24613052,Confirmatory,20181003,0,0,P03952,IC50,1000,ChEMBL,Inhibition of human plasma kallikerin using H-D-Phe-Pro-Arg-pNA (S-2302) peptide as substrate assessed as reduction of enzyme hydrolytic activity,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmc.2014.02.002,3.4.21.34,P03952
441655596,Unspecified,1129678,242619907,0,90655505,3818,9606,24613052,Confirmatory,20181003,0,0,P03952,IC50,1000,ChEMBL,Inhibition of human plasma kallikerin using H-D-Phe-Pro-Arg-pNA (S-2302) peptide as substrate assessed as reduction of enzyme hydrolytic activity,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmc.2014.02.002,3.4.21.34,P03952
441655597,Unspecified,1129678,242625169,0,90655485,3818,9606,24613052,Confirmatory,20181003,0,0,P03952,IC50,1000,ChEMBL,Inhibition of human plasma kallikerin using H-D-Phe-Pro-Arg-pNA (S-2302) peptide as substrate assessed as reduction of enzyme hydrolytic activity,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmc.2014.02.002,3.4.21.34,P03952
441655598,Unspecified,1129678,242625171,0,90655487,3818,9606,24613052,Confirmatory,20181003,0,0,P03952,IC50,1000,ChEMBL,Inhibition of human plasma kallikerin using H-D-Phe-Pro-Arg-pNA (S-2302) peptide as substrate assessed as reduction of enzyme hydrolytic activity,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmc.2014.02.002,3.4.21.34,P03952
441655599,Unspecified,1129678,242625178,0,90655494,3818,9606,24613052,Confirmatory,20181003,0,0,P03952,IC50,1000,ChEMBL,Inhibition of human plasma kallikerin using H-D-Phe-Pro-Arg-pNA (S-2302) peptide as substrate assessed as reduction of enzyme hydrolytic activity,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmc.2014.02.002,3.4.21.34,P03952
441655600,Unspecified,1129678,242625173,0,90655489,3818,9606,24613052,Confirmatory,20181003,0,0,P03952,IC50,1000,ChEMBL,Inhibition of human plasma kallikerin using H-D-Phe-Pro-Arg-pNA (S-2302) peptide as substrate assessed as reduction of enzyme hydrolytic activity,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmc.2014.02.002,3.4.21.34,P03952
441655601,Unspecified,1129678,242625174,0,90655490,3818,9606,24613052,Confirmatory,20181003,0,0,P03952,IC50,1000,ChEMBL,Inhibition of human plasma kallikerin using H-D-Phe-Pro-Arg-pNA (S-2302) peptide as substrate assessed as reduction of enzyme hydrolytic activity,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmc.2014.02.002,3.4.21.34,P03952
441655602,Unspecified,1129678,242625175,0,90655491,3818,9606,24613052,Confirmatory,20181003,0,0,P03952,IC50,1000,ChEMBL,Inhibition of human plasma kallikerin using H-D-Phe-Pro-Arg-pNA (S-2302) peptide as substrate assessed as reduction of enzyme hydrolytic activity,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmc.2014.02.002,3.4.21.34,P03952
441655603,Unspecified,1129678,242625176,0,90655492,3818,9606,24613052,Confirmatory,20181003,0,0,P03952,IC50,1000,ChEMBL,Inhibition of human plasma kallikerin using H-D-Phe-Pro-Arg-pNA (S-2302) peptide as substrate assessed as reduction of enzyme hydrolytic activity,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmc.2014.02.002,3.4.21.34,P03952
441670520,Unspecified,1132633,242630926,0,118705717,3818,9606,660589,Literature-derived,20181003,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of 2 X 10'-7 M human plasma kallikrein using Z-Lys-nitrophenyl ester as substrate assessed as second-order rate inactivation constant incubated up to 1 hr at pH 7.4,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm00203a009,3.4.21.34,P03952
441670521,Unspecified,1132633,242630928,0,90674157,3818,9606,660589,Literature-derived,20181003,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of 2 X 10'-7 M human plasma kallikrein using Z-Lys-nitrophenyl ester as substrate assessed as second-order rate inactivation constant incubated up to 1 hr at pH 7.4,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm00203a009,3.4.21.34,P03952
441670523,Unspecified,1132633,242630935,0,90674167,3818,9606,660589,Literature-derived,20181003,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of 2 X 10'-7 M human plasma kallikrein using Z-Lys-nitrophenyl ester as substrate assessed as second-order rate inactivation constant incubated up to 1 hr at pH 7.4,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm00203a009,3.4.21.34,P03952
441670524,Unspecified,1132633,242630937,0,90674171,3818,9606,660589,Literature-derived,20181003,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of 2 X 10'-7 M human plasma kallikrein using Z-Lys-nitrophenyl ester as substrate assessed as second-order rate inactivation constant incubated up to 1 hr at pH 7.4,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm00203a009,3.4.21.34,P03952
441670525,Unspecified,1132633,242630927,0,118705718,3818,9606,660589,Literature-derived,20181003,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of 2 X 10'-7 M human plasma kallikrein using Z-Lys-nitrophenyl ester as substrate assessed as second-order rate inactivation constant incubated up to 1 hr at pH 7.4,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm00203a009,3.4.21.34,P03952
441670526,Unspecified,1132633,242630929,0,90674159,3818,9606,660589,Literature-derived,20181003,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of 2 X 10'-7 M human plasma kallikrein using Z-Lys-nitrophenyl ester as substrate assessed as second-order rate inactivation constant incubated up to 1 hr at pH 7.4,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm00203a009,3.4.21.34,P03952
441670527,Unspecified,1132633,242630936,0,90674169,3818,9606,660589,Literature-derived,20181003,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of 2 X 10'-7 M human plasma kallikrein using Z-Lys-nitrophenyl ester as substrate assessed as second-order rate inactivation constant incubated up to 1 hr at pH 7.4,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm00203a009,3.4.21.34,P03952
441670528,Unspecified,1132633,242630931,0,118705719,3818,9606,660589,Literature-derived,20181003,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of 2 X 10'-7 M human plasma kallikrein using Z-Lys-nitrophenyl ester as substrate assessed as second-order rate inactivation constant incubated up to 1 hr at pH 7.4,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm00203a009,3.4.21.34,P03952
441670529,Unspecified,1132633,242630932,0,118705720,3818,9606,660589,Literature-derived,20181003,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of 2 X 10'-7 M human plasma kallikrein using Z-Lys-nitrophenyl ester as substrate assessed as second-order rate inactivation constant incubated up to 1 hr at pH 7.4,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm00203a009,3.4.21.34,P03952
441670530,Unspecified,1132633,242630933,0,90674163,3818,9606,660589,Literature-derived,20181003,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of 2 X 10'-7 M human plasma kallikrein using Z-Lys-nitrophenyl ester as substrate assessed as second-order rate inactivation constant incubated up to 1 hr at pH 7.4,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm00203a009,3.4.21.34,P03952
441670531,Unspecified,1132633,242630934,0,90674165,3818,9606,660589,Literature-derived,20181003,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of 2 X 10'-7 M human plasma kallikrein using Z-Lys-nitrophenyl ester as substrate assessed as second-order rate inactivation constant incubated up to 1 hr at pH 7.4,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm00203a009,3.4.21.34,P03952
441670572,Unspecified,1132640,242630931,0,118705719,3818,9606,660589,Confirmatory,20181003,0,0,P03952,Ki,320,ChEMBL,Competitive inhibition of 2 X 10'-7 M human plasma kallikrein using Z-Lys-nitrophenyl ester as substrate incubated up to 1 hr at pH 6,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm00203a009,3.4.21.34,P03952
441671590,Unspecified,1132639,242630926,0,118705717,3818,9606,660589,Literature-derived,20181003,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of 2 X 10'-7 M human plasma kallikrein using Z-Lys-nitrophenyl ester as substrate assessed as half time required for enzyme inactivation at 5X10'-6 M at pH 7.4,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm00203a009,3.4.21.34,P03952
444240741,Unspecified,1180267,312348567,0,59020200,3818,9606,24951330,Confirmatory,20181005,0,0,P03952,Ki,11,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2014.05.101,3.4.21.34,P03952
446163656,Unspecified,1227165,318371590,0,122177744,3818,9606,25990761,Literature-derived,20181008,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of KLKB1 (unknown origin) at 100 uM,NULL,Plasma kallikrein (human),/gene/3818,10.1021/jm501840b,3.4.21.34,P03952
446207462,Unspecified,1235267,318378743,0,57842560,3818,9606,26151189,Confirmatory,20181008,0,0,P03952,Ki,6,ChEMBL,Inhibition of human plasma kallikrein using S2302 as substrate measured for 30 mins,NULL,Plasma kallikrein (human),/gene/3818,10.1021/acs.jmedchem.5b00788,3.4.21.34,P03952
446207469,Unspecified,1235267,318378736,0,57842673,3818,9606,26151189,Confirmatory,20181008,0,0,P03952,Ki,6,ChEMBL,Inhibition of human plasma kallikrein using S2302 as substrate measured for 30 mins,NULL,Plasma kallikrein (human),/gene/3818,10.1021/acs.jmedchem.5b00788,3.4.21.34,P03952
446366076,Unspecified,1257670,318418739,0,53345970,3818,9606,,Confirmatory,20181009,0,0,P03952,Ki,200,ChEMBL,Inhibition Assay: Inhibition of human t-PA was determined by the method described in [0092]-[0098] using recombinant human tissue-type plasminogen activator (Actilyse(R)) from Boehringer Ingelheim at 290 U/mL and Mes-d-Cha-Gly-Arg-pNA (Pefachrome tPA) at ,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
446366077,Unspecified,1257670,318418730,0,53346080,3818,9606,,Confirmatory,20181009,0,0,P03952,Ki,500,ChEMBL,Inhibition Assay: Inhibition of human t-PA was determined by the method described in [0092]-[0098] using recombinant human tissue-type plasminogen activator (Actilyse(R)) from Boehringer Ingelheim at 290 U/mL and Mes-d-Cha-Gly-Arg-pNA (Pefachrome tPA) at ,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
446366078,Unspecified,1257670,318418731,0,53346181,3818,9606,,Confirmatory,20181009,0,0,P03952,Ki,100,ChEMBL,Inhibition Assay: Inhibition of human t-PA was determined by the method described in [0092]-[0098] using recombinant human tissue-type plasminogen activator (Actilyse(R)) from Boehringer Ingelheim at 290 U/mL and Mes-d-Cha-Gly-Arg-pNA (Pefachrome tPA) at ,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
446366079,Unspecified,1257670,318418728,0,53345968,3818,9606,,Confirmatory,20181009,0,0,P03952,Ki,50,ChEMBL,Inhibition Assay: Inhibition of human t-PA was determined by the method described in [0092]-[0098] using recombinant human tissue-type plasminogen activator (Actilyse(R)) from Boehringer Ingelheim at 290 U/mL and Mes-d-Cha-Gly-Arg-pNA (Pefachrome tPA) at ,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
446366080,Unspecified,1257670,318418727,0,53346079,3818,9606,,Confirmatory,20181009,0,0,P03952,Ki,50,ChEMBL,Inhibition Assay: Inhibition of human t-PA was determined by the method described in [0092]-[0098] using recombinant human tissue-type plasminogen activator (Actilyse(R)) from Boehringer Ingelheim at 290 U/mL and Mes-d-Cha-Gly-Arg-pNA (Pefachrome tPA) at ,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
446366081,Unspecified,1257670,318418743,0,53346081,3818,9606,,Confirmatory,20181009,0,0,P03952,Ki,100,ChEMBL,Inhibition Assay: Inhibition of human t-PA was determined by the method described in [0092]-[0098] using recombinant human tissue-type plasminogen activator (Actilyse(R)) from Boehringer Ingelheim at 290 U/mL and Mes-d-Cha-Gly-Arg-pNA (Pefachrome tPA) at ,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
446366083,Unspecified,1257670,318418729,0,53346082,3818,9606,,Confirmatory,20181009,0,0,P03952,Ki,60,ChEMBL,Inhibition Assay: Inhibition of human t-PA was determined by the method described in [0092]-[0098] using recombinant human tissue-type plasminogen activator (Actilyse(R)) from Boehringer Ingelheim at 290 U/mL and Mes-d-Cha-Gly-Arg-pNA (Pefachrome tPA) at ,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
446366084,Unspecified,1257670,318418737,0,53345861,3818,9606,,Confirmatory,20181009,0,0,P03952,Ki,200,ChEMBL,Inhibition Assay: Inhibition of human t-PA was determined by the method described in [0092]-[0098] using recombinant human tissue-type plasminogen activator (Actilyse(R)) from Boehringer Ingelheim at 290 U/mL and Mes-d-Cha-Gly-Arg-pNA (Pefachrome tPA) at ,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
446366129,Unspecified,1257670,318418735,0,53345863,3818,9606,,Confirmatory,20181009,0,0,P03952,Ki,200,ChEMBL,Inhibition Assay: Inhibition of human t-PA was determined by the method described in [0092]-[0098] using recombinant human tissue-type plasminogen activator (Actilyse(R)) from Boehringer Ingelheim at 290 U/mL and Mes-d-Cha-Gly-Arg-pNA (Pefachrome tPA) at ,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
446366130,Unspecified,1257670,318418740,0,53345652,3818,9606,,Confirmatory,20181009,0,0,P03952,Ki,50,ChEMBL,Inhibition Assay: Inhibition of human t-PA was determined by the method described in [0092]-[0098] using recombinant human tissue-type plasminogen activator (Actilyse(R)) from Boehringer Ingelheim at 290 U/mL and Mes-d-Cha-Gly-Arg-pNA (Pefachrome tPA) at ,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
446366131,Unspecified,1257670,318418733,0,53345752,3818,9606,,Confirmatory,20181009,0,0,P03952,Ki,200,ChEMBL,Inhibition Assay: Inhibition of human t-PA was determined by the method described in [0092]-[0098] using recombinant human tissue-type plasminogen activator (Actilyse(R)) from Boehringer Ingelheim at 290 U/mL and Mes-d-Cha-Gly-Arg-pNA (Pefachrome tPA) at ,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
446366132,Unspecified,1257670,318418745,0,53345653,3818,9606,,Confirmatory,20181009,0,0,P03952,Ki,80,ChEMBL,Inhibition Assay: Inhibition of human t-PA was determined by the method described in [0092]-[0098] using recombinant human tissue-type plasminogen activator (Actilyse(R)) from Boehringer Ingelheim at 290 U/mL and Mes-d-Cha-Gly-Arg-pNA (Pefachrome tPA) at ,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
446366133,Unspecified,1257670,318418746,0,53345654,3818,9606,,Confirmatory,20181009,0,0,P03952,Ki,200,ChEMBL,Inhibition Assay: Inhibition of human t-PA was determined by the method described in [0092]-[0098] using recombinant human tissue-type plasminogen activator (Actilyse(R)) from Boehringer Ingelheim at 290 U/mL and Mes-d-Cha-Gly-Arg-pNA (Pefachrome tPA) at ,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
446366134,Unspecified,1257670,318418726,0,53345860,3818,9606,,Confirmatory,20181009,0,0,P03952,Ki,20,ChEMBL,Inhibition Assay: Inhibition of human t-PA was determined by the method described in [0092]-[0098] using recombinant human tissue-type plasminogen activator (Actilyse(R)) from Boehringer Ingelheim at 290 U/mL and Mes-d-Cha-Gly-Arg-pNA (Pefachrome tPA) at ,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
446366135,Unspecified,1257670,318418725,0,53345755,3818,9606,,Confirmatory,20181009,0,0,P03952,Ki,20,ChEMBL,Inhibition Assay: Inhibition of human t-PA was determined by the method described in [0092]-[0098] using recombinant human tissue-type plasminogen activator (Actilyse(R)) from Boehringer Ingelheim at 290 U/mL and Mes-d-Cha-Gly-Arg-pNA (Pefachrome tPA) at ,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
446366136,Unspecified,1257670,318418732,0,53345862,3818,9606,,Confirmatory,20181009,0,0,P03952,Ki,100,ChEMBL,Inhibition Assay: Inhibition of human t-PA was determined by the method described in [0092]-[0098] using recombinant human tissue-type plasminogen activator (Actilyse(R)) from Boehringer Ingelheim at 290 U/mL and Mes-d-Cha-Gly-Arg-pNA (Pefachrome tPA) at ,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
446366137,Unspecified,1257670,318418734,0,53345967,3818,9606,,Confirmatory,20181009,0,0,P03952,Ki,200,ChEMBL,Inhibition Assay: Inhibition of human t-PA was determined by the method described in [0092]-[0098] using recombinant human tissue-type plasminogen activator (Actilyse(R)) from Boehringer Ingelheim at 290 U/mL and Mes-d-Cha-Gly-Arg-pNA (Pefachrome tPA) at ,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
446366138,Unspecified,1257670,318414408,0,60141050,3818,9606,,Confirmatory,20181009,0,0,P03952,Ki,20,ChEMBL,Inhibition Assay: Inhibition of human t-PA was determined by the method described in [0092]-[0098] using recombinant human tissue-type plasminogen activator (Actilyse(R)) from Boehringer Ingelheim at 290 U/mL and Mes-d-Cha-Gly-Arg-pNA (Pefachrome tPA) at ,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
452509712,Unspecified,1262330,336883781,0,101862198,3818,9606,26536069,Confirmatory,20180904,0,0,P03952,Ki,1000,ChEMBL,Inhibition of human plasma kallikrein for 15 mins using H-D-Pro-Phe-Arg-p-nitroanilide as substrate,NULL,Plasma kallikrein (human),/gene/3818,10.1021/acs.jmedchem.5b01128,3.4.21.34,P03952
452509786,Unspecified,1262353,336885585,0,127037264,3818,9606,26536069,Literature-derived,20180904,0,0,P03952,NULL,NULL,ChEMBL,"Selectivity ratio, ratio of Ki for human plasma kallikrein catalytic domain E217R mutant to Ki for human wild-type plasma kallikrein catalytic domain",NULL,Plasma kallikrein (human),/gene/3818,10.1021/acs.jmedchem.5b01128,3.4.21.34,P03952
452509956,Unspecified,1262352,336885585,0,127037264,3818,9606,26536069,Literature-derived,20180904,0,0,P03952,NULL,NULL,ChEMBL,"Selectivity ratio, ratio of Ki for human plasma kallikrein catalytic domain G99Y mutant to Ki for human wild-type plasma kallikrein catalytic domain",NULL,Plasma kallikrein (human),/gene/3818,10.1021/acs.jmedchem.5b01128,3.4.21.34,P03952
452509957,Unspecified,1262354,336883781,0,101862198,3818,9606,26536069,Confirmatory,20180904,0,0,P03952,Kd,1000,ChEMBL,Binding affinity to human plasma kallikrein by surface plasmon resonance assay,NULL,Plasma kallikrein (human),/gene/3818,10.1021/acs.jmedchem.5b01128,3.4.21.34,P03952
452510297,Unspecified,1262351,336886049,0,127037469,3818,9606,26536069,Literature-derived,20180904,0,0,P03952,NULL,NULL,ChEMBL,"Selectivity ratio, ratio of Ki for human wild-type plasma kallikrein catalytic domain to Ki for human plasma kallikrein catalytic domain G99Y mutant",NULL,Plasma kallikrein (human),/gene/3818,10.1021/acs.jmedchem.5b01128,3.4.21.34,P03952
452532322,Unspecified,1265734,336886667,0,127037804,3818,9606,26575094,Literature-derived,20180904,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein using D-Pro-Phe-Arg-pNA-2HCl as substrate at 100 uM measured for 5 mins by spectrophotometric assay,NULL,Plasma kallikrein (human),/gene/3818,10.1021/acs.jmedchem.5b01171,3.4.21.34,P03952
452532323,Unspecified,1265734,336886669,0,127037806,3818,9606,26575094,Literature-derived,20180904,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein using D-Pro-Phe-Arg-pNA-2HCl as substrate at 100 uM measured for 5 mins by spectrophotometric assay,NULL,Plasma kallikrein (human),/gene/3818,10.1021/acs.jmedchem.5b01171,3.4.21.34,P03952
452532325,Unspecified,1265734,336890588,0,127040832,3818,9606,26575094,Literature-derived,20180904,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein using D-Pro-Phe-Arg-pNA-2HCl as substrate at 100 uM measured for 5 mins by spectrophotometric assay,NULL,Plasma kallikrein (human),/gene/3818,10.1021/acs.jmedchem.5b01171,3.4.21.34,P03952
452532334,Unspecified,1265734,103246205,0,16231,3818,9606,26575094,Literature-derived,20180904,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein using D-Pro-Phe-Arg-pNA-2HCl as substrate at 100 uM measured for 5 mins by spectrophotometric assay,NULL,Plasma kallikrein (human),/gene/3818,10.1021/acs.jmedchem.5b01171,3.4.21.34,P03952
452532341,Unspecified,1265734,336886668,0,127037805,3818,9606,26575094,Literature-derived,20180904,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein using D-Pro-Phe-Arg-pNA-2HCl as substrate at 100 uM measured for 5 mins by spectrophotometric assay,NULL,Plasma kallikrein (human),/gene/3818,10.1021/acs.jmedchem.5b01171,3.4.21.34,P03952
452532349,Unspecified,1265734,336889158,0,127039709,3818,9606,26575094,Literature-derived,20180904,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein using D-Pro-Phe-Arg-pNA-2HCl as substrate at 100 uM measured for 5 mins by spectrophotometric assay,NULL,Plasma kallikrein (human),/gene/3818,10.1021/acs.jmedchem.5b01171,3.4.21.34,P03952
452532354,Unspecified,1265734,336886670,0,127037807,3818,9606,26575094,Literature-derived,20180904,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein using D-Pro-Phe-Arg-pNA-2HCl as substrate at 100 uM measured for 5 mins by spectrophotometric assay,NULL,Plasma kallikrein (human),/gene/3818,10.1021/acs.jmedchem.5b01171,3.4.21.34,P03952
452532355,Unspecified,1265734,336886671,0,127037808,3818,9606,26575094,Literature-derived,20180904,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein using D-Pro-Phe-Arg-pNA-2HCl as substrate at 100 uM measured for 5 mins by spectrophotometric assay,NULL,Plasma kallikrein (human),/gene/3818,10.1021/acs.jmedchem.5b01171,3.4.21.34,P03952
452532356,Unspecified,1265734,336891452,0,127041472,3818,9606,26575094,Literature-derived,20180904,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein using D-Pro-Phe-Arg-pNA-2HCl as substrate at 100 uM measured for 5 mins by spectrophotometric assay,NULL,Plasma kallikrein (human),/gene/3818,10.1021/acs.jmedchem.5b01171,3.4.21.34,P03952
452532360,Unspecified,1265734,103176153,0,16157,3818,9606,26575094,Literature-derived,20180904,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein using D-Pro-Phe-Arg-pNA-2HCl as substrate at 100 uM measured for 5 mins by spectrophotometric assay,NULL,Plasma kallikrein (human),/gene/3818,10.1021/acs.jmedchem.5b01171,3.4.21.34,P03952
452533385,Unspecified,1265727,336891452,0,127041472,3818,9606,26575094,Confirmatory,20180904,0,0,P03952,IC50,100,ChEMBL,Inhibition of human plasma kallikrein using D-Pro-Phe-Arg-pNA-2HCl as substrate measured for 5 mins by spectrophotometric assay,NULL,Plasma kallikrein (human),/gene/3818,10.1021/acs.jmedchem.5b01171,3.4.21.34,P03952
452565195,Unspecified,1271914,336865593,0,59402226,3818,9606,26704266,Confirmatory,20180904,0,0,P03952,Ki,6,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2015.11.089,3.4.21.34,P03952
452565240,Unspecified,1271914,336865594,0,59402046,3818,9606,26704266,Confirmatory,20180904,0,0,P03952,Ki,6,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.bmcl.2015.11.089,3.4.21.34,P03952
452802047,Unspecified,1278388,336886734,0,127037856,3818,9606,26827162,Literature-derived,20180905,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein using S-2302 as substrate at 100 uM preincubated for 10 mins followed by substrate addition measured for 5 mins by microplate reader analysis,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.ejmech.2016.01.023,3.4.21.34,P03952
452802048,Unspecified,1278388,336886719,0,127037845,3818,9606,26827162,Literature-derived,20180905,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein using S-2302 as substrate at 100 uM preincubated for 10 mins followed by substrate addition measured for 5 mins by microplate reader analysis,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.ejmech.2016.01.023,3.4.21.34,P03952
452802056,Unspecified,1278388,336887635,0,127038554,3818,9606,26827162,Literature-derived,20180905,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein using S-2302 as substrate at 100 uM preincubated for 10 mins followed by substrate addition measured for 5 mins by microplate reader analysis,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.ejmech.2016.01.023,3.4.21.34,P03952
452802061,Unspecified,1278388,336893423,0,127042901,3818,9606,26827162,Literature-derived,20180905,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein using S-2302 as substrate at 100 uM preincubated for 10 mins followed by substrate addition measured for 5 mins by microplate reader analysis,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.ejmech.2016.01.023,3.4.21.34,P03952
452802068,Unspecified,1278388,336892573,0,127042284,3818,9606,26827162,Literature-derived,20180905,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein using S-2302 as substrate at 100 uM preincubated for 10 mins followed by substrate addition measured for 5 mins by microplate reader analysis,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.ejmech.2016.01.023,3.4.21.34,P03952
452802069,Unspecified,1278388,103620205,0,24860440,3818,9606,26827162,Literature-derived,20180905,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of human plasma kallikrein using S-2302 as substrate at 100 uM preincubated for 10 mins followed by substrate addition measured for 5 mins by microplate reader analysis,NULL,Plasma kallikrein (human),/gene/3818,10.1016/j.ejmech.2016.01.023,3.4.21.34,P03952
453209279,Unspecified,1322424,374359337,0,134157353,3818,9606,27749053,Literature-derived,20180907,0,0,P03952,NULL,NULL,ChEMBL,Inhibition of KLKB1 (unknown origin) at 100 uM relative to control,NULL,Plasma kallikrein (human),/gene/3818,10.1021/acs.jmedchem.6b01276,3.4.21.34,P03952
453232186,Unspecified,1325960,374353334,0,25001205,3818,9606,27994741,Confirmatory,20180907,0,0,P03952,Ki,1,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/acsmedchemlett.6b00282,3.4.21.34,P03952
453232187,Unspecified,1325960,374325777,0,24999867,3818,9606,27994741,Confirmatory,20180907,0,0,P03952,Ki,1,ChEMBL,Inhibition of human plasma kallikrein,NULL,Plasma kallikrein (human),/gene/3818,10.1021/acsmedchemlett.6b00282,3.4.21.34,P03952
453294770,Unspecified,1337085,374266458,0,134131498,3818,9606,28197309,Confirmatory,20180907,0,0,P03952,IC50,53.2,ChEMBL,Inhibition of human plasma kallikrein using D-Pro-Phe-Arg-pNA as substrate preincubated for 30 mins followed by substrate addition,NULL,Plasma kallikrein (human),/gene/3818,10.1021/acsmedchemlett.6b00384,3.4.21.34,P03952
453294803,Unspecified,1337085,374264249,0,134130030,3818,9606,28197309,Confirmatory,20180907,0,0,P03952,IC50,3000,ChEMBL,Inhibition of human plasma kallikrein using D-Pro-Phe-Arg-pNA as substrate preincubated for 30 mins followed by substrate addition,NULL,Plasma kallikrein (human),/gene/3818,10.1021/acsmedchemlett.6b00384,3.4.21.34,P03952
453776675,Unspecified,1343924,374344305,0,58081313,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,100,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776680,Unspecified,1343924,374361455,0,58081350,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,85.8,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776709,Unspecified,1343924,374317847,0,58081303,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,100,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776710,Unspecified,1343924,374359970,0,58081323,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,62.7,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776714,Unspecified,1343924,374306274,0,58081362,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,67.3,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776727,Unspecified,1343924,374274106,0,58081224,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,100,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453776735,Unspecified,1343924,374274676,0,66723765,3818,9606,,Confirmatory,20180908,0,0,P03952,IC50,52.1,ChEMBL,"In-vitro Plasma Kallikrein Inhibition: Enzymatic reactions were conducted in a inverted question mark inverted question markassay buffera inverted question mark inverted question mark, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05",NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811698,Unspecified,1344651,374274303,0,134133692,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,13.02,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
453811736,Unspecified,1344651,374332393,0,134149730,3818,9606,,Confirmatory,20180908,0,0,P03952,Ki,13.02,ChEMBL,In Vitro Assay: Plasma kallikrein determinations were made in 0.1 M sodium phosphate buffer at a pH of 7.5 containing 0.1-0.2 M sodium chloride and 0.5% PEG 8000. Determinations were made using purified human plasma kallikrein (Enzyme Research Laboratorie,NULL,Plasma kallikrein (human),/gene/3818,NULL,3.4.21.34,P03952
